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1 Summary 
Uropathogenic E. coli (UPEC) are the number one cause of urinary tract infections 
(UTIs) and are responsible for a remarkable pathogenesis. Once in the bladder motile 
pathogens adhere to the epithelial cells lining the bladder lumen, internalise into superficial 
cells where they shift into a sessile biofilm-like state capable of persisting for a long time. 
Functioning as a protected reservoir of bacteria these intracellular biofilm like structures are 
believed to be the source for recurring UTIs. This transition of motile and virulent 
uropathogens into sessile and quiescent intracellular bacterial communities (IBCs) requires 
the presence of a developmental program that coordinates the presence or absence of 
virulence traits at the right time and place. This work investigates several characteristics of 
the developmental program governing the lifestyle-switch in UPECs. Two representative 
output systems are used to investigate the importance of the bacterial second messenger c-
di-GMP and the carbon storage regulator (Csr) system during the transition of motile to 
sessile bacteria. These output systems are type I fimbriae, associated with acute infections, 
and the biofilm matrix component poly--1,6-N-acetyl-glucosamine (PGA). 
The first manuscript included in this thesis (chapter 5) shows that biofilm formation of 
UPECs and their responsiveness to c-di-GMP levels is comparable to what was established 
for the non-pathogenic E. coli strain MG1655. It is shown that derepression of the carbon 
storage regulator (Csr) system is a prerequisite for in vitro biofilm formation of cystitis and 
pyelonephritis isolates and that this biofilm formation solemnly depends on the 
exopolysaccharide PGA. Furthermore, this PGA dependent biofilm formation is shown to 
respond to the second messenger c-di-GMP, which in the model cystitis isolate UTI89 
predominantly gets synthesised by the dedicated cyclase YdeH. Similar to MG1655, 
translation inhibitors are shown to mediate a reduction of the bacterial alarmone ppGpp, 
which then results in enhanced PGA dependent attachment. This project is rounded up by a 
murine cystitis model, which addresses the in vivo involvement of PGA dependent biofilm 
formation over the period of three weeks. 
The second manuscript of this thesis (chapter 6) shows that type I fimbriae have a 
negative effect on PGA dependent attachment. Furthermore, it reveals a regulatory cross talk 
between type I fimbriae and the exopolysaccharide PGA. Genetic approaches are used to 
show that this regulatory cross talk is mediated by the Csr system: it allows the expression of 
type I fimbriae if repressed and stimulates PGA dependent biofilm formation upon 
derepression. Moreover, this work introduces a model in which a derepressed Csr system 
negatively affects the phase variable expression of type I fimbriae by interfering with the 
activity of the FimE, but not the FimB recombinase. Furthermore, it is shown that CsrD of the 
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Csr system fine-tunes the expression of type I fimbriae during growth of a population over 
time.  
Chapter 7 was published in 2010 and introduces a standardised assay used to quantify 
type I fimbriae mediated aggregation of cells via their mannosylated surface-exposed 
receptors. The measured aggregation depends on FimH, which is found as tip adhesin on 
type I fimbriae and is proven essential in mediating mannose binding and initial 
establishment of cystitis. This method is then used to investigate the therapeutic potential of 
substances that interfere with FimH mediated adhesion of UPECs to highly mannosylated 
protein-receptors on eukaryotic cells. Tested substances are classified as α-D-
Mannopyranosides and are shown to be potent FimH antagonists as determined by 
measuring their effect on the disaggregation of UPECs from mannose moieties on Candida 
albincans cells and guinea pig erythrocytes (GPE). 
Finally the appendix in chapter 8 contains supplemental figures and additional data 
used to refine the model established in chapter 6. These results show that not only the Csr 
system has inversed effects on type I fimbriae and PGA expression but that ppGpp and 
presumably c-di-GMP also inversely affect the two output systems. In the end it is concluded 
that a regulatory network ensures expression of type I fimbriae during the planktonic lifestyle 
and switches to PGA expression upon i) derepression of the Csr system, ii) elevation of c-di-
GMP levels and iii) reduction of ppGpp levels. Last but not least the impact of this model with 
respect to the disease progression during UTI is briefly addressed. 
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3 General Introduction 
3.1 Two distinct bacterial lifestyles 
Evolution over several billion years allowed bacteria to adapt and colonise almost every 
habitat on this planet. For a long time bacteria were believed to live as primitive loners or 
planktonic cells deprived of any interaction with their relatives. Advances in microbiological 
techniques over the past 60 years led scientists realize that bacterial lifestyles are far more 
complex than initially described, as extensive microbial density on surfaces was revealed. By 
know it is well established that surface associated bacteria are generally enclosed in a 
protective, self-produced matrix composed of hydrated polymers that encase and immobilize 
the microbial aggregates, allowing growth as three-dimensional structures, generally referred 
to as biofilms. The oldest biofilms identified so far were found in fossils and date back to over 
3.2 billion years (1). Intriguingly, the discovery of bacteria by Antonie van Leeuwenhook in 
1676 was made from a sample most likely consisting of biofilm-derived bacteria, as the 
sample was scraped from dental plaques, a typical dental biofilm structure. Research over 
the last decade suggests that the prevalence of sessile lifestyles dominates over the 
planktonic lifestyle initially described for bacteria. By now biofilms have been identified in the 
entire bacterial kingdom and in virtually all niches: from space stations to deep-sea vents, 
from hot springs to arctic cold springs, from fossils to modern industrial plants but also in 
form of benign or pathogenic biofilms within hosts or on foreign body implants. A model 
organism often used to study biofilms is Escherichia coli (E. coli). 
 
3.2 Escherichia coli: A model organism with commensal or pathogenic traits 
E. coli are facultative anaerobic bacteria, which occur in the environment as 
commensals in the gastrointestinal tract or as pathogens that cause many different types of 
infections. They are generally classified into three different groups, commensal E. coli, 
intestinal pathogenic E. coli and extraintestinal pathogenic E. coli (ExPEC), which can all 
prevail in sessile lifestyles (2, 3). While commensal E. coli are generally benign, intestinal 
pathogenic E. coli (classified into EPEC, EHEC, ETEC, EAEC, EIEC and DAEC) might 
cause different enteric / diarrhoeal diseases within the lower digestive tract (2). Other than 
their intestinal relatives, ExPECs are capable to disseminate and colonize niches outside the 
gut. However, they retain their ability to survive within the gut (3). ExPEC strains, which 
colonize and infect the urinary tract, have further been classified as uropathogenic E. coli 
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(UPEC). This class of pathogens has been difficult to profile as it is not associated with the 
expression of specific traits or virulence factors (3-5). Based on the anatomical location of the 
niche colonised within the urinary tract, UPECs can further be subdivided into a variety of 
pathotypes including colonisation of the bladder (cystitis), colonisation of kidneys 
(pyelonephritis), asymptomatic bacteriuria (ABU; bacteriuria = bacteria in the urine) or 
catheter associated infections. Pyelonephritis pathotypes are often very similar to the 
pathotype of cystitis (see chapter 3.3). The majority of these strains initiate colonisation of 
the upper urinary tract and kidneys through the bladder, just like the cystitis isolates, which 
do not ascent into the kidneys. The most common model isolate for cystitis is UTI89 (6, 7). 
Isolates 536 and CFT073 are well-studied pyelonephritis isolates (8, 9). These three strains 
have all been sequenced and are used as laboratory strains since several years. The strain 
clin591 was isolated from a cystitis patient with a urethral stent and is used for comparison 
with the other cystitis isolates. In this work, clin591 represents the catheter-associated 
isolates, since no other catheter-associated isolate has yet been sequenced. Another class 
of E. coli strain has been shown to cause asymptomatic bacteriuria (ABU). ABU strains are 
closely related to pathogenic / symptomatic isolates but they prevail asymptomatically in the 
bladder for a long time and do not cause symptoms in carriers. The prototypic ABU isolate 
(83972) does not adhere to any cell types and it does not disseminate to kidneys or blood 
stream but can still persist in the bladder (10, 11). Furthermore, ABU strains do not trigger 
any host response while the causative agents of symptomatic urinary tract infections (UTIs) 
do so (12). The absence of immune response might be related to impaired bacterial motility 
and deprivation of extracellular structures including flagella, capsule and the O- respectively, 
K-surface antigens (12-14). 83972 is well adapted for growth in the urinary (10, 15) and has 
been used in extenso to deliberately establish protective ABU in patients suffering from 
severe chronic UTIs. Interestingly, investigations of 83972 re-isolates, show that the selective 
pressure within the patients bladder results in rapid and divergent evolution, as visualised for 
one of the 83972 re-isolate named PIII-4 (16, 17).  
 
3.3 Urinary tract infections 
The urinary tract offers several distinct niches, which are used by pathogens for 
colonisation and long-term persistence. UPECs are by far the most prevailing agents of UTIs 
accounting for up to 90 % of the cases (18). Different Gram-positive and Gram-negative 
bacteria, as well as different fungi cause the remaining 10 % (19, 20). The majority of 
microorganisms colonising the urinary tract originate from the rectal flora. After temporarily 
residing in the periurethra and vagina (21, 22) the pathogens ascend through the urethra into 
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the bladder lumen where they might colonise the urinary tract and cause UTIs. In the year 
2000, 14 million medical visits were associated with uncomplicated UTIs resulting in financial 
burdon of over 4 billion dollars (23). These uncomplicated cases of UTIs usually affect 
healthy female outpatients. However, sexual activity has been shown to be a predisposition 
for uncomplicated UTIs and might be responsible for some of these cases (24, 25). Other 
known predispositions for UTI besides structural and urodynamical abnormalities include 
pregnancy (26), diabetes (27), bladder cathetherisation (28) and urethral stents (DJ catheter) 
(29), prostate enlargement (23) or HIV infections (30). Currently it is estimated that 50 % of 
all women will suffer from a UTI at some point during their life and 25 % will suffer from a 
second UTI. Importantly, 3 % of all women are reported to suffer a third recurring UTI within 
six months following treatment of the preceding UTI (18). It was shown that the majority of 
recurring UTI cases arise from the same clonal strain as the initial UTI (18, 31, 32) and do 
not require re-migration of the clonal pathogen from the anus through the urethra into the 
bladder (33). Though generally caused by the same group of pathogenic E. coli the 
pathologies of UTIs might vary greatly i) in their precise location within the urinary tract, ii) the 
severity of the infection, iii) the treatment efficacy, iv) the bacterial burden or v) the arsenal of 
virulence factors used by the pathogens to cause disease. Uncomplicated cystitis can be 
treated effectively by antibiotic therapy in most of the cases, especially at the early onset of 
symptoms. Treatment becomes less effective or impossible once UPECs have effectively 
colonised the bladder, as this step involves intracellular bacteria, which might already be in a 
latent irresponsive state until the onset of recurring UTI (see chapter 3.3.2). In other cases, 
acute UTI turn into severe infections upon bacterial infiltration of the kidneys (pyelonephritis) 
though the ureter and possible dissemination of the pathogen into the bloodstream causing 
severe bacteraemia or sepsis.  
 
3.3.1 The pathogenesis of acute cystitis 
The ability of uropathogens to progress through the urethra into the bladder lumen is a 
prerequisite for successful colonisation of a healthy urinary tract, a process which is not fully 
understood. However, flagellar motility has been reported to facilitate ascension into the 
bladder and progression throughout the urinary tract (34, 35). Once in the bladder, it is 
important for the pathogen to circumvent washout upon bladder voidance. This is generally 
achieved through rapid adherence of the pathogen to the epithelial cells lining the bladder 
lumen (urothelium). At this stage of the infection, the titres of bacteria and leukocytes in the 
urine (pyuria) begin to be elevated, which is generally associated with an elevated urgency 
and frequency of painful urination (dysuria). During adhesion, the bladder epithelium 
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recognizes microbial structures like LPS, which trigger TLR4 signalling (36, 37) and 
production of IL-8 (38-40). The release of IL-8 induces the infiltration of neutrophils and 
dendritic cells to the site of infection. Neutrophils begin to phagocytose and kill UPECs by 
reactive oxygen species (ROS), nitric oxide NO or antimicrobial peptides, while dendritic 
cells phagocytose bacteria and present antigens to activate adaptive immune cells. 
Furthermore, the cell mediated host defence is supported by changes in urine composition 
(pH, osmolarity) and its increased flow (41). To prevent washing out, UPEC strains adhere 
through type I fimbriae, one of the best-characterised virulence factors in UPECs (see 
chapter 3.7) (42-44).  
 
3.3.2 The formation of intracellular bacterial reservoirs during UTIs 
Type I fimbriae are proteinacious adhesins that bind to mannosylated receptor proteins 
such as uroplakin 1a and the integrins β1 and α3 (45, 46), which are expressed on the apical 
surface of epithelial cells. This initial contact induces engulfment of UPECs into urothelial 
cells where they are protected from host response. In the cytoplasm of superficial cells lining 
the urothelium the pathogen can rapidly multiply and accumulate. Shifting into a sessile 
biofilm-like state, it can reside silently for a long time and serve as a reservoir for recurrent 
UTIs (47, 48).  
Figure 1: Schematic 
representation of the 
intracellular cycle of 
UPECs 
The first round of UPEC 
infection occurs in superficial 
bladder epithelial cells once 
bacteria attached to the 
intact epithelium. Upon 
invasion, a few UPECs gain 
access to the cytoplasm and 
its nutrients, the majority of 
bacteria get expelled again 
via vesicles (indicated by 
black arrows). Once in the 
cytoplasm, the acute phase 
of infection is initiated by fast 
growth (early). Latter is 
followed by the formation of 
Intracellular Bacterial Communities (IBC) (middle) and a subsequent aging process (late), in which some bacteria 
dissociate form the IBC regain motility and in the end result in the exfoliation of singe cells, bacterial filaments or 
entire IBCs from the superficial bladder cells. Exfoliation damages the intact urothelium and gives access to 
underlying urothelial cell layers, which can again be infected for bacterial reservoir formation. This image was 
taken from Hunstad DA and Justice SS 2010 (49). 
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* * * 
The formation of intracellular bacterial reservoirs occurs stepwise (Figure 1) (49). The 
internalisation of UPECs into urothelial cells is a passive process that is not triggered by the 
adhered bacterium but rather a consequence of vesicle transport to and from the membrane. 
However, bacterial binding to integrins (45, 46) results in localised actin rearrangements and 
membrane extensions around the bacterium, which finally leads to engulfment of the 
bacterium by the membrane and internalisation (50, 51). However, only a small number of 
bacteria is capable of persisting intracellularly, as the majority of the bacteria get expulsed 
again via exocytosis. Those bacteria that persist within epithelial cells gain access to the 
nutrient rich cytoplasm where they can grow exponentially and form amorphous, loose and 
unorganised bacterial clusters. The cytoplasmic environment causes reduced growth rates, a 
morphological shift toward coccoid structures and a reorganisation of the bacterial clusters 
into a tight highly organised bacterial clump. This new state of bacteria features several 
properties associated with classical biofilms (48) and is usually referred to as intracellular 
bacterial community (IBC). Among others, the autotransporter adhesive antigen 43 as well 
as type I fimbriae were shown to be expressed at this stage of pathogenesis (52). Upon slow 
growth of IBCs, the bacterial mass reaches the cell membrane of the epithelial cell and 
causes a pod like protrusion into the bladder lumen (52). The next maturation step of IBCs 
leads to the disassociation and regain of motility of some UPECs located at the edge of the 
IBC, a typical characteristic of mature biofilms. The trigger for this maturation step is believed 
to involve nutrient limitation, stress due to heavy bacterial burden and bacterial fluxing, or cell 
lysis. As a consequence, bacteria exit infected cells individually or by forming bacterial 
filaments, which consist of replicated bacteria that have not completed septation. 
Interestingly these filaments can also flux out of infected cells and it was shown that they 
cannot be attacked by polymorphonuclear leucocytes (PMNs) (48, 53). Loss of membrane 
integrity upon bacterial fluxing and bursting of cells thereafter is believed to release chunks 
or entire IBCs into the bladder lumen. Consequently these bacteria might disseminate 
through the urine to find a new niche or might re-initiate another round of intracellular IBCs 
(49). Interestingly, the second round of internalisation by UPECs appears to be slightly 
different from the first round described above. First of all, the second cycle appears to be 
slower and result in the infection of differentiated and undifferentiated urothelial cells, which 
have been exposed due to disruption of the superficial cell layer. Furthermore, instead of 
progressing through the IBC cycle described above, bacteria infecting these cells grow very 
slowly, localize to the late endosomal vesicles instead of the cytoplasm where they remain as 
quiescent intracellular reservoir (QIR) (6, 48, 54-56). The quiescent state of these bacteria 
does not interfere with the differentiation process of the epithelial cells and thus QIRs are 
maintained within infected cells until they have fully differentiated into superficial facet cells 
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(54). Localised in the superficial cell layer, the QIRs of UPECs are capable of re-emerging 
into the bladder and cause a recurrent UTI even after a long period without symptoms and 
the absence of bacteria in the urine. The pathogenesis described above indicates that acute 
episodes of cystitis might be associated to IBC formation while bacteria that 
asymptomatically dwell within epithelial cell layers reside QIRs. However, it was not yet 
possible to fully proof such a hypothesis, and elucidate the processes and conditions, which 
result in IBC and QIR formation, respectively (6, 47-49, 54-57). Indeed, the establishment of 
IBCs and even QIR has been reported for several UPECs isolates as well as K. pneumonia 
(58, 59), which indicates that this pathogenesis is not strain specific but rather a common 
process used by uropathogens. Although the pathogenesis behind IBC and QIR formation 
have only been studied in murine infection models, IBCs and filamentous UPECs have also 
been detected in exfoliated cells from the urine of human cystitis patients (60). Thus it is 
likely that IBCs and the underlying pathogenesis remains coserved among different UTO 
susceptible hosts.  
 
3.4 Temporal processes involved in the formation of biofilms 
Initiation and development of biofilms are conserved among most bacteria that form 
biofilms and apply to pathogenic as well as non-pathogenic bacteria. It involves transition 
through distinct stages of multicellular organisation accompanied by the expression of a 
coordinated set of genes (Figure 2). The initial stage is represented by planktonic bacteria, 
which are capable to move within their surrounding environment. This movement can be 
active e.g. through flagella or type IV pili, passive through Brownian motion or gravitational 
forces. Under certain circumstances and environmental signals such as nutrient availability, 
pH, temperature, ionic force of the medium surrounding the planktonic bacteria, or the nature 
of the surface, bacteria reversibly attach and induce gene expression of factors that stimulate 
biofilms formation (61-63). On abiotic surfaces such as polyvinylchloride (PVC) this weak 
initial interaction is non-specific and often involves a motility apparatus such as flagella or 
type IV pili (64). Non-motile bacteria lacking flagella or type IV pili might use other factors for 
initial contact with a surface, for example curli fimbriae (65) or conjugative plasmids (66), 
which can replace the force generating movements of flagella (67). The switch between 
reversible and irreversible surface attachment of bacteria occurs through the expression of 
adhesive proteinacious organelles of the fimbrial family, which strengthen the bacteria-to-
surface interactions. Examples include curli fimbriae, conjugative pili or type I fimbriae, 
structures that have all been determined as virulence factors in different pathogenic E. coli 
strains but also aid in bacterial attachment to surfaces or host cells. (42, 64, 66-72). (Type I 
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fimbriae and their relevance as a virulence factors will be explained in detail in chapter 3.7). 
Upon cell division of irreversibly attached bacteria or translocation of cells across surfaces, 
inter-bacterial adhesions and three-dimensional growth of the microcolony into a mature 
biofilm occurs (67, 73).  
Figure 2: The formation of Biofilms 
The formation of biofilms is a temporal process, which can be subdivided into eight steps. The first step involves 
initial contact and interaction of bacteria with a surface (1). Growth of bacteria on the surface results in the 
formation of microcolonies (2), which are characterised by bacteria-surface interactions (e.g. via type I fimbriae). 
The production of EPS including PGA results in bacterium-bacterium interactions and the formation of three-
dimensional structures (3). Maturation of this structure guaranties among others a hydrated environment with 
channels responsible for fluid and nutrient influx and waste product disposal (4). Finally, the biofilm and its 
bacterial community start to age (5) and bacteria at the periphery regain their motility and dissociate from the 
biofilm (6) re-entering their planktonic lifestyle (7). The cycle of biofilm formation is terminated once planktonic 
bacteria start to interact with surfaces again (8). Image was taken from 
cronodon.com/BioTech/Bacterial_Society.html 
* * * 
This three-dimensional structure is supported, and strengthened through the production 
of a matrix that embeds the bacteria and functions as protective scaffold between the cells. 
The “extracellular polymeric substances” (EPS) make up for 50 % to 90 % of the organic 
carbon within a biofilm (63). The nature of the polymers composing the EPS exhibit great 
variability, with a multitude of different chemical and physical properties (74), they are 
composed of different biopolymers, adhesive proteins, lipids, phospholipids, dead cells, or 
extracellular DNA, and can be quite heterogeneous, featuring adjustable physiochemical 
environments for bacteria (75). A biofilm’s EPS is highly hydrated, prevents desiccation and 
retains nutrients or metabolites (67, 75). Nutrient uptake and waste disposal is usually 
reassured in a mature biofilm matrix through the presence of channels, which infuse fluid 
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from the surrounding through the biofilm (76). Moreover, the EPS scaffold protects bacteria 
from the host defence by preventing the recognition of biofilm-enclosed bacteria and 
impeding bacterial accessibility (9, 77). In the scaffold of the biofilm matrix, bacteria have 
intense inter-bacterial interactions, cell-to-cell communication, facilitated horizontal gene 
transfer, protection against toxins, biocides and antimicrobial chemicals and long term 
persistence of a bacterial population. Numerous reports also document the importance of the 
bacterial second messenger c-di-GMP during the formation of biofilms (see chapter 3.6) (78-
84). In many species including E. coli, and Pseudomonas (85-90) elevated levels of c-di-
GMP result in an increased synthesis of EPS components, primarily proteinacious adhesins 
and exopolysaccharides (63, 67, 73, 75, 91, 92). Proteinacious adhesins are often involved 
in the irreversible attachment of bacteria to surfaces and host cells, and are expressed 
earlier than exopolysaccharides. In E. coli, the very heterogeneous family of proteinacious 
adhesins comprises several surface associated autotransporters like antigen 43, proteases, 
and a plethora of different fimbriae (67, 93-99). E. coli biofilms usually start to mature upon 
synthesis and secretion of several exopolysaccharides, including colanic acid (100, 101), 
cellulose (102), and poly β-1,6-N-acetyl-D-glucosamine polymers (poly-GlcNAc or PGA) 
(103, 104), the ladder of which is extensively explained in chapter 3.4.1. Importantly, this 
large arsenal of proteinacious adhesins and exopolysacchaides in pathogenic and non-
pathogenic bacteria offers the possibility to adapt the matrix of a biofilm according to its 
environmental conditions. Furthermore, lack of one specific factor can be compensated by 
other factors, at least in vitro. Such different matrix compositions under altered conditions 
however, require a tight and interlinked regulatory network whose investigations have only 
started recently (9, 105-109).  
Finally, the last maturations steps of the biofilm life-cycle coincide with an aging 
phenomenon, in which some bacteria undergo age related cell death and lysis (110). Also, 
this late stage is usually associated with bacterial dissociation from the biofilm matrix. 
Passive dispersal results from sloughing of cells and erosion from the biofilm. Active 
dispersal occurs through the highly regulated process within a few differentiated bacteria of 
the biofilm that regain their motility and disseminate into the environment. These planktonic 
cells finally finish the life-cycle of a biofilm. One faith of these so called dispersal cells is to 
recolonize a new surface or a new host and re-initiate the life-cycle of biofilms (110-113).  
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3.4.1 The exopolysaccharide β-1,6-N-acetylglucosamine is synthesised by PgaABCD 
Some environmental conditions, including carbon limitation might push bacteria to 
adapt their metabolism into glycogen synthesis. Glycogen synthesis and turnover was shown 
to be needed for optimal biofilm formation upon transition into stationary phase (114, 115). In 
E. coli, the biofilm induced mainly upon carbon limitation depends on β-1,6-N-
acetylglucosamine (PGA). PGA promotes intracellular adhesion as well as attachment to 
surfaces in mature biofilms (116). It is synthesised by the PgaABCD machinery and consists 
of β-1,6 linked GlcNAc aminosugars (Figure 3) (103, 117). The PGA machinery of E. coli 
consists of four proteins encoded by pgaA-D, which are transcribed as a poly-cystronic 
pgaABCD mRNA. The heterotetrameric machinery resides in the cell envelope where it uses 
UDP-GlcNAc as a precursor for the coordinated biosynthesis, partial deacetylation and 
export of PGA-polymers through the cell wall (Figure 3). Synthesis of PGA fully depends on 
PgaC and PgaD where PgaC functions as a glycosyltransferase in the inner membrane and 
executes the catalysis of PGA polymerisation from the UDP-GlcNAc precursor. The small 
inner membrane bound PgaD was shown to be essential for PGA biosynthesis although its 
precise role was not yet determined (103, 118, 119). PgaB is involved in partial N-
deacetlylation of PGA and is required for proper export of the polymer through the PgaA 
porin, which spans the periplasm and the outer membrane of E. coli (119).  
 
Figure 3: Synthesis of poly β-1,6-N-acetylglucosamine in E. coli 
Poly β-1,6-N-acetylglucosamine (PGA) is a sugar polymer of E. coli. A) PGA synthesised by a membrane 
spanning machinery encoded by pgaABCD. The large PgaA protein forms a pore, which is essential for the 
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synthesis and spans the periplasm and the outer membrane. The lipoprotein PgaB is required for partial N-
deacetlylation of PGA and is also essential for export of the polymer through the PgaA porin. Together with the 
unknown function of PgaD, the glycosyltransferase (PgaC) executes the catalysis of PGA polymerisation from the 
UDP-GlcNAc precursor in the inner membrane. B) Electron microscopy pictures of PGA knobs found on the 
bacterial surface. Adapted from T. Romeo 
Once synthesised and exported, PGA serves as an adhesin that stabilizes biofilms 
(103, 120) and forms knobs on the surface of bacteria (Figure 3B). Similar to its role as an 
adhesin in pathogenic Gram positive bacteria (104, 121-123), PGA was recently shown to be 
encoded and expressed in pathogenic E. coli strains isolated from the blood or the urinary 
tract (124). After intra-peritoneal injection of lethal doses of pathogenic E. coli strains, mice 
were protected by administration of antibodies raised against staphylococcal PGA (124). 
Thus, it appears that PGA is expressed by different pathogenic E. coli strains during infection 
and might serve as an important pathogenic trait during E. coli pathogenesis. 
 
3.4.2 The regulation of PGA synthesis 
The expression of E. coli pgaA-D is mainly controlled on transcriptional and 
translational level. Transcription of pgaA-D depends on its sole transcriptional regulator 
NhaR, which recognizes and binds to the single promoter of pgaA-D. NhaR is a DNA binding 
protein that belongs to the family of LysR type transcriptional regulators (LTTRs). LTTRs 
respond to elevated concentrations of sodium (125) and alkaline pH (126) by changing the 
conformation of the LTTR-DNA complex. NhaR was shown to be a virulence factor during 
UTIs caused by Proteus mirabilis (127) and has been suggested to promote survival of E. 
coli (126). On translational level, the expression of pgaA-D is controlled by CsrA, which binds 
the 5’ leader sequence of pgaA-D and nhaR mRNA and inhibits the initiation of translation 
(117, 128). 
 
3.5 The Carbon Storage Regulator (Csr) system  
3.5.1 The carbon storage regulator system and its central role in bacterial physiology 
The existence of global regulators, which function as a switch between different 
lifestyles greatly facilitate bacterial adaptation to altered conditions, especially since global 
regulators often inversely regulate antagonistic pathways. One of these global regulators is 
the Carbon Storage Regulator A (CsrA), the central component of the Csr system. This 61 
amino acid homodimeric protein was first identified in 1993 in a transposon mutagenesis 
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screen where the hit in csrA resulted in glycogen accumulation compared to the E. coli wild 
type (129). Further analysis showed that CsrA has an important regulatory role during carbon 
metabolism in general. It inhibits the storage of energy through gluconeogenesis and 
glycogenesis while stimulating glycolysis (130-132). Almost ten years after its initial discovery 
CsrA has been shown to regulate many other unrelated processes including biofilm formation 
(117, 133, 134), motility (135, 136), secondary metabolite production (136), environmental 
stress resistance (135, 137), cytotoxic factor production (134, 137), interaction with animal 
and plant hosts (134, 137, 138), quorum sensing (139), or oxidative stress (140). The 
regulatory influence by the Csr system is enabled by a unique mechanism, in which the RNA 
binding protein (CsrA) modifies the stability and/or translation of mRNAs and hence imposes 
a post-trancriptional level of control (115, 132, 141). In many cases CsrA prevents translation 
of mRNAs by binding to the 5’ leader of the trancript near the Shine-Dalgarno sequence and 
thus disables ribosomes from initiating translation. Lack of translation upon binding of CsrA 
often activates transcript degradation by endonuclease attack. The best characterised mRNA 
targets of CsrA are: i) the glgCAP encoding glycogen biosynthetic proteins (132), ii) the 
transcriptional regulator nhaR (128), or iii) pgaA-D (117) (see chapter 3.4.1 and 3.4.2). The 
mRNA of pgaA-D contains six distinct CsrA binding sites, one of which overlaps with the start 
codon of pgaA. Four of the remaining CsrA binding sites lie in the untranslated leader 
sequence of the mRNA and the last one overlaps the Shine-Dalgarno sequence, thus 
competing with the 30S subunit of the ribosome (117). Bound CsrA destabilizes the transcript 
of pgaA-D mRNA, and enhances its decay, which impedes PGA dependent biofilm 
formation. Besides inhibition of mRNAs, CsrA stabilizes some mRNAs and activates their 
gene expression by protecting the transcript’s degradation. A prominent examples of mRNA 
stabilisation by CsrA is the master transcriptional regulator of flagellum biosynthesis flhDC 
(142). 
The translation of many transcripts depends on the cellular concentrations of CsrA, 
which requires a tight and reactive regulation thereof, especially since modulation of CsrA 
levels often result in physiological adaptations. An example would be the transition from 
planktonic to sessile bacteria, in which CsrA can be seen as a checkpoint affecting signalling 
cascades that contribute to biofilm formation (Figure 4). Optimal biofilm formation requires 
glycogen synthesis and glycogen turnover but also synthesis of PGA, all of which are 
repressed by CsrA (103, 114, 143). Furthermore, CsrA inhibits glgCAP expression, which is 
necessary for carbon flux into glycogen and subsequent conversion of glycogen into glucose-
1-phosphate (a possible precursor of PGA), hence indirectly repressing PGA synthesis. With 
respect to such dramatic and often irreversible effects, the input(s), which govern the active 
levels of CsrA, have to be tightly controlled and contain several feedback loops that stabilize 
the system.  
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Figure 4: Schematic representation of the Csr System  
Regulation by Csr is limited to genes, which are involved in the transition of from planktonic to sessile bacteria. 
Positive effects are indicated with regular arrows, negative effects are indicated as (τ). The BarA/UvrY two 
component system (TCS) gets activated by different signals including formate, acetate, weak acids or Krebs cycle 
intermediates and upon activation positively regulates the small noncoding RNAs csrB and csrC. The RNAs csrB 
and csrC negatively control the activity of CsrA through sequestering the protein. Feedback control of the Csr 
system is ensured by CsrD, which targets csrB and csrC for RNase E mediated degradation and by a positive 
effect of CsrA on the BarA/UvrY TCS. CsrA binds to the 5’ untranslated region of mRNAs, which can either result 
in mRNA stabilisation (e.g. flhDC) or interfere with translation initiation and enhanced destabilisation (e.g. pgaA-D; 
ydeH; ycdT; nhaR; glgCAP; csrD; relA and spot). Several c-di-GMP metabolising enzymes are tightly linked to the 
status of the Csr system (e.g. YdeH and YcdT). A repressed Csr system results in high CsrA levels, which is 
associated witch planktonic bacteria and favours the expression of the PDEs YhjH and the c-di-GMP receptor 
protein YcgR. YhjH and YcgR together regulate flagellation of bacteria. De-repression of Csr system, e.g. upon 
entry into stationary phase results in low activity of CsrA, which again results in the expression of the DGCs YcdT 
and YdeH and thus elevated level of c-di-GMP. Elevated levels of c-di-GMP are associated with sessile bacteria 
and the formation of bacteria.  
* * * 
3.5.2 Post-translational regulation of CsrA levels  
The level of active CsrA is controlled post-translationally by two small non-coding 
RNAs (snRNA) called csrB and csrC (Figure 4). These two snRNA sequester CsrA through 
their multiple CsrA binding sites (139, 144-146) with the consensus sequence 5’-
RUACARGGAUGU-3’ (R = purin). The GGA motif of this sequence mostly localises in the 
loops of predicted hairpins in csrB and csrC where it increases the affinity of the cooperative 
CsrA-RNA interaction (139, 147). Interestingly the snRNAs known to sequester CsrA vary 
greatly in sequence and also in their number of CsrA binding sites. The 366 nucleotide long 
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csrB comprises 22 potential CsrA binding sites and was shown to sequester up to 9 CsrA 
dimers (145). The shorter csrC (245-nucleotides) only has 13 potential CsrA binding sites 
(144). Up to this point, the importance of the redundancy of csrB and csrC in E. coli remains 
unclear although it is believed that these two snRNAs might partially respond to different 
inputs. Similar to the distribution of CsrA in the bacterial kingdom, functional homologs of 
csrB and csrC can be found in many different species.  
It has been shown that csrB and csrC have a short half-life of ~ 1.5 – 4 minutes, thus 
enhanced turnover of csrB and csrC further contributes to the effectiveness and 
responsiveness of the Csr system. The turnover is mediated through degradation by RNAse 
E and is enhance by CsrD in an unknown mechanism (148). CsrD is a membrane bound 
protein with two domains usually associated to the synthesis (GGDEF-motif) and degradation 
(EAL-motif) of the bacterial second messenger c-di-GMP (see chapter 3.6). While both motifs 
have degenerate key residues in their GGDEF and EAL motifs and therefore do not influence 
the levels of the second messenger, the EAL motif was shown to be necessary for 
degradation of csrB and csrC by RNAse E (148).  
Several direct or indirect negative feedback loops within the Csr system exist, which 
promote homeostasis of CsrA levels under constant environmental conditions and allow 
quick adaptation of CsrA levels upon environmental alterations (Figure 4). One of these 
feedback loops affects csrD expression of E. coli (yhdA) and S. typhimurium (STM3375), and 
is imposed by the negative effects of CsrA on csrD translation (149, 150). The second known 
feedback loop is more indirect and involves the two-component system (TCS) BarA/UvrY, 
which is wide spread in the bacterial kingdom (151). In E. coli BarA is the sensor kinase of 
the TCS while UvrY is its cognate response regulator (146). Activation of this TCS was 
shown to cause elevated levels of the snRNAs csrB and csrC during the transition into 
stationary phase (144, 152) and hence results in an increased sequestration of CsrA. One of 
the components capable of activating the BarA/UvrY phosphorylation relay is CsrA itself. 
Until this TCS gets activated by an alternative signal, CsrA indirectly controls its own activity 
by stimulating csrB and csrC expression. Besides CsrA, the BarA/UvrY TCS has been shown 
be triggered in a pH dependent manner (153), an imbalance in Krebs cycle intermediates 
(154), or weak acids including formate or acetate (155). Interestingly, asymptomatic E. coli 
strains used for treatment of severe UTIs were shown to have elevated levels of csrB and 
csrC, if grown in urine or re-isolated from patients (156, 157). However, it is not known 
whether the elevated levels of the small RNAs is due to intrinsically activated BarA/UvrY TCS 
in asymptomatic UPECs once in the urinary tract. Recently it was shown that two 
components of the stringent response (DksA and ppGpp; see chapter 3.6.4) interacted with 
the Csr system on various levels. They activated the transcription of csrB and csrC 
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suggesting that the CsrA mediated regulation is relieved during the stringent response (158). 
However, CsrA also represses the translation of the ppGpp synthase gene relA, indicating 
that the Csr system might fine-tune the stringent response according to the environment 
(158).  
 
3.6 Bacterial second messengers modulate E. coli lifestyles 
Bacteria asses and register environmental signals and translate them into appropriate 
output system. Depending on environmental conditions, bacteria have to decide whether the 
conditions are favourable enough to persist within the colonised niche or whether movement 
into a new environment might enhance their fitness and survival. This vital switch between 
sessility and motility is often irrevocable and thus requires tight and robust control 
mechanisms (159). An important part in the molecular control mechanisms residing over 
sessility and motility can be assigned to the bacterial second messenger bis-(3′-5′)-cyclic 
dimeric GMP, which is present in the vast majority of eubacteria (160). C-di-GMP translates 
environmental signals into appropriate output systems, e.g. motility via flagellar rotation or 
EPS production for bacterial adhesion (67, 161-165). 
 
Figure 5: The principles of c-di-GMP signalling 
C-di-GMP is synthesised from two molecules GTP in the active site of GGDEF domains, which are part of 
diguanylate cyclases (DGC). Elevated levels of c-di-GMP result in a non-competitive inhibition of DGC, as 
indicated by with the (τ) symbol. Degradation of c-di-GMP requires the activity of specific phosphodiesterases 
(PDE). Two types of PDEs exist, which contain unrelated domains: EAL containing proteins degrade c-di-GMP 
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into a linear intermediate (pGpG) that is then further processed non-specifically into two molecules of GMP. 
Alternatively, HD-GYP domains degrade c-di-GMP into two GMP molecules in one step. The intracellular 
concentration of c-di-GMP is detected by c-di-GMP receptors, which then signal to different output systems. High 
concentrations of c-di-GMP are generally associated with sessile bacteria while low levels of c-di-GMP are 
associated with planktonic bacteria. Illustration was adapted from Tamayo et al., 2007 (164). 
3.6.1 The bacterial second messenger c-di-GMP 
C-di-GMP was first discovered in 1987 by Benziman and his co-workers in 
Gluconacetobacter xylinus where it allosterically activated the synthesis of cellulose (166). 
Biochemical analysis and reverse genetics identified two classes of multi-domain enzymes 
involved in synthesis and degradation of c-di-GMP (167). diguanylate cyclases (DGCs) 
contain the GGDEF domain while phosphodiesterases (PDEs) contain EAL domains (Figure 
5). The enzymatic activity of DGCs requires the GG(D/E)EF motif, which defines the active 
site of the protein (A-site) (98, 168-180). Only upon dimerization of two DGCs the A-site, 
which is located at the dimer interface, becomes complete and active and synthesizes c-di-
GMP. In the process of synthesising c-di-GMP each GG(D/E)EF motif binds and contributes 
one GTP and any alterations of the A-site abrogates c-di-GMP synthesis (170-173, 181). 
Most DGCs are subject to an allosteric product inhibition, imposed through binding of c-di-
GMP with high affinity to the proteins inhibitory site (I-site). This I-site consists of the RxxD 
motif, which is located in the GGDEF domain but separated from the A-site through five 
amino acids and positioned distant from the dimer interface. Binding of c-di-GMP to the I-site 
avoids excessive consumption of GTP, buffers against stochastic variations in intracellular c-
di-GMP concentration and most importantly sets an upper limit for the accumulation the 
second messenger (175). PDEs with EAL domains linearize c-di-GMP into 5’-
phosphoguanylyl-(3’-5’)-guanosine (pGpG), which is further transformed into two GMP 
molecules by nonspecific yet unidentified PDEs. The specific action of the first step requires 
the presence of an active monomeric EAL domain, which is named after the amino acids in 
the active site, and requires the presence of either Mg2+ or Mn2+ as co-factor (98, 174, 176-
178). Recently, another family of proteins with specific phosphodiesterase activity was shown 
to degrade c-di-GMP. Their potential to degrade c-di-GMP was associated to the HD-GYP 
domain, which is completely unrelated to the EAL domain (182). HD-GYP domain proteins 
are members of the metal-dependent phosphohydrolase superfamily and were shown to 
degrade c-di-GMP into GMP in one step (179). 
 
3.6.2 C-di-GMP input systems and c-di-GMP receptor proteins 
The era of whole genome sequencing has shed some light on the vast abundance and 
distribution of GGDEF, EAL and HD-GYP containing proteins and has provided substantial 
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evidence that these families of signalling proteins together with c-di-GMP are near-ubiquitous 
in eubacteria (183). Sequence analysis of GGDEF and EAL domains has further shown that 
most of these domains are linked directly or indirectly via a two-component phosphorylation 
cascade to a signal input domain (184). These signal input domains (including PAS, blue 
light sensing (BLUF), haemerythrin, GAF, CHASE and MASE domains) link numerous 
environmental and intracellular signals to the production of c-di-GMP and create a diverse 
set of modules, each of which translates into a defined physiological output system. In these 
modules c-di-GMP acts as a second messenger that positively or negatively affects specific 
and often important cellular functions. Some of the best characterised functions are the 
formation of biofilm through biosynthesis of adhesins and exopolysaccharide matrix 
components (e.g. PGA; see chapter 3.4.1 and 3.4.2) (133, 168, 185-192), regulated 
proteolysis or cell cycle progression (180) and bacterial virulence (165, 177, 193-197).  
In order to fulfil these diverse functions, c-di-GMP must be sensed or bound by an 
effector molecule, which than transmits the signal to a specific output system (Figure 5). So 
far, several different types of c-di-GMP sensing and signal transfer system have been found. 
Many of the identified effectors belong to the PilZ family of proteins, which are activated upon 
binding of c-di-GMP. PilZ proteins translate the signal through protein-protein interactions 
into several different cellular outputs (189, 198-202). The first identified protein of this family 
was PilZ of Pseudomonas aeruginosa where it has a negative effect on twitching motility 
(198). In some cases, PilZ domains remained attached to the C-terminus of the GGDEF, 
EAL or HD-GYP domains. In other cases a PilZ domain is linked to a protein directly involved 
in generating an output, for example cellulose or alginate synthases (189, 203, 204). Other 
recently identified c-di-GMP effector proteins show no homology to PilZ proteins. One of 
these proteins is FleQ (205), which is a master regulator of flagellar gene expression in P. 
aeruginosa and functions as a c-di-GMP effector protein. Upon binding of c-di-GMP, the 
association of FleQ with the pel promoter is released and the pel operon gets derepressed, 
which results in the production of the Pel exopolysaccharide. Another class of effector 
proteins bind c-di-GMP at a site, which resemble an I-site (191). An example from this class 
is PleD of P. aeruginosa. The fourth known type of effectors is often represented by PopA of 
Caulobacter crescentus. PopA has a GGDEF domain with a degenerate and thus inactive A-
site, but contains a canonical I-site that can still bind c-di-GMP. It was shown that its action 
requires an intact I-site but not its A-site for correct functioning. Upon binding of c-di-GMP to 
the I-site PopA migrates to the cell pole of C. crescentus where it exerts its crucial function in 
cell cycle control (180). The example of PopA shows that evolution of GGDEF (and/or EAL) 
domains can result in molecules that have lost their metabolising activity but gained a 
function, which transduces a signal upon binding to c-di-GMP (161). An example of a protein 
with a degenerate and enzymatically inactive EAL domain with retained c-di-GMP binding is 
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LapD of P. fluorescence. It controls biofilm formation by communicating the intracellular c-di-
GMP concentration to a membrane associated attachment machinery (206). Several other 
degenerate GGDEF and/or EAL proteins have been identified and linked to a cellular output 
recently. However, it still needs to be proven that the novel function of these proteins still 
involves binding of c-di-GMP. An example would be CsrD of E. coli, which harbours a 
degenerate GGDEF and a degenerate EAL domain. Both domains are catalytically inactive 
but necessary for its function in mediating the RNase E dependent degradation of the small 
RNAs csrB and csrC (see chapter 3.5) (148). Aside from this diverse group of c-di-GMP 
binding proteins, it was recently described that conserved RNA domains known as 
riboswitches and present in the 5’ untranslated region of different mRNAs are also capable of 
specifically binding c-di-GMP (207, 208) adding a new class of effector molecules to the 
rapidly growing list.  
 
3.6.3 Regulation of c-di-GMP metabolism 
The number of DGCs, PDEs and c-ci-GMP effectors or receptors varies greatly within 
different bacteria. Besides the few species with no reported c-di-GMP metabolism e.g. 
Haemophilus influenzae and some bacteria with as much as 98 (Shewanella oneidensis) 
GGDEF, EAL or HD-GYP domain proteins, the majority of eubacteria encode for an 
intermediate number thereof. In E. coli, the number of GGDEF, EAL or HD-GYP domain 
proteins even varies between different strains. The non-pathogenic E. coli MG1655 strain 
harbours 9 EAL, 12 GGDEF and 7 GGDEF/EAL composite proteins. Pathogenic E. coli have 
lost one GGDEF domain protein (YddV) but have gained either one or two EAL domain 
proteins (homologs of Q0TL46 and Q0TDN1), which are associated with different 
pathogenicity islands. The abundance of GGDEF and EAL domain proteins generates a 
flexibility of signalling but raises the question of system redundancy and signal specificity. 
The question arises how the c-di-GMP network system can get buffered against signalling 
noise and unspecific signal transduction upon variations in c-di-GMP. The specificity of signal 
transduction can be controlled through protein expression levels, protein stability, specific 
activity of DGCs or PDEs, as well as through different affinities of binding sites for c-di-GMP. 
However, these levels of control might circumvent unwanted crosstalk between different c-di-
GMP dependent regulatory pathways. This emphasise on the question whether all proteins 
involved regulate one global c-di-GMP pool or whether defined c-di-GMP modules act on 
separate local pools. Global and/or local pools call for some sort of distribution, in which not 
all proteins are present and active at the same time and location within the cell. Temporal 
distribution of c-di-GMP would limit the type and number of GGDEF and EAL domain 
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proteins expressed under specific conditions and allow switching to another set upon 
alterations in the environment (190, 192). An example of such a temporal distribution is the 
regulation of the switch between flagellar motility and adhesion at the transition from late 
exponential to stationary phase in E. coli. In this example, YcgR interacts with MotA upon 
binding of c-di-GMP and reduces the rotational speed of flagella and thus overall motility, 
which in turn favours bacterial adhesion at the transition into stationary phase (81). The PDE 
YhjH enhances motility upon degradation of c-di-GMP. Both YhjH and YcgR are under the 
control of the flagellar master regulator FlhDC and are thus co-regulated with flagella. FlhDC 
regulated genes are expressed in early stages of growth but are downregulated at the 
transition into stationary phase (142, 190, 209-212). The conditions, which disfavour flagellar 
expression favour the expression of the DGCs YdeH and YcdT in a CsrA dependent manner 
(Figure 4). In stationary phase intracellular c-di-GMP levels increase and allow PGA 
dependent adherence. In this example, the activities of YhjH and YcgR are separated in time 
from the activities of YcdT and YdeH. As indicated in chapter 3.5, the basis of this temporal 
distribution of c-di-GMP metabolising enzymes partially depends on the levels of the carbon 
storage regulator CsrA (117, 133, 139, 213). 
Temporal distribution however, is not conceivable with a situation where several 
independent but parallel pathways are required. The presence of several parallel c-di-GMP 
signalling pathways would rather support the model of spatial and functional distribution of 
DGCs, PDEs and effector proteins into “micro compartments” with local c-di-GMP pools (179, 
210, 214, 215). The likelihood of such micro-domains is supported by the domain 
architecture of proteins where GGDEF, EAL or HD-GYP domains are covalently linked to 
putative output domains and possibly sequester c-di-GMP to the protein’s close surrounding 
(204). In E. coli, the DGC YegE and the PDE YhjH control flagellar motility and modulate the 
transcription of csgD, the activator gene of curli. However, the DGC YdaM and the PDE 
YciR, which get expressed under the same conditions as YegE and YhjH affect the 
expression of csgD but not flagellar motility (190, 210) and hence some of the output 
systems require to be uncoupled from parallel pathways in order to fulfil their highly specific 
and locally confined functions. Similar examples can be found in several articles and reviews 
(161, 168, 192, 212, 214, 216). The water bacterium C. crescentus is an excellent model 
organism for spatial distribution of GGDEF, EAL and effector proteins as its asymmetric cell-
division requires localisation of c-di-GMP dependent proteins at the cell poles during cell-
cycle progression (170, 180, 217, 218).  
In the end, bacterial cells have evolved a wide range of diverse regulatory mechanisms 
to monitor the activity of DGCs and PDEs including control of protein levels, protein activity 
and stability, allosteric binding, phosphorylation of covalently bound domains in the protein, 
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or localisation of c-di-GMP modules to micro-domains within the cell. Despite the scarcely 
identified target molecules and effector mechanisms involved in c-di-GMP signalling, c-di-
GMP was revealed to control cellular functions at transcriptional, translational and even 
posttranslational levels (79, 80, 210, 219, 220).  
 
3.6.4 The bacterial alarmone ppGpp 
Independent of the environment in which bacteria reside, nutrients will become limiting 
at some point. Upon starvation bacteria produce the stress alarmone ppGpp (Guanosin-3′,5′-
bispyrophospha). RelA, which synthesises ppGpp and SpoT, which synthesises and 
degrades ppGpp, control the cellular levels of ppGpp. PpGpp is synthesised via RelA upon 
amino acid starvation but it is also synthesised in response to deprivation of carbon sources, 
fatty acids, iron or phosphorous. However, under these conditions SpoT catalyses the 
synthesis of ppGpp (221). The ppGpp response to starvation is generally referred to as 
stringent response and affects transcription, translation or replication of many genes and 
many cellular processes, including PGA dependent biofilm formation in E. coli (133, 222). 
When ppGpp levels are low in E. coli, PGA dependent biofilm formation is maximal. Thus, 
ppGpp links PGA dependent biofilm formation to ribosomal stress (133, 222). Recently, 
ppGpp has also been linked to the Csr system (see chapter 3.5) shown to be under the 
control of CsrA (133, 158). This clearly indicates the regulatory complexity behind the 
induction of biofilms at the transition into stationary phase. Furthermore, ppGpp has also 
been reported to modulate the expression of type I fimbria, which play a role in attachment of 
bacteria to a surface or host cells and promote virulence during UTIs (223, 224).  
 
3.7 Fimbriae and Pili in bacteria 
Long bacterial protrusions named pili or fimbriae serve bacteria to overcome net 
repulsive forces derived from the negatively charged bacterial and host-cell membrane. They 
also serve as mediators for host-pathogen interactions through their action as adhesins. 
Surface-exposed adhesins improve binding of UPECs or other pathogens to host tissue, 
interactions required for successful colonisation. In the host-pathogen interaction the fimbrial 
adhesin functions as lectin, which recognizes oligosaccharide residues of glycoprotein. or 
glycolipid-receptors exposed on the host cell surface. The combination of the expressed 
bacterial adhesion factor and the expressed host receptor determine the tropism of the 
pathogen toward a specific tissue, for example UPECs towards the urothelium lining the 
bladder lumen.  
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According to their assembly pathways, fimbriae can be subdivided into four distinct 
groups including i) type I fimbriae and P pili, which are assembled by the chaperone-usher 
pathway, ii) type IV pili, iii) pili assembled by the extracellular nucleation / precipitation 
pathway, (e.g. curli pili), and iv) pili assembled by the alternative chaperone-usher pathway, 
e.g. the CS1 pilus family (96). Despite the different assembly pathways, the pilus shaft or 
fimbrial rod of Gram-negative bacteria is generated by non-covalent homopolymerisation of 
the major pilus subunit protein called pilin. Rods can contain several hundreds if not 
thousands of the major pilin subunit. The addition of minor pilins to the shaft of the pilin fiber 
render fimbriae useful for functions aside from host cell adhesion, including biofilm formation, 
phage transduction, DNA uptake or twitching motility. With respect to the content of this 
dissertation, this introduction of fimbriae will focus on type I fimbriae and their role in host cell 
adhesion. Other types of fimbriae and their functions are detailed in several reviews (44, 96, 
225).  
 
3.7.1 Type I fimbriae of UPECs 
Type I fimbriae can be found throughout the family of Enterobacteriaceae including 
UPECs. These type I fimbriae represent one of the most important and best-characterised 
virulence factor required for successful establishment of UTIs. Using electron microscopy the 
composite structure of the pilus rod was determined. It comprises a 6.9 nm thick and 1-2 mm 
long rod with 300-1000 major pilins (FimA) arranged in a right-handed helix. The end of the 
fimbrial rod is built by FimF, which connects the rod to the short 3 nm wide linear tip fibrillum 
(FimF, FimG, FimH) (Figure 6).  
Figure 6: Type I Fimbriae of Gram-negative E. coli 
Type I fimbriae are composed of four different pilin subunits. The helical 
pilus rod (turquois) consists of up to several thousand FimA subunits 
and is connected to the fibrillum through the pilin FimF. Aside FimF the 
linear fibrillum consists of FimG and the adhesin FimH, which has an 
acidic pocket that can bind mannose and mediated adhesion to 
mannosylated receptor proteins on eukaryotic cells. The structure of all 
pilins consists of one (FimA, FimG or FimF) or two (FimH) incomplete 
Ig-like folds. The incomplete Ig-like fold gets transiently completed 
through the chaperone protein FimC or upon polymerisation of pilin 
subunits. Polymerisation of pilin subunits requires the periplasmic 
chaperone protein FimC and the membrane bound usher FimD. 
Translocation of pilin subunits into the periplasm occurs via the 
SecYEG pathway. (E: extracellular milieu; OM: outer membrane; P: 
periplasm)This figure was adapted from Geibel S. and Waksman G. 
2010 (9). 
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* * * 
While the fimbrial rod remains rigid, the tip fibrillum with the monomeric FimH at its tip 
remains flexible (225-227). FimH encodes the type I fimbrial specific adhesin (228, 229), 
which contains an acidic pocket at the distal tip that accommodates mono-mannose 
oligosaccharides and is responsible for the adhesive properties of type I fimbriae. 
Consequently, the adhesin binds to surface exposed glycosylated receptors, which contain 
accessible mannose moieties (230-233). Prominent receptors for FimH are the uroplakins 
UP1a, which line the luminal surface of the urothelium as a protective coat (45, 234) or β1 
and α3 integrins (46). The uroplaking UP1a presents high amounts of terminally exposed 
mannose residues, which are specifically bound by FimH. The structure of FimH revealed a 
two-domain fold, which separates the C-terminal pilin domain from the N-terminal receptor-
binding domain comprising the mannose binding pocket. Both C- and N- terminal domains 
have an immunoglobulin (Ig) –like fold (230). Importantly, the Ig-like fold of pilin domain 
remains incomplete, as it misses the seventh strand. This strand is usually provided by either 
the chaperone FimC or by another pilin subunit, as explained in chapter 3.7.2 that follows. 
 
3.7.2 The chaperone/usher dependent assembly of type I fimbriae 
Upon expression of the fimAICDFGH genes, they are secreted into the periplasm via 
the SecYEG translocon of the type II secretion system. In the periplasm the pilins FimA, 
FimF, FimG, FimH form a stable complex with FimC, a chaperone protein with boomerang-
like shape and composed of two ig-like domains. The interactions of the chaperone-pilin 
subunit were revealed for the FimC-FimH complex by X-ray (230, 235). In this structure it 
became visible that the pilin subunits have an Ig-like fold composed of six β-strands that 
harbour a hydrophobic groove, which needs to be filled with a seventh β-strand for 
stabilisation. This seventh β-strand is provided either by other pilin monomers or transiently 
by the chaperon FimC. The interactions between FimC and the pilins in the hydrophobic 
groove are based on alternating hydrophobic chaperone residues of the G1 donor strand, 
which interact with hydrophobic residues of the F β-strand of the pilin. This protein-protein 
interaction is denoted “donor strand complementation” (236). During donor strand 
complementation, the donor β-strand G1 of the chaperon runs parallel to the pilin’s F β-
strand (Figure 7).  
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Figure 7: Ribbon model of Ig-like folds during donor strand complementation and 
donor strand exchange 
Biosynthesis of type I fimbriae occurs in the periplasmic space via the chaperone usher pathway. Once pilins 
(light and dark green) have reached the periplasmic space, they bind to a specific chaperone (FimC; red), which 
prevents premature assembly of the subunits and aids in proper protein folding via donor strand 
complementation. The pilin/chaperone (light green/red) complex is then transported to the usher protein (FimD) 
localised in the outer membrane where donor strand exchange occurs. The interactions in the ternary FimC-pilin-
FimD complex result in a stepwise replacement of the chaperone’s β G1 strand (red) with the Nte of the pilin 
subunit. Other than in FimC-pilin interaction the Nte gets inserted into the preceding pilin groove (dark green) in 
an antiparallel fashion and thus complements the Ig-like fold. The interaction of the Nte of the newly incorporated 
pilin (light green) with the F strand of the preceding pilin (dark green) are known as donor strand exchange. For 
more details see text. The ribbon models illustrated here were derived from the Pap-pilins, which are homologous 
to the Fim-pilins. Image was adapted from Geibel S. and Waksman G. 2010 (9).  
* * * 
 
Once the FimC-FimH complex is formed, the transient chaperone-pilin complex is 
guided to the FimD usher. The usher, a homodimeric channel spanning the outer membrane, 
catalyses the polymerisation of the pilus subunits and can be subdivided into four functional 
domains: i) an N-terminal periplasmic domain required for chaperone-pilin recognition and 
pilus assembly, ii) a domain encoding the central translocation pore, which is located in the 
outer membrane and mostly consists of antiparallel β-sheets, iii) a plug domain, which 
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resides within the translocation pore and is required for pilus assembly, and iv) a C-terminal 
periplasmic domain, which is also required for proper binding of the chaperone-pilin complex 
(225). The usher catalyses the ordered assembly of pilin subunits while releasing the 
chaperon and simultaneously translocating the growing pilus to the outer surface (237). This 
process is called “donor strand exchange” and results in a growing pilus that protrudes 
through the outer membrane. Donor strand exchange by the usher is similar to the donor 
strand complementation but with some important differences: Besides their incomplete Ig-like 
fold, each pilin subunit comprises a 10-20 amino acid long N-terminal extension peptide (Nte) 
with 4 alternating hydrophobic residues, essential for polymerisation. During polymerisation 
of pilus rod, the Nte of an incoming pilin takes over the position of the chaperone’s G1 β-
strand of the previously incorporated pilin (Figure 7) (238). This replacement occurs 
progressively by exchanging one hydrophobic residue after another, resulting in a ternary 
chaperone-pilin-Nte complex. Other than the chaperone’s G1 β-strand, the Nte interacts with 
the pilin’s F β-strand in an antiparallel fashion and thus completes the canonical Ig-fold (237, 
239). Based on the mechanism of donor strand exchange and the fact that the tip of the pilus 
is composed of FimH, FimH does not require an Nte, and serves as first pilin integrated into 
the “empty” usher FimD (238). The ordered assembly of the pilus relies on the higher affinity 
of the usher for the chaperone-adhesin complex, rather than the adhesin or chaperone 
alone. It also depends on the specific recognition of the FimH lectin domain by FimD (240). 
Once FimH is bound to FimD, the catalytic activity of the usher gets enhanced through an 
increased donor strand exchange rate between FimC-FimA complexes. Furthermore, bound 
FimC-FimH results in a conformational charge in FimD, which moves the plug domain 
located inside the translocation pore aside, and thus allows pilus growth. Once FimD 
incorporates FimH, correct assembly of the tip fibrillum and the whole pilus is reassured by 
the different affinities of the Nte for their cognate pilin. Presumably, also the N-terminus of 
FimD is capable of discriminating between different pilin subunits, as it was shown to 
specifically interact with them (237, 241). Importantly, the energy, which drives pilus 
assembly, is stored in the fold of the chaperone-pilin intermediates and gets released upon 
donor strand exchange (238).  
 
3.7.3 Regulation of type I fimbriae and the phase variation of fimS 
The promoter for the expression of type I fimbriae is located on a 314 bp long invertible 
DNA element termed fimS, which precedes the structural fimAICDFGH genes (Figure 8). 
This fimS is essential for the typical phase variable expression known for type I fimbriae, in 
which the structural genes of type I fimbriae are only expressed if the promoter on fimS is 
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oriented towards the fim structural genes (ON phase). In the OFF phase, the promoter is 
directed away from the structural genes and hence bacteria remain non-fimbriated (242-244). 
The inversion of fimS involves two inverted repeats (IRs) encoded by the 5’ TTGGGGCCA 3’ 
sequence flanked on both sides by Fim recombinase binding sites, termed half sites. Thus, 
fimS comprises four binding sites with different sequences and affinities for the Fim 
recombinases.  
 
 
 
Figure 8: The architecture of the invertible element fimS 
Expression of type I fimbriae depends on the orientation of an invertible element termed fimS (blue box). This 
invertible fimS element precedes the structural genes of type I fimbriae (white box) and harbours the promoter for 
fimAICDFGH. The inversion of fimS depends on the action of the recombinases FimB and FimE (orange boxes), 
which act on two Inverted Repeats (IR; black triangles). IRs are part of the IRL (left) and IRR (right). Besides the 
IR itself IRL and IRR are composed of an invariable region (light blue) named IRL-outside and IRR-outside and a 
region, which is part of the inverted DNA (dark blue) and whose DNA sequence changes upon inversion of fimS. 
These variable regions are called IRL-inside and IRR-inside. IRL and IRR together comprise four binding sites 
(red stars) for the Fim recombinases (red stars). Expression of the recombinases is controlled by three (FimB) 
and a single (FimE) promoter(s), which are positively (black arrow) or negatively (τ) regulated by different 
regulatory proteins of multiple pathways (orange lettering). In addition, the region between fimE and fimA 
comprises binding sites for IHF (light green hexagons), LRP (dark green ellipse) and H-NS (violet drops), which 
contribute to the orientational bias of fimS and assist during the inversion process. The complete H-NS binding 
site (entire drop) is subdivided in three half-sites (half drops) and depending on the orientation of fimS a complete 
binding site is formed on either the IRL or IRR. Other components which affect the switch of fimS indirectly or in 
an unknown mechanism are written in dark blue. (Positive effect (black arrows), negative effect (τ)). 
* * * 
The IR on the 3’ end of fimS is termed IRL (left hand inverted repeat), the IR on the 5’ 
end is termed IRR (right hand inverted repeat) (Figure 8). Both IRL and IRR are subdivided 
into an IR-insight and an IR-outside. During the recombination process, the sequence of IRL-
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outside and IRR-outside remain constant while the IRL-inside, the IRR-inside and the 
sequence containing the fimAICDFGH promoter get inverted by the Fim recombinases. This 
variable composition of fimS upon inversion is important for the directional preferences of the 
Fim recombinases mediating the DNA inversion (243). In E. coli, the predominant Fim 
recombinases residing over the directionality or phase of fimS are located upstream of it and 
are encoded by fimB and fimE (Figure 8). They bind to four overlapping half sites on IRL and 
IRR and following occupancy of these sites they recombine the switch within the IR 
sequence. Both recombinases belong to the λ integrase family of tyrosine site specific 
recombinases and share 48% amino acid homology with each other (242, 244, 245). The 
action of Fim integrases or recombinases is unusual as they promote a DNA inversion rather 
than promoting a DNA-integration or -excision process reported for classical integrases. In 
addition, both recombinases have been shown to act independent of each other, however 
they have different directional preferences for the inversion of fimS (242, 246-248). Co-
expression experiments of FimB and FimE indicate that the activity of FimE dominates over 
the activity of FimB in vitro (245, 247, 249-251). FimE has been shown to predominantly 
catalyse the inversion from the ON phase into the OFF phase. Expression of fimE is under 
the control of a single promoter upstream of fimE (252). The stability of the fimE transcript 
depends on the orientation of fimS, as it determines the length and 3’ sequence (253, 254). 
Consequently, fimE mRNA is likely to be degraded faster when the switch is in the OFF 
orientation as when it is in the ON orientation. Furthermore, FimE was shown to preferentially 
bind fimS in its ON conformation, adding to the directional bias (255). FimB on the other 
hand has bidirectional activity and is capable of inverting fimS in both directions, with a slight 
bias for the OFF to ON inversion (247, 255). Its expression was reported to depend on either 
two or three promoters, depending on the study (256, 257). The third promoter (P3) of fimB is 
predicted to be very distant from the transcriptional start site and respond to sialic acid and 
GlcNAc. Besides the differential control of expression of fimB and fimE, both proteins also 
exert different inversion frequencies, with the FimB frequencies being markedly lower (10-3 to 
10-4 per cell per generation) compared to FimE (0.3 per cell per generation) (258, 259). FimB 
was also shown to be susceptible to the level of DNA supercoiling (242). FimB switches fimS 
into the ON state as soon as DNA relaxes, e.g. at the onset of stationary phase (260, 261). 
Several clinical E. coli strains have recently been reported to encode additional 
recombinases acting on the inversion of fimS. These pathogen associated recombinases 
include proteins like IpuA, IpuB and IpbA of CFT073 (262), HbiF of the meningitis isolate 
RS218 (263) and FimX of the uropathogenic isolate UTI89 (264). The recently identified 
FimX recombinase of UTI89 is a homolog of FimB, which is bidirectional and also shows a 
slight bias for the OFF to ON inversion of fimS. The inversion frequencies as well as the 
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promoters of this recombinase have not yet been described. However, FimX is reported be 
slow in vitro but highly active in vivo (264). 
Besides the direct effect of the recombinases FimB, FimE and FimX in UTI89, a 
plethora of other proteins were shown to contribute to the overall architecture of the fimS 
switch, summarised in Figure 8. H-NS (histone-like structuring protein) is a global regulator 
responsible for histone-like functions and was shown to contribute to the phase of fimS in 
different ways (265). It binds to sequences at the edges of the fimS switch (266-268) and so 
far, three incomplete H-NS binding sites have been identified. These incomplete binding sites 
are located on fimS adjacent to the fimbrial promoter, the IRL-outside and IRR- outside 
regions respectively. A complete H-NS binding site is formed at the IRR when fimS is in the 
ON orientation while the complete H-NS binding site localises to the IRL when fimS is in the 
OFF orientation (Figure 8). However, the effects of H-NS binding to IRL or IRR and the 
inversion process are not yet clear (268). Furthermore, H-NS was also shown to repress the 
transcription of both recombinases (252, 269, 270) and to affect fimbriation by repressing the 
transcription of lrp gene (271). The leucine-responsive regulatory protein (Lrp), which mostly 
regulates genes involved in metabolic functions (272) binds to three different sites within 
fimS, which are all in proximity to the IRL site (Figure 8). Binding of Lrp increases the 
switching frequency of fimS (251, 268, 273-276), and it was shown that Lrp interaction with 
fimS might change upon alterations in the intracellular alanine and leucine concentrations 
(276). Another co-factor for fimS switching is the integration host factor (IHF) (249, 250). 
Mutations in IHF were shown to lock fimS in either the ON or the OFF orientation and affect 
the orientational bias of FimB recombination (248, 251, 267, 277, 278). The intergenic region 
between fimE and fimA comprises two binding sites for IHF (249-251), as illustrated in Figure 
8 (273). Binding of Lrp and IHF results in bending of the fimS DNA region, leading to the 
formation of a hairpin loop that juxtaposes IRL and IRR and thus facilitates the recombinase 
mediated inversion of fimS (268, 273). If neither Lrp nor IHF are bound to fimS, H-NS will 
bind and maintain the OFF phase of fimS (279). While H-NS, Lrp and IHF are crucial for 
phase switching, several other genes have been shown to affect the expression of type I 
fimbriae. LrhA (LysT-type regulator), OmpX (outer membrane protein X), OmpR (outer 
membrane protein R), or the gene products of ibeA and IbeT act more indirectly by 
influencing the expression of the recombinases Figure 8. LrhA was found to repress type I 
fimbriae expression by activating fimE through binding to its promoter region (280). Deletion 
of OmpX was shown to increase FimA production and result in a modification of the cell 
surface composition (281). Deletion of ibeA resulted in diminished fimbriation and a lowered 
transcription of fimB and fimE, while ibeT deletions resulted in a state where fimS was 
preferentially in the OFF phase (282). Furthermore, another study indicates that the 
alternative stationary sigma factor RpoS represses fimB transcription (283). Deletion of 
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OmpR of the EnvZ/OmpR two component regulatory system (284) led to derepression of 
fimB and fimE transcription compared to wild-type cells (269). Beside the mentioned 
proteins, c-di-GMP and ppGpp have also been implicated to affect the phase variable 
expression of type I fimbriae (Figure 8). C-di-GMP (see chapter 3.6) has recently been linked 
to fimbriation in a study, which showed that increased expression of the phosphodiesterases 
YhjH or YahA resulted in an increased expression of I type I fimbriae (285). The involvement 
of ppGpp in fimbrial regulation is not fully understood yet. It is currently believed that ppGpp 
promotes fimbrial biofilm formation through increased type I fimbrial expression by affecting 
the P2 promoter of fimB. (223). Furthermore, DskA, a co-factor required for ppGpp mediated 
positive regulation of several promoters of amino acid biosynthesis was shown to activate 
transcription of the fimB P2 promoter (224, 286). Even genes involved in metabolism have 
directly been linked to phase variation, like the N-acetylglucosamine-6-P responsive protein 
NagC and the sialic acid-responsive protein NanR. NagC and NanR bind to two 
deoxyadenosine methylation sites within the intergenic region that contains the P3 promoter 
of fimB (259, 287-290) and stimulate the expression of fimB (Figure 8). It is believed that 
UTIs initiated by type I fimbriae of UPECs elicit an inflammatory response that leads to 
increased levels of both sialic acid and N-acetylglucosamine, which in turn will abolish 
transcription of fimB (291). Several studies linked the expression of type I fimbriae to the 
expression of other surface exposed structures. Examples are the pyelonephritis associated 
pili (Pap) regulator PapB (292-294), which represses fimB expression, or the two proteins 
SfaB and SfaX, which are associated with S fimbriae and negatively affect the expression of 
type I fimbriae (295). These cross-talks suggest the presence of a competition between 
different fimbria and indicate that the expression of different types of fimbriae is preferentially 
avoided by bacteria.  
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4 Aims of this Thesis 
The transition of planktonic to sessile lifestyles in bacteria rests upon a tightly 
controlled program that gets triggered by the environmental composition and whose 
implementation requires multiple feedback controls. Uropathogenic E. coli (UPEC), the 
predominant agents of urinary tract infections, use this lifestyle switch to shift from acute to 
chronic, biofilm associated infections. While the acute phase of infection is dominated by the 
expression of virulence factors such as type I fimbriae, biofilm matrix components including 
PGA prevail during biofilm associated infections. In this work, factors reported to induce a 
lifestyle switch will be used in UPECs to investigate their effects on the expression patterns 
of two output-systems (type I fimbriae and PGA) during lifestyles transition. To achieve this, it 
will be assessed if PGA dependent biofilm formation in UPECs requires derepression of the 
carbon storage regulator (Csr) system. Furthermore, it will be investigated if PGA dependent 
biofilms respond to the bacterial second messenger c-di-GMP or the alarmone ppGpp of the 
stringent response and if PGA contributes to UTI pathogenesis. Finally, this work aims at 
clarifying the role of type I fimbriae in PGA dependent attachment and investigates if the 
expression patterns of the two surface-exposed structures are subject to a regulatory cross-
talk. 
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5.1 Statement of work 
In this study, I have constructed all UTI89 strains except ΔcsrB, ΔcsrC, ΔcsrD, and 
ΔcsrBC, which were constructed by Alexander Harms, a rotation student I supervised. 
Roswitha Schiller has introduced me to the murine cystitis model and assisted me during the 
murine in vivo assays, which were performed in the animal facility of the Institut für 
Molekulare Infektionsbiologie at the Julius-Maximilians-Universität Würzburg in Germany.  
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5.2 Abstract  
Recent reports have shown that recurring infections of the urinary tract are associated 
with the formation of intracellular biofilm-like structures of uropathogenic Escherichia coli 
(UPECs). While the molecular components and regulation of biofilm formation are well 
established in non-pathogenic E. coli strains, these processes are still poorly defined in 
pathogenic E. coli strains. One of the principle structural components of E. coli biofilm 
formation in vitro is the exopolysaccharide poly-GlcNAc (PGA). The PGA machinery is 
regulated by the global carbon storage (Csr) control module on the translational level and by 
the second messenger c-di-GMP on the allosteric level. Here we analysed the role of the Csr 
system, c-di-GMP and PGA in biofilm formation on selected clinical UPEC isolates In 
UPECs, derepression of the translational control by the Csr system induced attachment in a 
PGA dependent manner. The levels of PGA production depended on c-di-GMP and the 
ribosomal stress alarmone ppGpp. We show that enhanced production of c-di-GMP induces 
PGA dependent attachment and that YdeH is the main contributor to this induction. 
Attachment in the presence of translation inhibitors derepressed PGA dependent attachment 
via SpoT-mediated reduction of ppGpp levels. Initial in vivo data derived from murine cystitis 
infections indicate however that PGA does not play a crucial role during acute cystitis. 
Further studies will have to analyse the role of PGA in chronic and recurring urinary tract 
infections.  
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5.3 Introduction 
Pathogenic Escherichia coli (E. coli) cause a number of severe acute infections, including 
gastroenteritis (1), neonatal meningitis (2) or urinary tract infections (UTI) (3). Infections 
caused by E. coli or other pathogens can switch from an acute stage to a latent stage where 
bacteria chronically persist within their hosts. Patients suffering from initially acute UTI by 
uropathogenic E. coli (UPEC) often suffer from recurrence of symptoms after termination of 
antibiotic treatment (4). While acute and uncomplicated UTIs can often be treated effectively, 
recurrent infections are associated with episodes of little or no symptoms of inflammation and 
are thus difficult to eradicate. They often require patients to undergo repeated cycles of 
antimicrobial therapy. Thus, recurrent infections are associated with considerable morbidity 
and health care costs (5). The pathogenesis underlying persistent UTIs is not well 
understood and only very few of the bacterial factors involved in persistence have been 
identified so far (2, 3). Recurring UTIs are usually associated with the formation of 
intracellular biofilm-like structures called ‘intracellular bacterial communities’ (IBC) (6, 7). 
These structures might explain how the UPEC clone responsible for the initial infection can 
persist chemotherapy and cause recurrent UTIs after prolonged periods without symptoms 
(8). 
Biofilms are tissue or surface attached aggregates of bacterial cells, which are encased in 
a self-produced matrix of proteinaceous adhesive organelles, such as different fimbriae and 
varying exopolysaccharides (9). Together these factors form a viscous matrix, which protects 
bacteria within biofilms from the host immune system and presents a diffusion barrier for 
most antibiotics. In addition, biofilms harbour subpopulations of bacteria with little metabolic 
activity. These dormant ‘persister’ cells are insensitive to the action of most antibiotics and 
may serve as a reservoir for recurring infections (6, 10). Other than in UPECs, the molecular 
basis underlying biofilm formation of non-pathogenic E. coli strains including MG1655 has 
already intensively been studied. Biofilm formation is tightly controlled by the components of 
the Carbon Storage Regulator (Csr) system. The CsrA protein binds to the 5’ UTR of the 
pgaACBD operon, which encodes the biosynthetic machinery of the biofilm matrix 
component poly--1,6-N-acetyl-glucosamine (PGA or poly-GlcNac) (11). Two small non-
coding regulatory RNAs, csrB and csrC, can sequester CsrA and thereby regulate CsrA 
targeted genes. The expression of csrB and csrC is itself regulated by the BarA/UvrY two 
component system (TCS), which responds to the metabolic status of E. coli (12, 13). Also, 
CsrA indirectly activates the transcription of csrB and csrC via its inducing effects on 
BarA/UvrY TCS (14). This positive autoregulatory loop imposes rapid upregulation of Csr 
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target genes upon environmental alterations. CsrA further represses NhaR, the 
transcriptional regulator of the pgaA-D operon, adding an additional level of complexity to the 
regulation of PGA (15). PgaA, B, C, and D localise to the cell envelope where they catalyse 
the synthesis and export of the PGA polymer. PgaA forms the export pore in the outer 
membrane while PgaB deacetylates the PGA polymer in the periplasm (16). The 
glycosyltransferase PgaC resides in the inner membrane where it catalyses the formation of 
PGA from its precursors UDP-GlcNAc. Although the inner membrane protein PgaD is 
essential for the synthesis of PGA (16, 17), its precise function remains unclear (18). 
To experimentally derepress PGA biogenesis and biofilm formation in the absence of 
physiological signals a csrA::Tn5 allele which encodes a partially inactivated CsrA protein is 
generally used (designated as csrA- throughout this work) (11, 19). When challenged with 
subminimal inhibitory concentrations (sub-MICs) of translation inhibitors, E. coli MG1655 
csrA- responds with a strong increase in PGA dependent biofilm production (20). Stimulation 
of the PGA machinery under these conditions involves an increase of the second messenger 
c-di-GMP (20) and a SpoT-mediated reduction of the alarmone ppGpp. The second 
messenger c-di-GMP is a small intracellular signalling molecule that governs the transition 
from a motile planktonic to a sessile surface attached lifestyle (21-23). The synthesis of c-di-
GMP requires two GTP molecules and is performed by diguanylate cyclases (DGC) through 
their conserved catalytic GGDEF domain. Degradation of c-di-GMP to the linear product 
pGpG is mediated by the catalytic EAL phosphodiesterases (PDE) domain (24). Several 
DGCs are controlled by the Csr system (20, 25). This includes YdeH, which was further 
shown to be important for PGA biogenesis. CsrD, a catalytically inert member of the GGDEF-
EAL domain protein family targets csrB and csrC for degradation by RNase E (26). 
In this study, we analyse the role of the Csr system, c-di-GMP and PGA, for biofilm 
formation of several clinical UPEC isolates. These including UTI89, a UPEC isolate from a 
patient with an acute bladder infection (27, 28) and two pyelonephritis isolates, CFT073 (29) 
and 536 (30). We also analyse the prototypic asymptomatic bacteriuria (ABU) isolate 83972, 
a strain that is well adapted for growth in the urinary tract and establishes long-term 
bacteriuria (31-33). 83972 has been used to deliberately establish protective ABU in patients. 
PIII-4 is a re-isolate from a patient who received 83972 as therapeutic treatment (34). Our 
studies show that most UPECs have a functional Csr system and are able to form PGA 
dependent biofilms. In UTI89, elevated levels of c-di-GMP strongly boost biofilm formation 
with YdeH being the primary DGC contributing to biofilm increase. Translation inhibitors 
stimulate PGA dependent biofilm formation in UPECs in a ppGpp dependent manner. 
Preliminary in vivo data indicate that PGA does not contribute to acute cystitis in a mouse 
model.  
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5.4 Material and Methods 
5.4.1 Bacterial strains and plasmids 
UPEC wild type strains and isogenic deletion mutants used in this study are listed in 
Table 1. Plasmids used are listed in Table 2. Table 3 lists all sequenced UPEC strains as 
well as the clinical isolates screened for biofilm induction upon addition of translation 
inhibitors.  
 
5.4.2 Standard growth conditions 
Unless mentioned otherwise, E. coli strains were grown in Luria-Bertani (LB) broth at 
37 °C while aerated through rotation of cultures by 170 rpm. When required, media were 
supplemented with antibiotics. The optical density (OD) of bacterial cultures were determined 
at 600 nm using a photo spectrometer (Genesys6, Thermo Spectronic, WI, USA) 
 
5.4.3 Selection of UPEC isolates inducible by sub-MICs of tetracycline 
All clinical isolates listed in Table 3 were isolated at the University hospital of Basel 
from the urine of hospitalised patients. UTI89 and 536 have been included in the screening 
as well characterised and sequenced wild type (wt) strains. For the screening, bacteria were 
grown overnight cultures in tryptic soy broth (TSB). Bacteria were than subdiluted 1:40 in 
fresh TSB and exposed to serial dilutions of sub-MIC tetracycline in a 96-well plates, grown 
statically for 24 h at 37° C and then processed as described for attachment assays in chapter 
5.4.7. Strains with interesting screening behaviour were selected and their susceptibility to 
sub-MICs of different translation inhibitors (tetracycline, chloramphenicol, and streptomycin) 
was confirmed in attachment assays. 
 
5.4.4 Congo red binding assay 
Single colonies of each strain were picked from a fresh LB agar plate and restreaked 
onto a fresh LB plate containing either 0.1% congo red or 0.04 % congo red and 20 μg / ml 
Coomassi brilliant blue (35). After overnight incubation, plates were kept at 4° C for 2 days 
for more intense congo red binding of colonies. Images of clones with representative congo 
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red binding were taken with a Nikon Coolpix through a binocular (Wild; Heerbrugg M3Z) at a 
magnification of 24x and processed with Photoshop CS5. Plates containing 0.1% congo red 
were illuminated with the light source from above while 0.04 % congo red and 20 μg / ml 
Coomassi brilliant blue plates were translucent enough to be imaged with a light source 
shining through the plate. This ladder illumination method allowed for more subtle differences 
in congo red binding. 
 
5.4.5 Motility assay 
Strains subjected to motility assays were freshly streaked onto LB plates from the 
UPEC strain collection, than single colonies were picked with toothpicks and transferred onto 
TB swarmer plates (0.3 % agar). Motility was quantified by scanning the plates on a 
ScanMaker i800 (Microtek) after 6.5 h of incubation at 37°C. If needed, TB swarmer plates 
were supplemented with 100 μg/ml ampicillin or 12.5 μg/ml tetracycline for plasmid selection 
and 100 μM IPTG or 0.2 % arabinose for plasmid induction. Images were processed with 
Photoshop CS5 (Adobe). 
 
5.4.6 Construction of isogenic deletion mutants 
The parent strains used in this study are the sequenced clinical UPEC isolates UTI89 
(27, 28), CFT073 (29), 536 (30) 83972 (34, 36) and a re-isolate of 83972, named PIII-4 (34). 
In addition we used two novel clinical isolate, termed clin571 and clin591. Clin 591 was 
isolated at the University of Basel from a 76 year old female patient carrying a urethral stent 
and clin571 was isolated from an 82 year old female patient with a UTI.  
The construction of isogenic deletion mutants was performed as previously published 
(37). In brief, the corresponding UPEC wild type strains were transformed with the 
temperature sensitive plasmid pKM208 (Addgene plasmid 13077) containing the red 
recombination genes (38). Once transformed, the parent strain with pKM208 was stocked 
and used for subsequent gene deletions and modifications. To generate isogenic mutants, 
the UPEC strain with pKM208 was cultured at 30° C in LB without NaCl and supplemented 
with ampicillin (100 μg/ml) until the culture reached the end of the logarithmic phase (OD600 
of 0.9). At this state, cultures were shifted to 37° C and the λRED genes were induced for 30 
min with 1 mM IPTG. Cultures were than subjected to a 15 min heat shock at 42 °C and 
rapidly cooled in ice slurry before washing once with 10 % glycerol and concentrating 100-
fold in cold 10 % glycerol.  
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The kanamycin and chloramphenicol resistance cassettes were PCR amplified from 
pKD4 or pKD3 (39) with primers designed specifically to delete the desired region in the 
genome of UTI89. Each λRED primer contains a constant 3’ sequence that binds to the 
resistance cassette (chloramphenicol or kanamycin) from pKD3 or pKD4, respectively. In the 
forward primer (P1) this constant region is TGTAGGCTGGAGCTGCTTCG and in the reverse 
primer (P2) it is CATATGAATATCCTCCTTAG. Furthermore, the 5’ end of each λRED primer 
contains a homology region (HR) of roughly 50 nt that binds to the flanking regions of the 
gene to be deleted. λRED primers used in this study to make isogenic deletion mutants are 
listed in Table 4. The following genes were deleted by λRED-mediated recombination: For 
pgaA-D primers 1545-ycdP_KO_P2 and 1546-ycdS-KO-P1 were used, for ydeH primers 
2400-ydeH_KO_P1 and 2401-ydeH_KO_P2 while csrB was deleted via primers 
1143_csrB_KO_P1 and 1144_csrB_KO_P2. Primers 1145_csrC_KO_P1 and 
1146_csrC_KO_P2 were used for csrC, 3880_CsrD_KO_P1, and 3881_CsrD_KO_P2 for 
csrD. The UPEC specific genes c1116 and c1117 were deleted via 2878_c1116_KO_P1 and 
2879_c1116_KO_P2 or 3547_c1117_KO_P1 and 3548_c1117_KO_P2, respectively. Finally, 
primers 2125-spoT_KO_P1 and 2126-spoT_KO_P2 were used to delete spoT in a UTI89 
ΔrelA background. Other than the mutants listed above where DNA was amplified from pKD3 
or pKD4, some DNA fragments used for λRED mediated gene deletion were amplified from 
the comprehensive `Keio collection` published in 2006 (40). Amplification of the locus 
containing the deleted gene in the collection was performed with normal test primers (~20 nt) 
and the PCR product was then used to delete the gene in UPECs via λRED mediated 
recombination. For ycdT the primers used were 2402_ycdT_seq_fwd1 and 
2762_ycdT_KO_P2. Analogously we used primers 3927_relA_test_rev and 
3928_relA_test_fwd for the deletion of relA. After amplification, PCR fragments were gel 
purified (MN Nucleospin Extract II, Machery Nagel, Oensingen, Switzerland). 10 to 100 ng 
purified DNA were added to 65 μl of cold recombination competent bacterial cells and 
subjected to electroporation in 1 mm Gene Pulser cuvettes using a Gene Pulser (BioRad, 
Reinach, Switzerland) set to 1.75 V, 25 μF and 400 Ω. Electro-shocked cells were mixed with 
cold (4 °C) salt optimised broth (2 % (w/v) bacto trypton; 0.5 % (w/v) yeast extract; 10 
mMNaCl and 2.5 mMKCl), incubated for 1.5 h at 37 °C and plated on LB agar plates 
containing 50 μg/ml kanamycin or 20 μg/ml chloramphenicol. After growth, resistant clones 
were colony purified on LB agar plates containing kanamycin or chloramphenicol and tested 
by PCR for correct insertion of the resistance cassette. Thereafter, the strain was 
transformed with pCP20 to remove the resistance cassettes by Flp recombinase-mediated 
site-specific recombination (39). Loss of the resistance cassette was again checked by PCR.  
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5.4.7 Attachment assay 
Freshly grown LB overnight cultures were diluted 1:40 into 200 μl LB medium. When 
appropriate bacteria were grown with the following concentrations of antibiotics to select for 
plasmids: 12.5 µg/ml tetracycline (pME6032 plasmids) or 100 µg/ml ampicillin (pcj30) and 
were induced with 100 µM IPTG unless mentioned otherwise. The 96-well plates (Falcon, 
ordering number 353072) were incubated without shaking for 24 h at 37 °C unless mentioned 
otherwise after which cell density was recorded on a plate reader at 600 nm. Subsequently, 
the medium with the non-attached cells was discarded by thorough rinsing of the microtiter 
plates with deionised water from a hose. Once dried, wells were filled with 200 μl crystal 
violet staining solution [0.1 % (W/V) crystal violet (Sigma Aldrich, Article No. C-3886), 1.7 % 
(W/V) 1-propanol, 1.67 % (W/V) methanol (96.7:1.66:1.66)] and stained on a platform shaker 
for 15 min at room temperature (RT). The staining solution was discarded and wells were 
washed and dried as before. Retained crystal violet was dissolved in 200 μl of 20% acetic 
acid and quantified at 600 nm in a plate reader. If measurements were outside the dynamic 
range of the plate reader, crystal violet solutions were further diluted in 20% acetic acid. As 
previously published (20, 41), bacterial biofilms were quantified as the amount of biomass 
attached to the polystyrene surface (as absolute attachment). Relative attachment values are 
ratios of the optical density of dissolved crystal violet (corresponding to the attached 
biomass) divided by the total cell density (corresponding to bacterial growth). If attachment is 
indicated as percentage, the relative attachment value is normalised to the corresponding 
wild type strain carrying the csrB overexpressing plasmid, which was determined as 100 %. 
Error bars were calculated as the standard errors of the mean.  
 
5.4.8 Electron microscopy 
For the acquisition of electron microscopy micrographs, bacteria were prepared 
essentially as described in chapter 5.4.7 but attachment assays were performed in 24-well 
plates instead of 96-well plates (20). Each well contained 2 ml of LB supplemented with 100 
μg/ml ampicillin and 100 μM IPTG and a sterile glass slide. After biofilm formation for 24 h, 
the glass slides were removed, rinsed gently with 1×PBS and fixed in 1×PBS containing 2.5 
% glutaraldehyde for 1 h at room temperature. Then, the glutaraldehyde was washed out 
with 1×PBS and the samples were gradually dehydrated for 10 min per step in acetone step 
gradient (30%, 50%, 70%, 90%, 100%). Finally, samples were critical point-dried and 
sputter-coated with a 3–5 nm Pt layer. Micrographs were recorded on a Hitachi S-4800 field 
emission scanning electron microscope with an acceleration voltage between 1.5 and 5 kV.  
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5.4.9 Allelic exchange  
To obtain MG1655 clones with foreign ydeH alleles, ydeH of MG1655 was first 
replaced by the λRED technology with a counter-selectable marker (the toxin ccdB under 
control of the L-rhamnose promoter plus a linked kanamycin resistance cassette) (39). In a 
second λRED recombineering step the ccdB-kanamycin marker was replaced with foreign 
ydeH alleles, which were amplified by PCR from UTI89 and 83972 with primers 1651-
ydeH_test_fwd and 1652-ydeH_test_rev. After electroporation and phenotypic expression 
bacteria were plated on minimal medium containing 0.2 % L-rhamose as sole carbon source 
and thus selected for rhamnose resistant clones containing foreign ydeH alleles. Rhamnose 
resistant clones were colony purified, checked for loss of kanamycin resistance and the ydeH 
locus was sequenced to exclude point mutants. After successful allelic exchange of ydeH, 
the csrA- allele was introduced by P1 transduction (see chapter 5.4.11) and the resistance 
cassettes of csrA-::kan was removed by Flp recombinase-mediated site-specific 
recombination (39).  
5.4.10 Preparation of P1 phage lysates 
The preparation of P1 lysates was performed essentially as described by Miller in 1992 
(42). Briefly, bacteria were grown in 5 ml LB medium until they reached an OD600 of roughly 
0.3. Then CaCl2 was added to a final concentration of 10 mM and 10 μl of the pure MG1655 
P1 lysate were added. Next, bacteria were re-cultivated at 37° C for 3-4 hours until the 
culture became clear and displayed cellular debris. At this point 250 μl chlorophorm was 
added, the tube was centrifuged at 5000 rpm for 10 min in an SS34 rotor for removal of 
cellular debris. The supernatant containing the phages was transferred into sterile glass 
screw cap. Finally 50 μl chloramphenicol were added to kill residual bacteria. Lysates were 
stored at 4° C until further use. 
 
5.4.11 P1 Transduction 
The protocol used for P1 transduction was essentially performed as previously 
described (42). Briefly, the recipient strain was grown in LB medium to and OD600 between 
0.5 and 0.8 after which CaCl2 was added to a final concentration of 10mM. To 1 ml of 
bacterial culture 100 μl of P1 phage lysate (chapter 5.4.10) was added and the mixture was 
incubated at room temperature for 15 min. Thereafter Na-Citrate was added to a final 
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concentration of 100mM and the bacterial suspension was phenotypically expressed for at 
least one hour. Then the suspension was plated on selective medium containing 20 mM 
citrate. Before use, single colonies were colony purified twice on selective plates containing 
20mM citrate to remove residual phages.  
 
5.4.12 Preparation of bacterial inoculum for murine cystitis model 
Bacteria were grown under aerated conditions at 37° C overnight after which they were 
rediluted to an OD600 of 0.05 and regrown at 37° C until an OD600 of 1.2 was reached. 
Bacteria were collected by centrifugation, washed twice with cold sterile 0.9 % saline solution 
and concentrated to a final OD600 of 80. The CFU of the inoculum was tested on LB plates by 
serial dilutions.  
 
5.4.13 Infection of mice 
For our animal models 6 to 8 week old C57BL/6 female mice were infected with ~ 
1,5x109 bacteria concentrated in 30 – 45 μl 0.9 % saline solution. The transurethral infection 
was performed essentially as described by Garofalo et al, (43) on anesthetised animals 
(isofluoran and oxygen Mixture). Weight of each mouse was measured prior infection, the 
first three days after infection and regularly thereafter or until mice were sacrificed. Weight 
loss was used as a parameter for the wellbeing of infected mice. At the endpoint of infection, 
mice were euthanised by CO2 and death was confirmed by tweaking the animals between 
their toes. Once sacrificed, both kidneys as well as the bladder were collected as sterile as 
possible in 1 ml sterile 0.9% saline solution. Bladders were cut open to remove residual urine 
from the bladder lumen and dissected into small pieces, which were then again collected in 1 
ml sterile 0.9 % saline solution. Kidneys were left intact but rinsed before collecting the 
organs again in 1ml 1×PBS. All organs were weighted prior homogenisation in 1ml 1×PBS. 
Organ homogenates were serially diluted and plated out for colony forming unit (CFU) 
determination on EMB agar plates (BD Diagnostic Systems Switzerland).  
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5.5 Results 
5.5.1 General characterization of motility and Congo red binding of different UPEC 
strains  
The Csr cascade inversely regulates motility and PGA biogenesis (16, 44). As a 
general characterization of this pathway, we first assessed motility behaviour and congo red 
binding of different UPEC isolates and compared it to different MG1655 strains. As shown in 
Figures 1 and 2, MG1655 csrA- has reduced motility and an enhanced propensity to form 
biofilms. Consistent with earlier reports on MG1655 (20, 25) this behaviour is dependent on 
the DGC YdeH. In comparison, the previously described UPEC strains (UTI89, 536, CFT073, 
83972, and PIII-4) showed only weak binding of congo red (Figure 1). Contrary, the newly 
isolated and uncharacterised clin571 showed increased congo red binding. Motility of the 
UPEC strains was variable but generally reduced as compared to MG1655 wild type, 
especially in the two newly isolated strains clin571 and clin591. Interesting motility behaviour 
was observed for the ABU strains 83972 and its patient re-isolate PIII-4. While 83972 cells 
formed poorly motile, biofilm-like microcolonies on motility plates, this behaviour reversed in 
strain PIII-4, as it had regained the ability to swim homogeneously (Figure 2).  
 
5.5.2 Biofilm formation in UPECs is regulated by the Csr cascade and by c-di-GMP 
To test if PGA expression and biofilm formation in the UPEC isolates requires 
activation of the Csr cascade we assayed their behaviour in the absence of the CsrA protein. 
Several attempts were performed to insert the csrA- allele into UTI89 via λRED, which were 
unsuccessful due to reactivation of the Tn5 transposon of the csrA::Tn5 allele. As an 
alternative way to derepress Csr target genes, we made use of a plasmid, which 
overexpresses csrB (pCsrB). As shown in Figure 3A, overexpression of csrB lead to a 
stimulation of biofilm formation in MG1655, comparable in extent to the behaviour observed 
for the csrA::Tn5 strain. Stimulation of biofilm formation is slightly stronger upon 
overexpression of csrB as compared to partial inactivation of CsrA. Importantly, csrB 
overexpression also strongly stimulated biofilm formation of strains UTI89, 89372, and PIII-4 
(Figure 3B). In contrast, attachment of clin591 was already strongly increased without 
overexpression of csrB and could not be further induced by csrB overexpression. This 
indicates that the catheter-derived strain carries genetic modifications that constitutively 
Results 
44 
upregulate biofilm formation. Together these data indicate that in most UPEC isolates the 
Csr cascade is functional and required for the derepression of the PGA pathway. 
To test if c-di-GMP is involved in the stimulation of PGA-dependent biofilm formation in 
UPECs we analysed the behaviour of strains expressing a heterologous DGC (DgcA from 
Caulobacter crescentus). In agreement with Csr playing a key role in PGA control, plasmid 
driven dgcA expression stimulated biofilm formation in all strains but only when csrB was 
overexpressed at the same time (Figure 3C). The attachment of clin591 showed a modest 
increase upon overexpression of csrB and/or dgcA, reinforcing the constitutive nature of 
biofilm formation in this strain. These data suggest that in most UPECs PGA biogenesis and 
biofilm formation follows similar regulatory principles as in non-pathogenic E. coli strains.  
To further investigate the role of c-di-GMP and the Csr system in UPEC motility control, 
we have chosen UTI89 as a representative UPEC strain. As shown in Figure 4, the 
overexpression of csrB completely abolished UTI89 motility. Likewise, overexpression of the 
DGC WspR (pME6010 WspR) or DgcA (pAB551) had the same effect. A catalytic mutant of 
DgcA (D164N) did not affect motility, arguing that the observed interference with cell motility 
is caused by elevated levels of c-di-GMP. These data argue that the Csr system together 
with c-di-GMP co-ordinately control the motile-sessile switch in clinical UPEC isolates. 
To demonstrate that Csr controlled biofilm formation in UTI89 depends on PGA, we 
overexpressed csrB in a mutant lacking the entire pga operon (pgaA-D). As shown in Figure 
5A a pga mutant completely failed to induce biofilm formation, even when csrB was 
overexpressed from plasmid. This argues that PGA is the primary EPS responsible for 
biofilm formation in UPECs under conditions that derepress the Csr system. In the non-
pathogenic E. coli strain MG1655, activation of the Csr system also leads to enhanced 
expression of two DGCs YcdT and YdeH (16, 25, 45), both of which are required to fully 
stimulate the production of PGA (20) (Master Thesis, A. Casanova). As shown in Figure 5A, 
both YdeH and (to a lesser extent) YcdT were required for full induction of PGA-mediated 
biofilm formation once the Csr system is derepressed in UTI89. To strengthen these results 
scanning electron micrographs were taken from wild type and mutant UTI89 biofilms 
overexpressing csrB. While wild type and the ΔycdT mutant formed a homogeneous, dense 
biofilm with few cavities (Figure 5B and 5C), the biofilm of ΔydeH appeared less 
homogeneous and contained larger voids reducing the total biofilm biomass of this strain 
(Figure 5D). The image of UTI89 ΔpgaA-D confirmed that PGA is absolutely essential for 
biofilm formation in UTI89 as only a few dispersed cells were visible on the glass slide 
(Figure 5E). Finally, the biofilm of the UTI89 ΔydeH ΔycdT double mutant was also strongly 
reduced (Figure 5F), confirming the critical role of c-di-GMP and suggesting that the two Csr-
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regulated DGCs YdeH and YcdT act synergistically to stimulate PGA-mediated biofilm 
formation in UPECs.  
We also analysed the requirement for biofilm formation of the UPEC isolate clin591 that 
showed Csr-independent biofilm formation. For this, pgaA-D, ycdT and ydeH were deleted in 
clin591 and the resulting mutants analysed with respect to surface attachment and biofilm 
formation. As shown in Figure 6 none of these deletions had a negative effect on clin591 
surface colonization, arguing that in this strain constitutive biofilm formation relies on different 
adhesins and/or matrix components than in other UPEC strains.  
 
5.5.3 Sub-MIC of translation inhibitors differentially stimulate attachment in UPECS 
When challenged with sub-minimal inhibitory concentrations (sub-MIC) of translation 
inhibitors, the non-pathogenic E. coli strain MG1655 CsrA- responds with increased PGA 
dependent surface attachment and biofilm formation (20). This finding is potentially highly 
relevant, as pathogens can be exposed to sub-MICs of drugs for several hours in patients 
undergoing antimicrobial chemotherapy (46). We therefore performed a screen to see if 
UPECs respond to sub-lethal doses of these drugs in a similar way as non-pathogenic E. 
coli. The strains used in this screen are characterised in Table 3 and were isolated from urine 
of hospitalised patients at the University hospital of Basel. Isolates derived from catheterised 
patients are mentioned in the table, together with the patient’s age and gender. UTI89 and 
the pyelonephritis isolate 536 were added to the screen as two well characterised isolates. 
As indicated above, the catheter derived isolate clin591 showed constitutive biofilm formation 
even in the absence of csrB overexpression and was not significantly induced by 
tetracycline, chloramphenicol or streptomycin (Figure 7). In contrast, clin571 showed no 
measurable attachment without translation inhibitors but showed strong induction upon 
addition of tetracycline (Figure 8), chloramphenicol or streptomycin (data not shown). In 
contrast, UTI89, 536 and the remaining 52 isolates tested were unable to respond to 
antibiotics without overexpression of csrB. However, upon derepression of the Csr system 
UTI89 responded strongly to tetracycline, chloramphenicol or streptomycin (Figure 9). 
Importantly, antibiotic-mediated biofilm induction was lost completely in a UTI89 Δpga mutant 
(Figure 10). 
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5.5.4 UTI89 attachment can be modulated by several unrelated genes 
So far, it has been shown that the mechanisms of biofilm formation are equal in 
MG1655 and in UPECs like UTI89. However, other factors are linked to this model and have 
thus been investigated in attachment assays. The first components investigated are genes 
involved in the Csr system. Though partially complemented through the overexpression of 
csrB, UTI89 ΔcsrB and ΔcsrC attachment decreased in both strains compared to UTI89 wt 
(Figure 11A). As csrB and csrC act synergistically in binding CsrA, a ΔcsrBC double mutant 
was investigated. Surprisingly, the UTI89 ΔcsrBC double mutant attached similar than UTI89 
ΔcsrC, suggesting that the attachment observed in any of these three mutants is 
predominantly caused by the overexpression of csrB in trans. In line with its reported 
function, UTI89 ΔcsrD showed a slightly increased attachment, which must be due to 
prolonged stability and activity of csrB and csrC. 
C1116 was recently identified as a UPEC specific phosphodiesterase, which clusters in 
the Sfa fimbrial operon on a pathogenicity island (47, 48). Being absent in non-pathogenic E. 
coli strains, we were interested to see if the presumed activity of c1116 affects PGA 
dependent attachment through degradation of c-di-GMP. As seen in Figure 11B, deletion of 
c1116 caused a small but reproducible increase in attachment, suggesting that C1116 is 
active as PDE and contributes to the c-di-GMP pools. Interestingly deletion of c1116 together 
with the gene adjacent to it (c1117) reduced attachment, just like the single deletion of 
c1117. Though the exact function of c1117 within the Sfa fimbriae has not yet been 
identified, it appears to affect PGA dependent attachment together with c1116 over which it 
dominates.  
Boehm et al., have recently shown that the biofilm induction by translation inhibitors 
depends on the ribosome itself (20). They have identified the alarmone ppGpp as signalling 
molecule that transfers the ribosomal stress state from the ribosome to the PGA machinery. 
To test if ppGpp affects PGA dependent biofilm formation in UPECs as well, a ppGpp zero 
strain (ppGpp0) was constructed. This required the deletion of the ppGpp synthases (RelA 
and SpoT) and its hydrolase (SpoT). As seen in Figure 11C, attachment of a UTI89 ppGpp0 
strain (UTI89 ΔrelAΔspoT) was massively induced upon overexpression of csrB compared to 
the wild type UTI89. This corresponds to the phenotype seen in MG1655 csrA- ppGpp0. 
Thus, ppGpp is required in UTI89 as well to signal between the ribosome and the PGA 
machinery and as a consequence influences biofilm formation.  
From these attachment assays, we can conclude that the components of the Csr 
system execute the same functions reported for MG1655: csrB and csrC boost PGA 
dependent biofilm formation by titrating away CsrA while CsrD controls the levels of csrB and 
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csrC by targeting them for degradation. Deletion of phosphodiesterases like c1116 affect 
PGA dependent biofilm formation by decreasing the pool of c-di-GMP which post-
translationally affects PgaA-D. Finally, the signalling cascade required to induce PGA 
dependent biofilm formation upon ribosomal stress depends on ppGpp and is retained in 
UPECs, arguing that this signalling cascade is conserved among all E. coli strains. 
 
5.5.5 UPEC ydeH alleles do not complement the function of MG1655 ydeH 
This study showed that YdeH is a crucial c-di-GMP synthesising enzyme, which 
stimulates PGA dependent biofilm production in UTI89. Besides this common function, it 
became clear that a ΔydeH deletion in UTI89 and MG1655 did not equally affect attachment 
and resulted in a more severe phenotype in MG1655 (see Figure 5A and Boehm et al., 2009 
(20). It is thus plausible that the activities of the different E. coli YdeH alleles are not the 
same. Sequence analysis of ydeH revealed a total of 21 SNPs between UTI89 and MG1655, 
3 of which were non-silent. The first identified SNP (H31R) was located to the signal input 
domain, the second SNP (N130S) was within the linker connecting the signal input domain 
with the domain harbouring the DGC activity. The third SNP (A217T) was in a loop in 
proximity of the protein’s I-site and thus in the DGC domain of the protein. All SNPs are 
illustrated in Figure 12. Interestingly the ydeH ORF of 83972 harbours a deletion of 70 bp. 
This causes a frame shift and introduces an early stop codon. Interestingly, the deletion also 
results in a secondary start site, which is in frame with the first ORF of ydeH83972. 
Consequently, YdeH83972 is cut into two ORFs, one of which contains the signal input domain 
and the other the DGC domain. If both ydeH83972 are expressed it would result a DGC domain 
which is uncoupled from the signal input and thus might be constitutively active or inactive.  
Based on the differences between the ydeHMG1655, ydeHUTI89, and ydeH83972, a 
comparison of the different ydeH alleles in the genetic context of MG1655 seemed important. 
The respective ydeH alleles of UTI89 and 83972 were therefore introduced by allelic 
exchange into the native MG1655 ydeH locus and CsrA was inactivated to allow attachment. 
The attachment of these strains at 37° C is shown in Figure 13A where it is compared to 
MG1655, AB958, and AB959. UTI89 wild type pCsrB was included in both assays as the 
natural context of the ydeHUTI89 allele. Surprisingly, attachment of both MG1655 ydeHUTI89 
and MG1655 ydeH83972 was more comparable to MG1655 csrA
- ΔydeH (AB959) than to 
MG1655 csrA- (AB958), indicating that both foreign ydeH are not capable of replacing the 
ydeHMG1655 allele at 37°C.  
Experiments have shown that UTI89 adheres better at 37° C while MG1655 adheres 
better at 30°C. Therefore, the assay was repeated at 30° C. The ydeHUTI89 and ydeH83972 
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alleles behaved similarly at 30° and 37° C and did not complement the function of the natural 
MG1655 ydeH allele (Figure 13B). Attachment of UTI89 pCsrB is greatly reduced compared 
to AB958 at 30 °C while it attaches equally well at 37°C. Furthermore, the attachment of 
UTI89 pCsrB was in the same range as the attachment of AB959 at 30 °C, indicating that in 
its natural genetic context either the YdeH of UTI89 or MG1655 is not equally active at 30° C 
and 37° C.  
If the two transferred alleles were inactive in MG1655 (as indicated by the attachment 
data), the intracellular c-di-GMP concentrations of MG1655 ydeHUTI89 csrA
- and MG1655 
ydeH83972 csrA
- would have to be in the same range as the concentrations measured for a 
ΔydeH strain. To investigate this, intracellular c-di-GMP concentrations were measured in 
cell lysates of MG1655 ydeHUTI89 csrA
- and MG1655 ydeH83972 csrA
-. The c-di-GMP 
concentrations of the control strains are shown in Figure 13C and were determined as 
followed: 5.35 ± 1.24 μM in AB958, 0.31 ± 0.07 μM in MG1655 wild type and below detection 
limit in AB959. The intracellular c-di-GMP concentration measured for MG1655 ydeH83972 
csrA- was only 0.32 ± 0.09 μM and thus even lower than MG1655. Interestingly, the 
measured intracellular c-di-GMP concentrations for MG1655 ydeHUTI89 csrA
- was at 16.27 ± 
3.75 μM and thus significantly higher than the concentrations measured in AB958, indicating 
hyperactivity of this allele in MG1655.  
 
5.5.6 Murine cystitis models over 3 weeks are not sufficient to determine a role for 
PGA in vivo  
Considering the ability of UPECs to form intracellular biofilm like communities, and the 
established model of PGA dependent biofilm formation, it was reasoned that PGA could be 
relevant during UTIs. We therefore investigated the relevance of PGA in a murine cystitis 
model where mice were infected transurethrally (43) with UTI89 wild type (positive control), 
UTI89 ΔfimA-H as negative control and UTI89 ΔpgaA-D (Figure 14A). For UTI89 the 
infection proceeded as following: After one day 1.56X1006 ± 5.51X1005 CFU / g of bladder 
were detected. Within 2 days after infection, the CFU count dropped two log scales and 
stagnated thereafter. The kinetics of UTI89 ΔpgaA-D were very similar to the one of UTI89 
wild type, starting at 8.60X1006 ± 5.41X1006 CFU / g of bladder after 1 day and decreasing by 
almost two log scales until day 2. Than the bacterial titres only marginally decreased and 
stagnated at the same level of the titres in UTI89 wild type. UTI89 ΔfimA-H is known to have 
a reduced fitness in the host (7). Therefore, it was expected that the bacterial titres of UTI89 
ΔfimA-H were strongly reduced compared to UTI89 wild type. However, we found that the 
bacterial titres of UTI89 ΔfimA-H remained constant over the whole experiment of three 
Results 
49 
weeks. This finding indicates that UTI89 ΔfimA-H is capable of persisting in the bladder at 
very low but detectable titres over 3 weeks, arguing that type I fimbriae are not the sole 
virulence factor required for in vivo survival.  
Considering the low bacterial titres after 1 day post infection it was crucial to 
investigate, if the established animal model allowed differentiating between a strain capable 
of residing in the bladder and cause cystitis (UTI89), a strain with reduced virulence 
(UTI89ΔfimA-H), a non-pathogenic strain (MG1655) and a sterility control. Six mice per strain 
were therefore infected with UTI89 wild type, UTI89 ΔfimA-H, or the non-pathogenic MG1655 
and two mice were infected with sterile PBS to see if a distinction between these four 
different strains is possible (Figure 14B). While we detected 1.56 X1006 ± 5.51 X1005CFU / g 
of bladder for UTI89 wild type the titres of UTI89 ΔfimA-H were at 1.70 X1004 ± 1.24 X1004 
CFU / g of and very similar to the titres of MG1655 were (1.87 X1003 ± 9.78 X1002 CFU / g of 
bladder). Thus, the CFU / g of bladder counts of MG1655 were more than 800 times lower 
than those of UTI89 and only 9 times lower than the CFU / g of bladder counts of 
UTI89ΔfimA-H. Similarly, the infection of UTI89 ΔfimA-H was 92 times lower than the one 
caused by UTI89 wild type.  
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5.6 Discussion  
Pathogenic bacteria often survive and persist in the host by forming biofilms, in which 
they are protected from antimicrobial therapies and the host immune system. Treatment with 
antimicrobial chemotherapies are inefficient in killing biofilm associated pathogens (20, 49-
51) but expose them to sub-MICs for several hours (46). Importantly, sub-MIC of translation 
inhibitors were shown to induce PGA dependent biofilms in non-pathogenic E. coli (20) and 
recent reports suggest that UPECs form biofilms and express PGA during infections (52, 53), 
arguing that PGA should be relevant during the pathogenesis caused by UPECs. Similar to 
non-pathogenic E. coli MG1655 (20), it is shown here that different UPECs form PGA 
dependent biofilms upon derepression of the Csr system as well. C-di-GMP synthesised by 
the DGC YdeH induced PGA synthesis. Furthermore, the PGA dependent biofilms increased 
upon addition of translation inhibitors, which induced SpoT-mediated hydrolysis of ppGpp. 
However, deletion of the functional PGA machinery did not affect survival of UPECs during 
acute cystitis infections in mice. However, this finding might not exclude the importance of 
PGA expression during chronic infections. Long term effects of PGA genes on chronic 
infections could not yet be determined. 
 
5.6.1 UPECs form PGA dependent biofilms upon derepression of the Csr system 
To investigate the regulation of biofilms by the Csr system, different strategies were 
compared in the non-pathogenic MG1655. CsrB overexpression induced more attachment 
than partial CsrA inactivation. Inactivation of CsrA was not successful in the UPEC strain 
UTI89, probably due to reactivation of the Tn5 transposon in the UPEC strain UTI89. The 
overexpression of CsrB induced biofilm formation in UTI89, 83972 and PIII-V and hence 
circumvented the need to inactivate CsrA. Indeed, CsrB-mediated derepression in UPEC 
strains was comparable to CsrA-mediated derepression of the biofilm in MG1655 (20). 
Elevated levels of csrB and csrC were reported upon colonisation or growth of 83972 in 
human urine (54, 55) arguing that the Csr system is derepressed in vivo and could thus 
favour biofilm formation of UPECs during infection. In the pyelonephritis isolate CFT073 and 
the E. coli isolate DS17, which are able to infect the urothelium, inactivation of BarA/UvrY 
TCS reduces virulence during cystitis (56, 57), indicating that the Csr system is an important 
component for UTIs. Since UTI89 forms biofilm like structures upon internalisation into 
urothelial cells (2, 3, 58, 59), further experiments will show whether derepression of Csr 
system is relevant for IBCs. Different environmental signals might have an important impact 
with respect to localisation/colonisation of ABU and cystitis strains.  
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In our study, we found evidence that the Csr system functions as reported for non-
pathogenic E. coli and other bacteria (12, 17, 60, 61). It is likely to speculate that CsrB 
overexpression results in translation of pgaA-D and thus enhanced biofilm formation in 
UPECs. Indeed, in vitro attachment and biofilm production decreased upon deletion of pgaA-
D similar to MG1655 (17, 20). In contrast, the pgaA-D deletion had no effect on bacterial 
burden despite persistence in the bladder of mice for up to 21 days. This in vivo phenotype of 
the pgaA-D mutant was unexpected, since several upstream components required for 
enhanced PGA synthesis or PGA itself, increased virulence/persistence of UPECs or closely 
related species (12, 28, 53-57, 62, 63). However, none of the studies investigated the 
function of UPEC pgaA-D during cystitis. For example, the transcriptional regulator of pgaA-
D (NhaR) was recently determined to be a virulence factor during Proteus mirabilis UTIs (62). 
Furthermore, it was shown that antibodies against Staphylococcus aureus PGA were 
protecting mice from lethal E. coli infections (53, 64). Whether PGA affects survival, 
persistence and recurrence of UTIs after more than 21 days has to be determined. Moreover, 
histological sections of the bladder should be included, as the lack of pgaA-D might affect the 
structure of IBCs or the recruitment of immune cells.  
 
5.6.2 Sub-MICs of translation inhibitors affect attachment of most UPECs  
Sub-MICs of translation inhibitors have been shown to stimulate PGA dependent biofilm 
formation in MG1655 (20) and in UTI89 (this study). Most newly isolated UPECs did not form 
biofilms without the overexpression of csrB or sub-MICs of translation inhibitors in vitro, 
similar to UTI89. Boehm et al. showed in detail that the effect of translation inhibitors on 
ribosomes results in a cascade that signals ribosomal stress to the PgaA-D machinery. This 
cascade depends on SpoT-mediated hydrolysis of the alarmone ppGpp as well as the DGC 
YdeH (20). Since lack of ppGpp strongly boosted PGA dependent biofilm formation in UTI89, 
we propose a conserved ppGpp signalling mechanism for most UPECs. However, in the 
isolate clin571, sub-MICs of translation inhibitors are sufficient to stimulate attachment in the 
absence of csrB overexpression. One can hypothesise that exposure of clin571 to sub-MICs 
during treatment uncoupled PGA dependent biofilms from the status of the Csr system. It 
needs to be demonstrated if attachment of clin571 is mediated by pgaA-D. Another 
interesting finding in the present study is the clin591 strain, which attached independent of 
pgaA-D. As discussed later, we want to characterize the alternative biofilm matrix 
component, which appears to be independent of the Csr system and dominant over PGA. In 
summary, clin591 appears to be an aberrant UPEC that is interesting to study but does not 
represent a subgroup of UPECS.  
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5.6.3 c-di-GMP increases attachment of UPECs 
The second messenger c-di-GMP is important in the signalling network that contributes to 
PGA dependent biofilm formation in MG1655 and UPECs. Similar to the effects of csrB 
overexpression in different UPECs, modulation of c-di-GMP levels has not the same impact 
on attachment of all UPECs. Nevertheless, once the Csr system was derepressed the c-di-
GMP mediated stimulation of biofilm production was reproduced in all strains upon DgcA 
overexpressed.  
In a screening of MG1655 mutants each lacking one DGC (GGDEF domain), PDE (EAL 
domain), or composite protein (GGDEF and EAL domain) at a time, only the ydeH (DGC) 
deletion mutant showed reduced attachment (20). We analysed DNA sequences in different 
UPECs and found that the amount and diversity of DGCs, PDEs, and composite proteins is 
similar to MG1655 (data not shown). Considering the similar availability of c-di-GMP related 
proteins in UPECs and MG1655 as well as the conserved function of PGA and the Csr 
system, we assumed that YdeH must be one of the major contributors of c-di-GMP in UTI89. 
We confirmed this hypothesis by demonstrating a decreased attachment in a UTI89 ΔydeH 
deletion mutant. This suggests that UPECs also use c-di-GMP synthesis to stimulate pgaA-D 
dependent biofilm formation. Importantly, we showed that PGA dependent attachment could 
still be modulated via alternative DGCs (e.g. ycdT) or PDEs (c1116) in the absence of YdeH.  
A recent study has shown that ycdT of E. coli is a DGC which is under positive selection in 
UPECs (28). However, did not find altered activity of the ycdT deletion in UPECs, indicating 
that ycdT is a weak diguanylate cycles in both MG1655 and UTI89. We observed that 
deletion of YdeH and YcdT together reduced the attachment more than deletion of YdeH 
alone. Despite of the missing ci-di-GMP measurements, we conclude that YcdT behaves like 
an active but weak DGC in UTI89. From the phenotypic comparison between UTI89 ΔydeH 
and UTI89 ΔycdT it appears that the strong DGC (YdeH) compensates for the lack of c-di-
GMP upon deletion of the weak DGC (YcdT). On the other hand, weak DGCs might not be 
able to complement the reduced production of c-di-GMP of a strong DGC mutant (YdeH). We 
speculate that strong DGCs like YdeH serve to promote major physiological adaptations, e.g. 
by stimulating PGA production, while weak DGCs (e.g. YcdT) have a modulatory function. 
This would allow hierarchical roles of DGCs (and PDEs) depending on transcriptional, 
translational (e.g. via CsrA), post-translational levels but also via protein activity (e.g. 
dimerisation) and stability. Additionally, the hierarchy must be influenced by the availability of 
external and internal signals that activate specific DGCs (or PDEs) via their signal input 
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domains. This would allow bacteria to change their lifestyle when strong DGCs or PDEs are 
activated. Evidence for this assumption is demonstrated by ribosomal stress affecting PGA 
dependent biofilm formation in a ppGpp and YdeH dependent manner (20). On the contrary, 
the signals of a weak DGCs (e.g. YcdT) or PDEs would be inferior and only marginally affect 
bacterial physiology. To predict the interplay of different c-di-GMP metabolising DGCs and 
PDCs, their activity and abundance needs to be assessed in vivo. Furthermore, animal 
experiments would be helpful to investigate the overall effects of c-di-GMP on the UPEC 
pathogenesis. Ideally, this could be achieved by overexpression of either strong DGCs or 
PDEs, under a constitutive promoter from the chromosome. To fully test our established 
attachment model, the phenotypes of UTI89 deletion mutants affecting the Csr system (e.g. 
BarA/UvrY, csrB, csrC or CsrD) also need to be investigated in vivo. 
 
5.6.4 Biofilm formation in clin591 is different than in UTI89 
Clin591 was originally included in this study because of its aberrant behaviour in biofilm 
formation compared to all the other UPECs that form PGA dependent biofilms. As already 
discussed above, the attachment of a pgaA-D mutant in clin591 depended on an alternative 
matrix component. Interestingly, clin591 attachment responded variably upon overexpression 
of csrB from different plasmids (pcj30 csrB vs. pCsrB). While the induction of pcj30 csrB 
resulted in a stimulation of biofilm, pCsrB induction had no effect on attachment. The 
difference might be caused by sequences around the two insertion sites of csrB on the two 
plasmids as well as the different transcriptional start sites in both vectors. Furthermore, the 
copy number of pcj30 and pME6032 per cell might be different influencing the level of 
plasmid derived csrB molecules per cell. From this we conclude that clin591 is more 
susceptible to fluctuations of csrB levels than other UPECs. The different attachment 
behaviour of clin591 could thus be attributed to altered sensitivity toward the Csr system. To 
test this idea, all known components of the Csr system (barA, uvrY, csrB, csrC, csrD and if 
possible csrA) have to be deleted in clin591 and phenotypically characterised in attachment 
assays. If any component affects clin591 attachment, they should be sequenced and 
compared to other UPECs.  
It is known that c-di-GMP positively activates many different forms of biofilm matrices (65-
67), arguing that elevated levels of c-di-GMP could still boost this non-PGA dependent 
biofilm formation of clin591. Overexpression of DgcA, as well as the deletion of ydeH showed 
the expected responsiveness of this strain to c-di-GMP. As this responsiveness only became 
apparent upon overexpression of csrB it can be argued that the non-PGA matrix component 
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remains dependent on the Csr cascade and c-di-GMP. Alternatively, it could be hypothesised 
that clin591 forms biofilms, which are composed of two matrix components other than type I 
fimbriae (data not shown) and PGA. In such a situation, one matrix component is always 
activated while the other one requires elevated levels of csrB and c-di-GMP to be induced. 
This hypothesis would also account for the fact that sub-MICs of translation inhibitors do not 
stimulate clin591 attachment, since this induction depends on pgaA-D. A transposon 
mutagenesis screen in clin591 might lead to the identification of the matrix components.  
 
5.6.5 YdeHUTI89 and YdeH83972 alleles do not complement YdeHMG1655 
YdeH was shown to be the DGC with the strongest attachment phenotype in MG1655 
(20) and UTI89 (this study). Other than ycdT this DGC is quite conserved among UPECs and 
other E. coli species (data not shown). Compared to MG1655 the allele of UTI89 contains 
three non-silent SNPs that are located evenly dispersed throughout the protein. According to 
the structure of YdeH (F. Zaehringer; unpublished data) these three SNPs localize in the 
dimerization interphase of the sensory domain, in the GGDEF domain that comprises the 
active site and in the loop connecting the two domains. Based on their localisation it was 
impossible to deduce the significance of any SNPs. Therefore, two different ydeH alleles 
(ydeHUTI89 and ydeH89372) were investigated in the genetic background of MG1655 csrA
-. We 
found that their effects on intracellular c-di-GMP levels and pgaA-D dependent attachment 
were different. The attachment and the intracellular c-di-GMP concentrations of MG1655 
csrA- ydeH89372 together indicate a low activity of ydeH89372. Despite its elevated level of c-di-
GMP determined for ydeHUTI89, this allele resulted in an attachment similar to a ydeH deletion 
mutant (AB959). Though counterintuitive these results have been observed in hyperactive 
ydeH alleles (A. Boehm, personal communication) indicating that maximal attachment can 
only occur in a specific margin of c-di-GMP levels. Thus hyperactivity of YdeHUTI89 could 
explain the observed phenotypes. A step by step modification of ydeHMG1655 towards 
ydeHUTI89 through insertion of one SNP at a time followed by a biochemical comparison of the 
different alleles would be very helpful in understanding which of the SNP / SNPs is / are 
responsible for the potentially more active ydeH of UTI89.  
In conclusion, the in vitro effect of PGA and c-di-GMP on biofilm formation of UPECs 
seems to be comparable to the model established in MG1655 (20); however, animal studies 
did not jet reveal the impact of PGA or c-di-GMP during chronic cystitis and requires further 
investigations. 
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5.7 Figure Legend 
Figure 1: Congo red binding in UPEC strains 
The ability of UPECs to bind congo red was compared to the laboratory MG1655 wild 
type strain, MG1655 csrA- (AB958) and MG1655 csrA- ΔydeH (AB959). A) Congo red 
binding on LB plates containing 0.1 % congo red. B) Congo red binding of selected UPEC 
strains on LB plates containing 0.04 % congo red and 20 μg / ml coomassie brilliant blue 
(35). These Images of colonies reveal more subtle differences compared to colonies in 
A).illumination from above. 
 
Figure 2: Motility of UPEC strains 
Motility of UPEC strains on 0.3 % TB swarm agar plates was compared to the 
laboratory MG1655 strain, MG1655 csrA- (AB958) and MG1655 csrA- ΔydeH (AB959). All 
motility plates were simultaneously scanned on a Microtek ScanMaker i800 scanner. The 
inlets of 83972 and PIII-4 are images of the same plates taken through a binocular (Wild; 
Heerbrugg M3Z) at a magnification of 24 x with a Nikon Coolpix 990. All images were 
processed with Photoshop CS5.  
 
Figure 3: Attachment of UPEC strains 
Comparative analysis of biofilm formation between different E. coli strains A) The 
attachment of MG1655 csrA- is compared to the attachment of MG1655 upon overexpression 
of csrB from plasmid (pcj30 csrB) or its control vector pcj30, respectively. B) Attachment of 
different UPEC strains and the effects of csrB overexpression from pcj30 csrB: Attachment 
values are shown as (surface-attached biomass divided by optical density of total cells). 
White bars show the attachment of strains with the empty vector (pcj30), black bars show 
attachment of strains carrying pcj30 csrB. C) Illustrates the effects of artificially increased 
cyclic-di-GMP levels on attachment. All data sets in C) have been normalised to the csrB 
induced biofilm of each wild type strain. The values are normalised as follows: ((surface-
attached biomass divided by optical density of total cells) in percentage of wild type pCsrB). 
The pME6032 plasmid is used as vector control for pME6032 csrB. Increased c-di-GMP 
values are achieved through overexpression of the diguanylate cyclase DgcA from pBAD18. 
Black bars represent data obtained for UTI89, data for 591 is illustrated in white, light grey 
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shows data for 83972 and dark grey illustrates attachment of PIII-4. All errors are standard 
errors of the mean and are calculated from at least 6 wells per strain.  
 
Figure 4: Influence of DGCs and csrB on motility of UTI89 
The influence of csrB (pcj30 CsrB), DgcA (pAB551), the point mutant DgcA D164N 
(pAC551), and WspR (pME6010 WspR) on motility of UTI89 upon overexpression from 
plasmid was analysed on 0.3 % TB swarm agar and compared to the motility of UTI89 
without plasmids and UTI89 with control plasmids. If necessary, TB swarm plates were 
supplemented with ampicillin (pcj30, and pBAD18) or tetracyclin (pME6032) and induced 
with 100 μM IPTG or 0.2 % arabinose. After 6h of growth at 37° C, swarm plates were 
scanned on a Microtek ScanMaker i800 scanner and images were processed with 
Photoshop CS5.  
 
Figure 5: The role of poly-GlcNAc, and diguanylate cyclases on UTI89 attachment  
Poly-GlcNAc and c-di-GMP contribute to efficient biofilm formation in UTI89: A) Bars 
are shown as percentage of UTI89 wild type pcj30 csrB attachment calculated as (surface-
attached biomass divided by optical density of total cells). Data obtained for the control 
plasmid pcj30 is show in white, data for pcj30 csrB is shown in black. Error bars are standard 
errors of the mean calculated over at least three independent assays. B – F): Electron 
micrographs of biofilms grown statically on glass slides for 24 h at 37°C in the presence of 
pcj30 csrB induced with 100 μM IPTG. Scale bars are indicated in each micrograph taken at 
a magnification of ~1000x. B) UTI89 wild type. C) UTI89 ΔycdT. D) UTI89 ΔydeH. E) UTI89 
ΔpgaA F) UTI89 ΔycdT ΔydeH.  
 
Figure 6: The role of poly-GlcNAc, and diguanylate cyclases on clin591 attachment  
Poly-GlcNAc and c-di-GMP do not majorly contribute to efficient biofilm formation in 
clin591: The data is shown as percentage of clin591 wild type pcj30 csrB attachment 
corrected for growth (surface-attached biomass divided by optical density of total cells). Data 
obtained for the control plasmid pcj30 is show in white, data for pcj30 csrB is shown in black. 
Error bars are standard errors of the mean. 
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Figure 7: Effects of translation inhibitors on clin591 biofilms at sub-MICs 
Biofilms of clin591 were grown in the presence of sub-MICs of (A) tetracycline, (B) 
streptomycin and (C) chloramphenicol. The concentrations used for each antibiotic are 
indicated on the x-axis of each graph. Bars indicate quantified attachment (left y-axis). 
Bacterial growth is indicated as curves on the right y-axis and was measured at an OD600. 
Error bars are standard errors of the mean. The left graphs illustrate the absolute attachment 
(OD600 of crystal violet staining) of clin591 while the right graphs show the relative attachment 
(OD600 of crystal violet staining / OD600 of growth).  
 
Figure 8: Effects of tetracyclin on clin571 biofilm at sub-MICs 
Biofilms of clin571 were grown in the presence of sub-MICs of tetracycline. The 
concentrations of tetracycline are indicated on the x-axis of the graph. Bars indicated the 
quantified attachment (left y-axis). Bacterial growth is indicated as curves on the right y-axis 
and was measured at an OD600. Error bars are standard errors of the mean. The left graph 
illustrates the absolute attachment (OD600 of crystal violet staining) of clin571 while the right 
graph shows the relative attachment (OD600 of crystal violet staining / OD600 of growth).  
 
Figure 9: Induction of UTI89 biofilms by sub-MICs of translation inhibitors and the 
importance of csrB overexpression 
UTI89 pcj30 csrB biofilms were exposed to sub-MICs of (A) tetracycline, (B) 
streptomycin and (C) chloramphenicol. The respective antibiotic concentrations are indicated 
on the x-axis of each graph. Uninduced UTI89 pcj30 csrB (black) was compared to UTI89 
pcj30 csrB induced with 10 µM IPTG (light grey) and UTI89 pcj30 csrB induced with 100 µM 
IPTG (dark grey). Bars indicate the quantified attachment (left y-axis). Bacterial growth is 
indicated as curves on the right y-axis and was measured at an OD600. Error bars are 
standard errors of the mean. On the left side, bacterial biomass is quantified as absolute 
values (OD600 of crystal violet staining) while the right graphs show relative attachment 
(OD600 of crystal violet staining / OD600 of growth).  
 
Figure 10: Biofilm induction by sub-MICs of tetracycline and the importance of pgaA-D  
UTI89 strains were exposed to sub-MICs of tetracycline for 24 h after which cell density 
(growth) and bacterial surface attachment was quantified. The antibiotic concentrations used 
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are indicated on the x-axis of each graph. UTI89 pcj30 is shown in light grey, UTI89 pcj30 
csrB in black and UTI89 ΔpgaA-D pcj30 csrB is shown in dark grey. Bars indicate the 
quantified attachment (left y-axis). Bacterial growth is indicated as curves on the right y-axis 
and was measured at an OD600. Error bars are standard errors of the mean. On the left side, 
bacterial biomass is quantified as absolute values (OD600 of crystal violet staining) while the 
right graph shows the relative attachment (OD600 of crystal violet staining / OD600 of growth). 
 
Figure 11: The importance of the Csr cascade, c1116 and ppGpp on UTI89 attachment  
Data is shown as percentage of UTI89 pCsrB attachment of (surface-attached biomass 
divided by optical density of total cells) . Data obtained for the control vector pME6032 is 
show in white, data for pCsrB is shown in black. Error bars are standard errors of the mean. 
A) Effects of csrB, csrC and csrD on poly-GlcNAc dependent attachment. The data was 
calculated as average over tree independent attachment assays. Bars are calculated from 
n≥10 wells. B) Attachment data of an UPEC specific PDE c1116 and its adjacent gene 
c1117: The data shown in the graph was calculated as average over two independent 
attachment assays and at least 7 wells. C) Attachment of a ppGpp0 UTI89 strain. The 
attachment was calculated over 6 wells per strain and plasmid and corrected for growth. 
 
Figure 12: SNPs between YdeH of MG1655 and UTI89 
The positions of non-silent SNPs found between MG1655 and UTI89 are shown on the 
structure of the MG1655 YdeH (Zaehringer et. al, manuscript in process). A) Structure of a 
YdeH dimer of MG1655. The protein comprises a signal input domain in the C-terminus and 
a DGC domain which comprised the active site (A-site) of the enzyme as well as the I-site of 
the protein. The two domains are connected via a linker that contains one of the three non-
silent SNP (N130S). The position of this SNP is marked with a red circle. B) Visualization of 
the DGC domain containing both the A-site and I-site of the protein. A217T is a SNP which is 
located on a loop in proximity of the I-site. A217 is encircled in red. C) Representations of the 
signal input domain of YdeH. The third SNP (H31R) is encircled in red in both 
representations. In the left illustration, the viewer looks down the dimerization interface of the 
protein. On the right side, the protein is tilted by 90° and thus shows the signal input domain 
of the protein.  
 
Figure 13: ydeH allelic exchange in MG1655 
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The attachment assay was performed at (A) 37° C and (B) 30° C to account for the fact 
that UTI89 adheres better at 37°C while MG1655 adheres better at 30°C. In UTI89 the 
pME6032 csrB plasmid was overexpressed and in MG1655 strains the CsrA was inactivated 
(csrA-). Bars are calculated as (surface-attached biomass divided by optical density of total 
cells) and then normalised to the attachment of MG1655 csrA- (100 %). Error bars are 
standard errors of the mean. C) Intracellular c-di-GMP concentrations of MG1655 with ydeH 
alleles of UTI89 and 83972. The c-di-GMP levels have been measured as triplicates via 
HPLC-MS/MS. Levels are indicated as total μM c-di-GMP concentration per bacterial cell. 
 
Figure 14: Murine cystitis model 
For each experiment, 6 mice were infected with 1.5x109 bacteria concentrated in 30-45 
μl sterile 0.9 % saline solution and observed for 1, 2, 3, 7, 14 or 21 days prior sacrifice. The 
data is represented as CFU / g of bladder with the median and the interquartile range over all 
animals (between 6 and 18 mice per strain and time point). CFU counts per animal are 
averaged from several plates of one bladder dilution series. None of the infected mice 
suffered from severe weight loss, died, or had to be sacrificed in advance, indicating that the 
wellbeing of the animals was never endangered during the experiment. The detection limit of 
10 CFU / g of organ is shown as a dotted line. A) UTI89 (●), UTI89 ΔpgaA-D (○) and UTI89 
ΔfimA-H (●). B) UTI89 (■), UTI89 ΔfimA-H (▲), MG1566 (▼) or PBS (♦), respectively. 
Values below the detection limit of 10 CFU per ml are indicated on the dotted line. 
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5.9 Tables 
Table 1: Strains used in this study 
Strain Genotypes Pathogenesis Reference 
MG1655 wt sequenced wild type non-pathogenic 
Blatter et al., 1997 
(68) 
AB958 csrA
-
::Tn5 N.A 
Boehm et al., 2009 
(20) 
AB959 csrA
-
::Tn5 N.A 
Boehm et al., 2009 
(20) 
AB1295 ydeH::ccdB kan pKD46 N.A this study 
AB1295 csrA
- 
ydeHUTI89 
csrA
-
::Tn5 ydeH::ccdB::ydeHUTI89 N.A this study 
AB1295 csrA
- 
ydeH83972 
csrA
-
::Tn5 ydeH::ccdB::ydeH83972 N.A this study 
536 wt sequenced wild type Pyelonephritis 
Hochhut  et al., 2006 
(30) 
clin571 wt wild type Cystitis this study 
clin591 wt wild type Catheter Associated UTI this study 
clin591 ΔycdT ycdT::kan  N.A this study 
clin591 ΔydeH ydeH::kan  N.A this study 
clin591 ΔpgaA-D pgaA-D::kan  N.A this study 
83972 wt sequenced wild type Asymptomatic bacteriuria 
Andersson  et al., 1991 (31) 
Lindberg et al., 1975 (32) 
CFT073 wt sequenced wild type Pyelonephritis 
Welch et al., 2002 
(29) 
PIII-4 83972 re-isolate Asymptomatic bacteriuria Zdziarski et al., 2008 (69) 
UTI89 sequenced wild type Cystitis 
Mulvey et al., 2001 (27)  
Chen et al., 2006 (28) 
UTI89 ΔycdT ycdT::FRT N.A this study 
UTI89 ΔydeH ydeH::FRT  N.A this study 
UTI89 Δycd ΔydeH ycdT::FRT ydeH::cat N.A this study 
UTI89 ΔpgaA-D pgaA-D::FRT N.A this study 
UTI89 ΔcsrB csrB::FRT N.A this study 
UTI89 ΔcsrC csrB::FRT N.A this study 
UTI89 ΔcsrBC csrBC::FRT N.A this study 
UTI89 ΔcsrD csrD::FRT N.A this study 
UTI89 Δc1116 c1116::FRT N.A this study 
UTI89 Δc1117 c1117::FRT N.A this study 
UTI89 Δc1116 Δc1117 c1116::FRT c1117::FRT N.A this study 
UTI89 ΔrelA ΔspoT relA::FRT spoT::kan  N.A this study 
UTI89 ΔfimA-H fimA-H::FRT N.A 
Abgottspon et al., 2010 
(37) 
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Table 2: Plasmids used in this study 
Plasmid name Relevant genotype Comments Reference 
pcj30 lacI
P 
bla
+ 
(Amp
R
) IPTG inducible expression vector 
Bibikov et al., 1997  
(70) 
pcj30 csrB  pcj30::csrB (Amp
R
) 
IPTG inducible expression vector; overexpression of 
csrB 
this study 
pME6032 
pVS1 derived shuttle 
vector (Tet
R
) 
IPTG inducible expression vector 
Heeb et al., 2000  
(71) 
pME6010 WspR  pME6010::wspR (Tet
R
) 
IPTG inducible expression vector; overexpression of 
WspR 
Malone et al., 2007 
(72) 
pCsrB pME6032::csrB (Tet
R
) 
IPTG inducible expression vector; overexpression of 
csrB 
this study 
pBAD18 araC
+ 
bla
+
 (Amp
R
) Arabinose inducible expression vector 
Guzman et al., 1995 
(73) 
pAB551 pBAD18::dgcA (Amp
R
) 
Arabinose inducible expression vector, 
overexpression of DgcA (cc3285) from C. 
crescentus; 
Boehm et al 2009 (20) 
Christen et al., 2006 
(74) 
pAC551 
pBAD18::dgcA-D164N 
(Amp
R
) 
Arabinose inducible expression vector, 
overexpression of DgcA D164N point mutant from 
C. crescentus; 
This study & Master 
thesis A. Casanova 
pKM208 lacI
P 
(Amp
R
) 
IPTG inducible, temperature sensitive replication; 
λRED-mediated recombinogenic plasmid  
Murphy et al., 2003  
(38) 
pKD46 araC
+
 (Amp
R
) 
Arabinose inducible, temperature sensitive 
replication; λRED-mediated recombinogenic 
plasmid 
Datsenko et al., 2000 
(39) 
pCP20  flp
+ 
(Amp
R
) (CM
R
) 
temperature-sensitive replication with inducible FLP 
recombinase 
Cherepanov et al., 
1995 
(75) 
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Table 3: Newly isolated UPECs from urine of hospitalised patients screened for sub-
MIC induction of biofilm 
Name TET 
R/S
 Biofilm*  
Tetracyclin
e induction
# 
 
Characteristics; comments 
Age 
Patient  
Gender 
Patient 
536 S -- -- Sequenced pyelonephritis isolate N.A N.A 
UTI89 S -- -- Sequenced cystitis isolate N.A F 
clin76 S -- -- Patient had chemo due to metastatic rectum cancer 74 F 
clin56 S -- -- Patient carried a DJ-Catheter 65 F 
clin162 S -- * Patient had urethral complications and cerebral lymphoma 77 F 
clin172 S -- * permanent catheter; patient had a spinal cord injury and UTI 94 F 
clin181 S -- -- N.A 45 F 
clin184 R -- -- N.A 75 F 
clin197 S -- -- Patient suffered from Campylobacter gastroenteritis 94 M 
clin211 R -- -- Patient with a permanent catheter 54 M 
clin217 S -- * N.A 91 M 
clin225 R -- -- Isolate was identified as ESBL; Patient was catheterised 75 F 
clin238 S -- -- Patient with chronic obstructive pulmonary disease 83 F 
clin241 R -- -- N.A 64 F 
clin248 S -- -- 
Patient suffered from an infra-renal rupture of an aortic 
aneurysm 
68 M 
clin257 R -- -- permanent catheter 83 M 
clin287 S -- -- N.A 59 M 
clin295 S -- -- N.A 88 M 
clin310 S -- -- permanent catheter 51 M 
clin334 R -- -- 
permanent catheter; patient suffered from an acute lymphatic 
leukaemia  
61 F 
clin340 S -- -- permanent catheter 86 F 
clin342 S -- -- N.A 35 F 
clin343 S -- -- N.A 34 F 
clin344 S -- -- N.A 73 F 
clin551 S -- -- N.A 78 F 
clin559 S -- -- permanent catheter 91 F 
clin565 S -- -- permanent catheter 78 M 
clin567 S -- -- N.A 37 F 
clin571 S -- *** N.A 82 F 
clin575 S -- -- N.A 89 M 
clin580 S -- -- N.A 74 F 
clin591 S *** ** Isolate from Urine of a patient carrying a D-J catheter 76 F 
clin594 S -- -- N.A 30 F 
clin601 S -- -- N.A 81 F 
clin602 S -- -- N.A 76 F 
clin619 S -- -- Patient was catheterised 87 F 
clin623 S -- -- N.A 23 F 
clin624 S -- -- N.A 69 M 
Tables 
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clin626 S -- -- N.A 90 F 
clin650 S -- -- N.A 58 F 
clin652 S -- -- N.A 86 F 
clin661 S -- -- N.A 81 M 
clin695 S -- -- N.A 79 F 
clin701 S -- -- N.A 50 F 
clin702 S -- -- N.A 89 F 
clin709 R -- -- Patient was catheterised 54 F 
clin712 R -- -- N.A 26 F 
clin717 S -- -- N.A 64 F 
clin719 R -- -- Isolate was identified as ESBL 87 F 
clin721 S -- -- N.A 74 F 
clin722 S -- -- N.A 66 F 
clin724 R -- -- N.A 40 F 
clin726 S -- -- N.A 51 F 
clin758 R -- -- Patient was catheterised 63 F 
clin769 S -- -- N.A 29 F 
clin787 S -- -- Patient was catheterised 83 F 
    
-- No biofilm or no biofilm induction by sub-MIC of tetracycline   
* Biofilm was quantified in LB with wild type strains and without sub-MIC of tetracycline (Csr components were left at steady state) 
# Biofilm was quantified in LB with wild type strains and sub-MIC of tetracycline (Csr components were left at steady state) 
N.A Data not available 
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Table 4: Primer List 
Primer name Primer Sequence 
1143_csrB_KO_P1 CTTGTAAGACTTCGCGAAAAAGACGATTCTATCTTCGTCGACAGGTGTGTAGGCTGGAGCTGCTTCG 
1144_csrB_KO_P2 CATAAAGCAACCTCAATAAGAAAAACTGCCGCGAAGGATAGCAGGCATATGAATATCCTCCTTA 
1145_csrC_KO_P1 TGGCGGTTGATTGTTTGTTTAAAGCAAAGGCGTAAAGTAGCACCCTGTGTAGGCTGGAGCTGCTTCG 
1146_csrC_KO_P2 GCCGTTTTATTCAGTATAGATTTGCGGCGGAATCTAACAGAAAGCCATATGAATATCCTCCTTA 
1545-ycdP_KO_P2 GTGCAGAGCCCGGGCGAACCGGGCTTTGTTTTGGGTGTTTATGCCCGTCACATATGAATATCCTCCTTA 
1546-ycdS-KO-P1 TAATTAGATACAGAGAGAGATTTTGGCAATACATGGAGTAATACAGGTGTGTAGGCTGGAGCTGCTTC 
1651-ydeH_test_fwd GCCGGACCAGATGATCAACATTAGTGG 
1652-ydeH_test_rev TGACTAATGAACGGAGATAATCCCTCACC 
2125-spoT_KO_P1 TGCTGAAGGTCGTCGTTAATCACAAAGCGGGTCGCCCTTGTATCTGTTTTGTAGGCTGGAGCTGCTTCG 
2126-spoT_KO_P2 GTTGGGTTCATAAAACATTAATTTCGGTTTCGGGTGACTTTAATCACATATGAATATCCTCCTTAG 
2145-fimA_KO_P1 GCCCATGTCGATTTAGAAATAGTTTTTTGAAAGGAAAGCAGCATGAAAATTGTAGGCTGGAGCTGCTTCG 
2146-fimH_KO_P2 GTAATATTGCGTACCAGCATTAGCAATGTCCTGTGATTTCTTTATTGATACATATGAATATCCTCCTTAG 
2400-ydeH_KO_P1 TAGAATAGCGCGCACAAGGAACTGTGAAAAAGGAGTGGCAATGATCAAGTGTAGGCTGGAGCTGCTTCG 
2401-ydeH_KO_P2 CACAGTAGCATCAGTTTTCTCAATGAATGTTAAACGGAGCTTAAACTCGCATATGAATATCCTCCTTAG 
2402_ycdT_seq_fwd1 TCATCATCGGTATTGTTTGTGGGCGG 
2762_ycdT_KO_P2 CCGGGGGGATGAGAAGCCCCAGGCGGAGGTCGACAACTAGCGACAGACTGCCGCTTTATGGTGACTCAC 
2878_c1116_KO_P1 CTTCTGGTCGGGAGGGGCTCATATTTCCGGAGGAGTAATGTCAGGGGCATGTGTAGGCTGGAGCTGCTTCG 
2879_c1116_KO_P2 GAACATAAATGCTGGCTGCTGACAAGTCTGTGAAAAAGGATTATCCATGCAGCATATGAATATCCTCCTTAG 
3547_c1117_KO_P1 GGAATAAATTGTAGTGGAAAGTCGAAGTTTACCGGATGACTGATGCGCTGTGTAGGCTGGAGCTGCTTCG 
3548_c1117_KO_P2 GTCTTTCTGCAACACTACTGCTTTCAACAAGTCAGGCATTTCACACTTTATGACATATGAATATCCTCCTTAG 
3880_CsrD_KO_P1 GCTAGTATGCCCGCTTCCTCACTATCGGAGTTAACACAAGGATGAGATGTGTAGGCTGGAGCTGCTTCG 
3881_CsrD_KO_P2 GCAGCGCGCGTTATTCTACGTGAAAACGGATTAAACGGCAGGTTAAACCGACATATGAATATCCTCCTTAG 
3927_relA_test_rev CAATAATTAATTTGCCATCC 
3927_relA_test_rev CAATAATTAATTTGCCATCC 
3928_relA_test_fwd ATAAAACTGGAACCTATTCG 
3928_relA_test_fwd ATAAAACTGGAACCTATTCG 
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6.2 Abstract 
The successful establishment of acute and chronic urinary tract infections by 
uropathogenic E. coli strongly depends on the expression of type I fimbriae. Chronic bladder 
infections are mostly associated with sessile bacteria that persist in the host as multicellular 
communities for up to 3 years. These persister cells are encased in a self-produced matrix 
composed of varying components that include proteinacious structures e.g. type I fimbriae, or 
exopolysaccharides like poly β-1,6-N-acetylglucosamine (PGA). This in vitro study shows 
that expression of type I fimbriae p   negatively interfere with PGA dependent biofilm 
formation in the cystitis isolate UTI89. To avoid interference UTI89 inversely regulates the 
expression of the two adhesins in a process that depends on the carbon storage regulator 
(Csr) system. Important players include csrB, the invertible element fimS as well as the 
recombinase FimE. We conclude that the inversed regulation by the Csr pathway, known to 
stimulate the PGA expression, simultaneously affects phase variation of type I fimbriae and 
pushes fimS into an OFF orientation. The studies unravel a novel regulatory feature of the 
global Csr system as mediator of an inverse regulation of two important surface adhesins, 
possibly to mediate the switch from an acute, type I fimbriae dependent infection to a 
persistent PGA-dependent sessile state of infection. 
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6.3 Introduction 
Uropathogenic Escherichia coli (UPEC) are the primary cause of human urinary tract 
infections (UTI) and are responsible for a remarkable progression of disease. Once in the 
bladder the pathogen adheres to the urothelium, internalises into superficial facet cells where 
it rapidly multiplies before shifting into a sessile biofilm-like state, which can persist for up to 
3 years (1-4). Functioning as a reservoir of bacteria, these intracellular biofilm-like structures 
are believed to be the source for recurring UTIs (2, 5-8). The initial step during UPEC 
pathogenesis depends on a virulence factor, which enables bacteria to adhere to eukaryotic 
cells. This is a long linear polymer termed type I fibrillum, which protrudes from the surface of 
the bacterium and is encoded by the fimAICDFGH (fimA-H) genes (9). With these hair-like 
structures, UPECs are capable to overcome possible repulsive forces between the bacterial 
and eukaryotic surfaces and thereby initiate host contact (10). Type I fimbriae are composed 
of a pilus rod (FimA) and a tip fibrillum consisting of three monomeric proteins, FimF, FimG 
and the distal tip adhesin FimH. FimH binds to surface exposed mannosylated host proteins, 
including β1 and α3 integrins or the uroplakin UP1a (11-14). If Fim-mediated contact is 
missing, the virulence of UPECs massively decreases (15). The expression of type I fimbriae 
underlies a complex and tightly controlled regulatory network that governs the directionality 
of a DNA element (fimS) preceding the structural genes of type I fimbriae (fimA-H). The fimS 
switch-region is an invertible element of 314 bp that is flanked by inverted repeats (IRs) and 
contains the promoter of fimA-H and a multitude of binding sites for factors that influence the 
orientation of fimS (16). If the promoter located on fimS is oriented toward fimA bacteria 
express type I fimbriae (ON phase), but if the promoter is directed away from fimA bacteria 
are non-fimbriated (OFF phase). The directionality or phase of fimS is determined by three 
recombinases, FimB, FimE, and FimX, which belong to the λ integrase family of site-specific 
recombinases (16-18). While FimB and FimE have long been identified, FimX, which is not 
part of the fimA-H operon, was only recently determined as a FimB homolog in UPECs, 
where it was reported to be highly active in vivo but not in vitro (19). Importantly, the 
recombinases determining fimS orientation act independently (18, 20-23) and their 
directional preferences for fimS switching are different (16, 22, 24). FimE catalyses the 
inversion from ON to OFF, while FimB and its homolog FimX, although capable of catalysing 
the inversion of fimS in both directions, show a slight bias for the OFF to ON direction. 
Furthermore, the inversion frequencies triggered by FimB are markedly lower than the ones 
of FimE (21, 25). The inversion frequencies of FimX have not yet been investigated or 
compared to the ones of FimB and FimE. As the regulation of fimB, fimX and/or fimE 
expression is multifactorial as well and their action can be influenced by several factors that 
facilitate or hinder their recombineering action (16, 26), the equilibrium residing over the 
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phase of fimS is complex and difficult to predict. Despite this complexity, the regulation of 
fimS in the bladder appears to favour the fimbriated state of bacteria and hence bacterial 
adherence, infection of superficial facet cells, and ultimately the formation of intracellular 
bacterial communities (IBCs) and bacterial reservoirs (2, 3). Bacterial reservoirs or other 
chronic and recurrent infections are generally associated with the formation of bacterial 
biofilms, for example in cystic fibrosis, periodontitis or many others (27-30). The formation of 
biofilms is a complex process, which is highly regulated on both temporal and spatial levels. 
Bacteria within biofilms are encased in a self-produced matrix of proteinacieous adhesins 
and exopolysaccaride structures, which protects cells from assaults by the host immune 
system and from chemical threats. Interestingly, type I fimbriae of UPECs have also been 
implicated in the successful establishment of IBC formation during cystitis, where they are 
presumed to promote bacterial inter-adhesion (31) and thus biofilm formation. However, the 
exact involvement of type I fimbriae in E. coli biofilms during pathogenesis remains unclear 
(32-34). 
Several Gram-positive (Staphylococcus aureus and Staphylococcus epidermidis (35-
38)) and Gram-negative bacteria (E. coli, Actinobacillus actinomycetemcomitans and 
Actinobacillus pleuropneumoniae (39, 40)) utilise poly β-1,6-N-acetylglucosamine (poly-
GlcNAc or PGA) as major exopolysaccharide component of their biofilm matrix. These PGA 
polymer components of the matrix have been implicated in cell-cell adhesion and bacterial 
attachment to surfaces and are reported in different studies as virulence factors (41). In E. 
coli the PGA synthesising machinery is encoded by the pgaABCD operon (40). It encodes 
four proteins that localise to the cell envelope where they catalyse the biosynthesis and 
export of PGA. PgaA, a porin spanning the outer membrane and PgaB, an N-
acetylglucosamine deacetylase, are both required for export of the polymer (42). PgaC is an 
inner membrane glycosyltransferase that recognises UDP-activated GlcNAc monomer 
precursors and catalyses their polymerization. Finally, PgaD, although being essential for 
PGA formation, has a function that is not fully understood (40, 42, 43). The expression of 
PGA is tightly controlled by a variety of factors. Most importantly, the pgaA-D genes are 
repressed by the global Carbon Storage Regulator A (CsrA), which binds to the 5’ UTR of 
many mRNAs involved in motility, cyclic-di-GMP signalling, carbon metabolism, virulence or 
other (44, 45). As for the regulation of contributing to the PGA synthesis CsrA not only binds 
to the transcripts of pgaA-D itself (46) but also controls nhaR, the transcriptional regulator of 
pgaA-D (47). This post-transcriptional repression by CsrA is counteracted by two small 
regulatory RNAs called csrB and csrC, which bind to CsrA and titrate it away from its target 
mRNAs (48). This ultimately leads to the derepression of several targets including the pgaA-
D mRNA. The expression of csrB and csrC is regulated by the BarA/UvrY two-component 
system (TCS) (49), which responds to metabolic signals (50, 51). The additional auto-
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regulatory loop between CsrA and the BarA/UvrY TCS further imposes a stringent regulation 
of the Csr system by positively affecting csrB and csrC expression (52). Finally, csrB and 
csrC stability is regulated by CsrD (YhdA), which targets both RNAs for degradation by 
RNase E. Although the precise activity of CsrD is unclear it requires its degenerate GGDEF 
and EAL domains, which usually metabolise c-di-GMP, to mediate degradation of csrB and 
csrC (53, 54).  
Another readout controlled by the Csr system of E. coli is bis-(3’-5’)-cyclic dimeric GMP 
(c-di-GMP) (45), a ubiquitous bacterial second messenger, which functions as a switch 
between a free-living, planktonic and a sessile, biofilm forming lifestyle in bacteria (55). This 
signalling molecule is synthesised by diguanylate cyclases (DGC) via their catalytic GGDEF 
domains (56-58) and degraded by phosphodiesterases (PDE) via catalytic EAL or HD-GYP 
domains (59-62). In response to internal and external cues, the DGCs and PDEs modulate 
the cellular concentration of c-di-GMP (63). The diversity of DGCs and PDEs in domain 
architecture and the abundance of these proteins in many bacteria accounts for the plethora 
of cellular processes that are controlled by c-di-GMP. These include motility (64), synthesis 
of exopolysaccharides (55, 65, 66) cell cycle progression (67), the expression of toxins (68), 
virulence factors (69-76) and many more. CsrA controls at least two DGCs (ydeH and ycdT) 
(45). Moreover, elevated levels of c-di-GMP stimulate PGA-dependent biofilm formation post-
translationally (65).  
This study reports that PGA dependent biofilm formation in UPECs is negatively 
affected by the expression of type I fimbriae in vitro. The basis for this negative effect of type 
I fimbriae on PGA biofilms was further investigated. It was elucidated that the regulatory 
mechanisms, which govern the expression of type I fimbriae and PGA are linked through 
their dependence on the Csr regulation system. It is shown that this novel function of the Csr 
system in modulating type I fimbriae expression affects the orientation of the switchable 
element fimS. Furthermore it is demonstrated that the Csr system acts on the site-specific 
recombinase FimE to exert its effects on fimS and requires CsrD to do so. It is demonstrated 
that the Csr system inversely controls PGA biogenesis and the expression of type I fimbriae, 
suggesting that this regulatory network is designed to separate the production of two surface 
adhesins that have distinct roles and negatively interfere with each other. 
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6.4 Material and Methods 
6.4.1 Strains and plasmids used in this study 
All strains used in this study are listed in Table 1, the plasmids are listed in Table 2.  
 
6.4.2 Construction of isogenic deletion mutants 
The strains used in this study are the sequenced clinical UPEC isolates UTI89 (7, 77), 
and isogenic mutants thereof. Construction of isogenic deletion mutants was performed as 
previously published (78). Briefly, the strain to be mutated was transformed with the 
temperature sensitive plasmid pKM208 (Addgene; plasmid 13077) containing the λRED 
recombination genes (79). To generate mutants, the UPEC strain carrying pKM208 was 
grown in LB medium without NaCl, supplemented with ampicillin (100 μg/ml), and grown at 
30 °C to late logarithmic phase (OD600 0.9). Thereafter, λRED gene expression was induced 
for 30 min with 1 mM IPTG at 37 °C. Bacteria were than subjected to a 15 min heat shock at 
42 °C, rapidly cooled in ice slurry, before washing twice with sterile 1×PBS and concentrating 
100-fold in cold 10 % glycerol. The kanamycin and chloramphenicol resistance cassettes 
were used to replace the gene to be deleted. They were PCR amplified from pKD4 or pKD3 
(80) with primers designed specifically to delete the desired region in the genome of UTI89. 
These λRED primers are composed of two parts, in their 3’ regions they prime to the regions 
in pKD3 and pKD4 that contain the resistance cassettes and therefore remain constant in all 
primers: In the forward primer (P1) this constant region is TGTAGGCTGGAGCTGCTTCG 
and in the reverse primer (P2) it is CATATGAATATCCTCCTTAG. The 5’ region of λRED 
primers consists of roughly 50 nt of homology regions (HR) flanking the gene to be deleted 
and include the first 2-3 (HR1) respectively the last 2-3 codons (HR2) of the ORF to be 
deleted. In the end the λRED primers have the following composition: 5’-HR1-P1-3’ 
respectively 5’-HR2-P2-3’. The sequences of primers used to make genomic deletion are 
listed in Table 3. The linear DNA used to delete pgaA-D was amplified with primers 1546-
ycdS-KO-P1 and 1545-ycdP_KO_P2. To delete fimA-H primers 2145-fimA_KO_P1 and 
2146-fimH_KO_P2 were used. Similarly, deletion of ydeH was achieved with DNA amplified 
from primer 2400-ydeH_KO_P1 and 2401-ydeH_KO_P2. Deletion of fimH was enabled with 
DNA amplified with primers 3156_fimH_KO_P1 and 2146-fimH_KO_P2. Primers 2125-
spoT_KO_P1 and 2126-spoT_KO_P2 amplified DNA used to delete spoT in a ΔrelA strain. 
Linear DNA used to delete fimX was produced with primers 3541_fimX_KO_P1 and 
3542_fimX_KO_P2. In some cases, the DNA used to delete genes was not amplified from 
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pKD3 or pKD4 but was amplified from a pre-existing mutant of the comprehensive `Keio–
collection` (81) using simple test primers. This was the case for the DNA used to delete ycdT 
(primer: 2402_ycdT_seq_fwd1 and 2762_ycdT_KO_P2) as well as for relA (primer: 
3927_relA_test_rev and 3928_relA_test_fwd) and yhjH (primer: 1658_yhjH_test_fwd_new 
and 1659_yhjH_test_rev_new). After amplification of the linear DNA by PCR, all PCR 
fragments were gel purified (MN Nucleospin Extract II, Machery Nagel, Oensingen, 
Switzerland) and 10–100 ng purified DNA was mixed to 65 μl recombination competent 
bacterial cells followed by electroporation in 1 mm Gene Pulser cuvettes using a Gene 
Pulser (BioRad, Reinach, Switzerland) set to 1.75 V, 25 μF and 400 Ω. Electro-shocked cells 
were mixed with cold (4 °C) salt optimised broth (2 % (w/v) bacto trypton; 0.5 % (w/v) yeast 
extract; 10 mM NaCl and 2.5 mM KCl), incubated for 1.5 h at 37 °C and plated out on LB 
agar plates containing 50 μg/ml kanamycin or 20 μg/ml chloramphenicol, respectively. 
Resistant clones were colony purified on LB medium containing kanamycin or 
chloramphenicol and tested by PCR for correct insertion of the resistance cassette. Finally, 
the resistance cassette of all deletion mutants was removed via Flp recombinase-mediated 
site-specific recombination upon transformation of mutants with pCP20 as described by 
Datsenko and Wanner (80, 141). The loss of the resistance cassette was checked once 
more by PCR.  
 
6.4.3 Construction of pfimA-H Locked strains (pfimA-H 
ON and pfimA-H 
OFF) 
In order to have strains, which are blind to FimB, FimE, FimX mediated inversion of 
fimS, several pfimA-H 
ON and pfimA-H 
OFF strains were constructed. In these strain the invertible 
element (fimS) preceding the structural genes of type I fimbriae (fimA-H) can no longer be 
inverted. To engineer these construct, fimS was amplified in the ON-phase by colony PCR 
from UTI89 wild type with primers 3509_fimS_ON_fwd and 3510_fimS_ON_rev, both of 
which could only bind to the ON orientation of fimS (pfimA-H 
ON). Similarly, fimS in the OFF-
orientation (pfimA-H
OFF) was amplified with primers 3511_fimS_OFF_fwd and 
3512_fimS_OFF_rev. Another PCR was performed on pKD4 with primers 
3513_FimBE_KO_P1 and 3514_FimBE_KO_P2, which amplified the kanamycin cassette 
described by Datsenko et al. (80). The latter DNA fragment had flanking regions around the 
kanamycin cassette, which were homologous to fimBE and could thus be used to delete 
fimBE (fimBE::kan). These two PCR products (fimBE::kan and pfimA-H
OFF or pfimA-H
ON) were 
than fused by splice overlap extension PCR (SOE-PCR) as described by Higuchi et al. (82). 
The resulting PCR fragments were termed ΔfimBE::kan pfimA-H 
ON and fimBE::kan pfimA-H 
OFF, 
respectively. Next, these two DNA fragments were used to construct chromosomal UTI89 
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ΔfimBE::kan pfimA-H 
ON and a UTI89 ΔfimBE::kan pfimA-H 
OFF mutants via λRED. The orientation 
of fimS as well as the absence of undesired point mutations was checked by sequencing the 
corresponding region in UTI89 ΔfimBE::kan pfimA-H 
ON and UTI89 fimBE::kan pfimA-H 
OFF. One of 
the sequenced UTI89 fimBE::kan pfimA-H 
OFF clones had an additional point mutant inside one 
of the inverted repeats bordering fimS. This point mutant (TTGGGGCCAA in wild type vs. 
TTAGGGCCAA in ∆fimBE pfimA-H 
OFF) further ensures that the fimS remains in the OFF 
confirmation. It was thus used as a negative control for phase variation of the two pfimA-H
Locked 
strains (UTI89 ΔfimBE::kan pfimA-H 
ON and UTI89 fimBE::kan pfimA-H 
OFF) and was named 
fimBE::kan pfimA-H 
OFF*. In all three pfimA-H
Locked strains the kanamycin cassette was removed by 
Flp recombinase-mediated site-specific recombination (80, 141). Additionally, the third 
reported recombinase of UTI89 (fimX) (19) was deleted in all three pfimA-H
Locked strains, 
resulting in UTI89 ΔfimXΔfimBE::FRT pfimA-H 
ON, UTI89 ΔfimXΔfimBE::kan pfimA-H 
OFF and 
UTI89 ΔfimXΔfimBE::kan pfimA-H 
OFF*. The resistance cassette of all these pfimA-H
Locked strains 
was again removed as previously described (141). 
 
6.4.4 Construction of fimA::gfp and fimH-gfp reporter constructs 
Fluorescent reporter strains were constructed to effectively study phase variation of the 
fimA-H operon. GFP was inserted in two distinct loci whose expression depends on the 
orientation of fimS: (i) in fimA, causing inactivation of the entire fimA-H operon and (ii) in the 
3’ UTR of fimH, leaving all structural fimA-H genes intact. In both reporters, the GFP 
construct was amplified by PCR from SDFR3 (a Salmonella mutant provided to us by Dirk 
Bumann). In SDFR3 the gfp sequence is linked to a kanamycin cassette, which can be 
removed by Flp recombinase-mediated site-specific recombination (141). In UTI89 fimA::gfp 
the reporter fragment used for λRED was amplified from SDFR3 with primers 
3187_FimA_GFP_repl_P1 and 3188_FimA_GFP_repl_P2. Since the polycistronic mRNA of 
fimAICDFGH is disrupted by the gene replacement, this reporter is non-fimbriated. In order to 
have a fimbriated reporter UTI89 fimH-gfp was constructed, where GFP is expressed as a 
function of the fimbrial promoter together with fimA-H. This construct was made with primers 
3916_fimH-reporter_rev and 3917_fimH-gfp_fwd, to amplify DNA that inserts the gfp at the 3’ 
end of fimH. Noteworthy, primer 3917_fimH-gfp_fwd contains a Shine-Dalgarno sequence, 
which ensures that translation and the transcription of the fimA-H continues after fimH and 
includes gfp. The linear DNA used to construct both reporter strains was further used to 
create pfimA-H
Locked reporter strains. To do so both reporter DNA fragments were introduced via 
λRED into the pfimA-H
Locked strains, where they should either report 100 % or 0 % GFP signal or 
fimbriation, respectively. FimA::gfp was inserted into all 6 locked strains (∆fimBE ∆fimA::gfp 
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pfimA-H
OFF, , ∆fimBE ∆fimA::gfp pfimA-H
ON, ∆fimBE ∆fimA::gfp pfimA-H
OFF* ∆fimX∆fimBE ∆fimA::gfp 
pfimA-H
OFF, ∆fimX∆fimBE ∆fimA::gfp pfimA-H
ON and ∆fimX∆fimBE ∆fimA::gfp pfimA-H
OFF*) while 
fimH-gfp was only inserted into the locked strains where all three recombinases have been 
deleted. These strains were called ∆fimX∆fimBE fimH-gfp pfimA-H 
OFF, ∆fimX∆fimBE fimH-gfp 
pfimA-H 
ON and ∆fimX∆fimBE fimH-gfp pfimA-H 
OFF*. In all UTI89 fimA::gfp strains as well as UTI89 
fimH-gfp strains the resistance cassette have been removed, as previously reported (141). 
 
6.4.5 Construction of deletion mutants in UTI89 fimH-gfp 
To test any potential involvement of selected genes implicated in c-di-GMP signalling 
or elements of the carbon-storage-regulation system on phase variation of the fim operon, 
the reporter construct from above (fimH-gfp) was combined with several additional mutations. 
First, the fimH-gfp reporter was transformed with pKM208 and then used as parent strain to 
construct several deletion mutants. The strains constructed from fimH-gfp and the 
corresponding deletion primers are listed in Table 3 and hereafter: fimH-gfp ΔfimB 
(3182_FimB_KO_P1 and 3183_FimB_KO_P2), fimH-gfp ΔfimE (3184_FimE_KO_P1 and 
3185_FimE_KO_P2), fimH-gfp ΔcsrD (3880_CsrD_KO_P1 and 3881_CsrD_KO_P2), fimH-
gfp ΔcsrB (1143_csrB_KO_P1 and 1144_csrB_KO_P2), fimH-gfp ΔcsrC (1145_csrC_KO_P1 
and 1146_csrC_KO_P2), fimH-gfp Δc1116 (2878_c1116_KO_P1 and 2879_c1116_KO_P2), 
fimH-gfp Δc1117 (3547_c1117_KO_P1 and 3548_c1117_KO_P2), fimH-gfp ΔfimBE 
(3185_FimE_KO_P2 and 3182_FimB_KO_P1), fimH-gfp ΔfimX (3541_fimX_KO_P1 and 
3542_fimX_KO_P2), fimH-gfp ΔycgR (1456-ycgR_KO_P1 and 1457-ycgR_KO_P2), fimH-gfp 
ΔcsgD (1680-csgD_KO_P1 and 1681-csgD_KO_P2), fimH-gfp ΔbcsA (3560_BcsA_KO_P1 
and 3561_BcsA_KO_P2), fimH-gfp ΔydeH (2400-ydeH_KO_P1 and 2401-ydeH_KO_P2), 
fimH-gfp ΔpgaA-D (1546-ycdS-KO-P1 and 1545-ycdP_KO_P2). Furthermore, fimH-gfp 
ΔyhjH (1658_yhjH_test_fwd_new and 1659_yhjH_test_rev_new) as well as fimH-gfp ΔycdT 
(2402_ycdT_seq_fwd1 and 2762_ycdT_KO_P2) were constructed but other than the above 
mutants these two strains were made by amplifying the DNA from the ΔyhjH and ΔycdT 
strains of the `Keio–collection` (81) rather than pKD3 or pKD4. Finally, the reporter was 
inserted into ΔrelAΔspoT, resulting in fimH-gfp ΔrelAΔspoT. In this strain the fimH-gfp 
containing DNA fragment was introduced into the ΔrelAΔspoT double mutant by λRED. Also, 
in all mentioned mutants, the resistance cassette was eliminated before characterising the 
mutants (141). 
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6.4.6 Preparation of guinea pig erythrocytes for aggregometry 
Guinea pig erythrocytes (GPE) were isolated from fresh guinea pig blood (Charles 
River Laboratories, Sulzfeld, Germany) and prepared as previously described (78). Briefly, 
an equal volume of guinea pig blood was carefully pored over Histopaque (density of 1.077 
g/ml at 24 °C, Sigma-Aldrich, Buchs, Switzerland) and then centrifuged at 4 °C for 30 min at 
400 g. After elimination of the supernatant, the purified erythrocytes were adapted in sterile 
1×PBS to a final OD600 of 2, 4 or 8. 
 
6.4.7 Aggregometry 
Bacterial mediated aggregation of GPE was measured and quantified on an APACT 
4004 aggregometer (Endotell AG, Allschwil, Switzerland) as previously described (78). 
Bacteria were statically grown in 10 ml LB in a 50 ml falcon tube for 24 h at 37 °C. Cells were 
then collected by centrifugation (1 min at 8000 rpm), washed twice in sterile 1x PBS and 
adapted to an OD600 of 2 or 4. Prior to each measurement, the instrument was calibrated by 
defining the two parameters PPP and PRP. PPP stands for protein poor plasma and defines 
100 % aggregation while PRP stands for protein rich plasma and defines 0 % aggregation. 
Pure 1x PBS was used to define 100% aggregation and pure erythrocytes (adapted to an 
OD600 of 2, 4, 8) to define 0 % aggregation. The aggregation measurements of bacteria were 
performed after the addition of 50 µl bacteria to 250 µl GPE and continuously measured at 
OD740 nm over 10 min at 37 °C. To avoid sedimentation, the bacterial solutions in the 
cuvettes were continuously stirred at 1000 rpm.  
 
6.4.8 Biofilm assay 
Freshly grown LB overnight cultures were diluted 1:40 into 200 μl LB medium in 96-well 
polystyrene microtiter plates (Falcon, ordering number 353072). When appropriate bacteria 
were grown with the following concentrations of antibiotics to select for plasmids: 15.5 µg/ml 
tetracycline (pME6032 plasmids) or 100 µg/ml ampicillin (pcj30 and pPKL4) and were 
induced with 100 µM IPTG unless mentioned otherwise. The 96-well plates were incubated 
for 24 h at 37 °C without shaking and cell density was recorded at 600 nm on a plate reader. 
Subsequently, the medium with the non-attached cells was discarded through vigorous 
washing of the microtiter plates with deionised water from the hose. Once dry, wells were 
filled with 200 μl crystal violet solution [0.1 % (W/V) crystal violet (Sigma Aldrich, Article No. 
 Material and Methods 
- 94 - 
C-3886), 1.7 % (W/V) 1-propanol, 1.67 % (W/V) methanol (96.7:1.66:1.66)] and stained on a 
platform shaker for 15 min at room temperature (RT). The staining solution was discarded 
and wells were washed, and then dried. Retained crystal violet stained biomass was 
dissolved in 200 μl acetic acid (20 %) and quantified at 600 nm on a plate reader. If 
measurements were outside the dynamic range of the plate reader, crystal violet solutions 
were further diluted in 20 % acetic acid. Bacterial biofilms were than quantified as the amount 
of biomass attached to the plastic surface of 96-well plates, essentially as described (65, 83). 
The relative attachment values are ratios of the optical density of dissolved crystal violet 
(corresponding to the attached biomass) divided by the cell density (total growth). The 
attached bacterial biomass is always illustrated in percentage of the biomass of UTI89 
overexpressing csrB and corrected for growth (relative attachment). The values plotted into 
histograms are than compared to the values of UTI89 wild type carrying the csrB 
overexpressing plasmid pME6032 csrB (pCsrB) or pcj30 csrB, which is set to 100%. Single 
data points represent the mean of at least six wells. Error bars were calculated as the 
standard errors of the mean.  
 
6.4.9 Scanning electron microscopy 
For the acquisition of micrographs, bacteria were prepared essentially as described in 
chapter 6.4.8 for the attachment assay (65). Instead of using 96-well plates biofilms were 
prepared in 24 well plates. Each well contained 2 ml of LB supplemented with 100 μg/ml 
ampicillin and 100 μM IPTG (to select and induced pcj30 csrB) as well as a sterile glass 
slide. After biofilm formation for 24 h, the glass slides were removed, carefully washed with 
1×PBS and fixed at room temperature in 1×PBS containing 2.5 % glutaraldehyde. After 1 h 
the glutaraldehyde was removed by washing with 1×PBS and then the glass slide was 
gradually dehydrated with an acetone step gradient (30%, 50%, 70%, 90%, 100%; 10 min 
each). Finally samples were critical point-dried and sputter-coated with a 3–5 nm Pt layer. 
Micrographs were recorded on a Hitachi S-4800 field emission scanning electron microscope 
with an acceleration voltage between 1.5 and 5 kV.  
 
6.4.10 Phase variation PCR 
The orientation of the invertible element fimS was evaluated in a three primer based 
PCR as described in (84). 2296_fimA is the primer, which binds to fimA and 2295_fimE binds 
to fimE. These two primers amplify a DNA fragment of 1221 bp, which is always produced. 
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The third primer (2297_inv) binds inside the invertible element. Depending on the orientation 
of fimS, 2297_inv amplifies the ON product of 450 bp together with primer 2296_fimA or the 
OFF product of 750 bp together with primer 2295_fimE. After amplification, the PCR products 
were then visualised on a 1 % agarose gel and the intensities of the OFF and ON bands 
were determined using ImageJ 1.43 (NIH, USA). After background subtraction, a ratio 
between the intensity of the OFF and ON bands were calculated for at least 10 replicas per 
strain and conditions. Outlayer values were excluded from further processing. The mean 
intensity ratios were plotted as dot blots with their interquartile range and compared to wild 
type UTI89. Statistical significance was calculated with GraphPad Prism 4 with P>0.05 being 
significant. 
 
6.4.11 Analysis of fimA::gfp and fimH-gfp by flow cytometry 
Phase variation and reported fimbriation of strains carrying the fimA::gfp and fimH-gfp 
reporter constructs was analysed by of flow cytometry. The reporter strains were grown 
under different conditions as indicated in the results section, collected by centrifugation (1 
min; 8000 rpm), washed twice with sterile filtered 1×PBS and fixed in a final concentration of 
1 % Roti Histofix (Roth, ordering number A146.4). Fixed bacteria were stored at 4° C until 
sample acquisition in a Canto II FACS (BD Bioscience) cytometer. Unless mentioned 
otherwise, 50’000 events per sample were recorded and analysed with FlowJo version 9.3.3. 
The Alexa-Fluor488-H (Ex488_LP_525_BP_542/27-H) filter was used to record GFP and the 
PE-H (Ex405_LP_495_BP_514/30-H) filter to control the level of background fluorescence. 
The recorded data was then plotted according to the size distribution in a forward (FSC-H) 
vs. sideward scatter (SSC-H). In this plot contaminating particles (e.g. bacterial debris) was 
separated from bacterial cells by gating all events into four quadrants (Q1-Q4), where Q2 
contains bacteria. Events in Q2 were then further analysed for their GFP signal (Alexa-Fluor 
488-H). GFP signals were plotted as fluorescence intensity histograms. To distinguish 
bacteria, which express GFP from those that do not, the histogram of a UTI89 wild type 
control strain (no GFP signal) was overlaid with histograms of strains expressing GFP. Then, 
the GFP-positive events were separated from GFP-negative events by dividing the histogram 
into two sections. The fraction of GFP negative and GFP positive bacteria are indicated in 
each histogram. 
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6.4.12 Fluorescent staining of surface-exposed type I fimbriae via indirect 
immunofluorescence  
Being surface exposed structures, type I fimbriae can be labelled with an antibody 
against FimA-H (85). To label bacteria, they were statically grown in LB for 24 hours, 
harvested by centrifugation (8000 rpm for 10 min at 4 °C), washed twice in sterile 1x PBS 
and adapted to an OD600 of 2. From this solution 150 µl per strain were aliquoted into wells of 
a 96 well plate and centrifuged at 3800 rpm for 10 min at 24 °C. After removal of the 
supernatant, the pellet was resuspended in 40 µl 1x PBS containing a 1:250 dilution of the 
anti-type-1-Pili rabbit serum and 2 % BSA (gift of Beat Ernst’s laboratory at the 
Pharmacentrum in Basel). The samples were incubated for one hour at 4 °C with the primary 
antibody, than washed twice by centrifugation. After incubation for one hour with the 
secondary anti-rabbit antibody (Invitrogen) (1:200 in 1x PBS containing 2 % BSA) cells were 
washed 3 x by centrifugation in 1x PBS and resuspended in a final volume of 300 µl 1x PBS 
and the Alexa 647 signal was analysed by flow cytometry on a CyAn (Beckman Coulter) in 
the APC filter. The scatter properties of the bacteria were first visualised in a forward (FS 
Log: FS) sideward (FS Log: SS) scatter. In this plot, bacteria were gated by subdividing the 
scatter into quadrants Q1-Q4, bacteria being in Q2. Next, the events from Q2 were plotted 
into a histogram that indicates the signal intensity obtained in the APC channel. All non-
fimbriated strains (ΔfimA-H, ΔfimXΔfimBE pfimA-H
OFF and ΔfimXΔfimBE pfimA-H
OFF* were used to 
identify the section of the histogram where non-fimbriated bacteria localise. Every event with 
intensities higher than the one defined as non-fimbriated was defined as being fimbriated.  
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6.5 Results 
6.5.1 Type I fimbriae interfere with PGA-mediated attachment 
Lack of type I fimbriae greatly reduces the survival of UPEC cells in a cystitis mouse 
model (8, 13, 14, 31, 86-91). Thus, a fim mutant strain was originally constructed in the 
UTI89 background as a negative control to investigate the role of PGA in a murine model of 
cystitis (Hosch et al., unpublished manuscript). The ΔfimA-H mutant used in this study was 
constructed by λRED-mediated gene replacement (78) resulting in a clean deletion of all 
structural genes (fimAEFGH) as well as their assembly machinery (fimCD) and fimI. To fully 
characterise this strain it was included in all our in vitro assays. 
FimH-mediated attachment to mannosylated receptors can be easily quantified by 
aggregometry. Scoring of guinea pig erythrocyte (GPE) aggregation is a measure for the 
expression and functionality of type I fimbriae (78). This aggregation assay was used to 
reconfirm that the aggregation of GPE is impaired in a UTI89 ΔfimA-H as well as in a UTI89 
ΔfimH mutant strain (Figure 1A). Aggregation of both mutants was fully restored in the 
presence of a plasmid constitutively expressing the fimA-H genes in trans from pPKL4 (92). 
We next assayed the role of type I fimbriae in PGA dependent biofilm formation of UTI89 
((65) and Hosch et al., unpublished manuscript). Under laboratory conditions PGA 
dependent biofilm formation is repressed by CsrA, which binds to the pgaA-D mRNA and 
hinders translation. However, PGA dependent biofilm formation can be induced in non-
pathogenic E. coli K12 strains and in the uropathogenic strain UTI89 either by inactivating 
csrA (65) or as done in this work by overexpressing the small RNA csrB from plasmid (Hosch 
et al., unpublished manuscript) (Figure 1B). Surprisingly, a UTI89 ΔfimA-H showed a 
significantly increased surface attachment (260%) compared to wild type. Like in wild type, 
attachment of the mutant was fully dependent on PGA (Figure 1B). The increased 
attachment of the ΔfimA-H mutant was reduced to wild type levels in the presence of fimbriae 
expressed from plasmid (Figure 1C). Interestingly, fimbriae expressed from plasmid also 
reduced attachment in the UTI89 wild type arguing that type I fimbriae structurally or 
functionally interfere with PGA-dependent biofilm formation in this model system.  
 
6.5.2 Type I fimbriae functionally interfere with PGA dependent attachment  
The interference of type I fimbriae with PGA-mediated attachment prompted us to 
analyse the biofilm morphology of wild type and mutant strains using scanning electron 
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microscopy. Low magnification images showed denser and more protruding biofilm 
structures for the mutant lacking fimbriae as compared to wild type and confirmed the 
absence of biofilm in a pgaA-D mutant (Figure 2A). Images were also taken at higher 
magnifications to visualise extracellular structures (Figure 2B). In UTI89 wild type biofilms 
two distinct surface structures were observed: small knob-like protrusions and long, thin, 
hair-like structures extending into the medium and onto neighbouring bacteria (Figure 3C). 
The knobs were recently identified in E. coli MG1655 as surface aggregates of PGA, which 
serve as glue to stick bacteria together and allow adhesion to a surface (65). In agreement 
with this, these structures were observed on cell surfaces of UTI89 wild type and the ΔfimA-
H mutant, but not in a ΔpgaA-D mutant (Figure 2B and C; black arrows). The thin hair-like 
structures are absent in the ΔfimA-H mutant, arguing that they represent type I fimbriae 
(Figure 2B and C white arrows). Interestingly, type I fimbriae and PGA knobs did not seem to 
be equally distributed on the surfaces of all bacterial cells within a biofilm. While PGA knobs 
were abundant on most wild type cells, type I fimbriae were commonly found only on a few 
closely grouped bacteria. As for the ΔpgaA-D mutant, the amount of attached bacteria was 
too little to identify those bacteria that express type I fimbriae. Moreover, the majority of cells 
expressing type I fimbriae on their surface exhibited very few or no PGA knobs (Figure 2B 
and C). This indicated that type I fimbriae are rarely expressed under the conditions used for 
biofilm formation and that the type I fimbriae and PGA adhesins may not be present on 
individual bacteria at the same time.  
The structural studies above together with the observation that type I fimbriae interfere 
with PGA-mediated biofilm formation prompted us to test, if a regulatory mechanism to 
temporally uncouple the two surface adhesins exists. The regulation of fimA-H gene 
expression not only depends on promoter activity but primarily on the orientation of fimS, the 
invertible DNA cassette preceding the structural genes of type I fimbriae and which contains 
the fim promoter (16, 17, 93). To test if the regulatory pathway governing PGA-dependent 
biofilm formation in UTI89 affects fimS, a three primer based PCR method (84) was used to 
elucidate if plasmid-based overexpression of csrB (pcj30 csrB) influences phase variation. 
Comparison of colonies with induced versus non-induced csrB expression showed that the 
OFF ratio was significantly increased in a csrB dependent manner in all tested mutant strains 
(Figure 3). This finding suggests that conditions, which derepress the global Csr regulon and 
induce PGA-mediated biofilm formation, preferentially switch fimS to the OFF phase. From 
the observation that csrB overexpression equally affects the OFF to ON ratios in the wild 
type and the tested mutants known to affect PGA dependent attachment, it was concluded 
that the effects observed are independent of ycdT, ydeH and pgaA-D. These findings might 
provide the regulatory background of the functional interference observed between type I 
fimbriae and PGA surface adhesins. 
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6.5.3 csrB overexpression has no effects on fimbriation if fimS switching is impaired.  
The results shown above indicate that the Csr cascade might affect fimbriation by 
influencing the orientational bias of fimS or alternatively affect the frequency or efficiency of 
fimS inversion. If so, csrB should no longer be capable of influencing fimbriation in strains 
that have fimS locked in the ON or OFF phase. To test this, mutants were constructed that 
have fimS locked in the ON or OFF phase, respectively (Figure 4A). In all these strains, 
either the recombinases FimB and FimE or the recombinases FimB, FimE, and FimX have 
been deleted and fimS was inserted in the ON or OFF orientation, respectively. Some 
strains, described as pfimA-H
OFF* additionally carried a mutation in one of the inverted repeats 
of fimS (see Materials & Methods). First, we analysed overall attachment upon csrB 
overexpression. As shown in Figure 4B, strains with a locked OFF copy of fimS showed 
increased attachment (135.8 % ± 6.6% for ∆fimBE pfimA-H 
OFF; 117.6% ± 3.8% for ∆fimBE pfimA-
H
OFF*; 124.1% ± 5.4% for ∆fimX∆fimBE pfimA-H
OFF; 108.9% ± 4.4% for ∆fimX∆fimBE pfimA-H 
OFF*) 
compared to the wild type. Thus, the phase of fimS and lack of recombinases affects PGA 
dependent attachment. However, none of the strains with fimS in the OFF phase reached the 
attachment levels of a ΔfimA-H mutant (190% ± 8.8%). This suggests that fimS in an OFF 
orientation alone is not sufficient for the increase in attachment of the ΔfimA-H mutant, 
arguing that also lack of the fimbrial genes (fimA-H) somehow affect PGA dependent 
attachment. This hypothesis could be tested by expressing type I fimbriae in strains where 
fimS is locked OFF in trans and check if attachment decreases thereafter. In contrast, strains 
with fimS locked in the ON phase showed decreased attachment compared to wild type 
(41.7% ± 2.2% for ∆fimBE pfimA-H
ON and 30.4% ± 2.5% for ∆fimX∆fimBE pfimA-H
ON). 
Interestingly, deletion of fimX caused a decrease in attachment by roughly 10% in all strains 
as compared to the parent strains lacking FimB and FimE alone, again suggesting that the 
orientation of fimS affects the attachment of UTI89 and that FimX acts as recombinase to 
convert fimS into the ON position.  
The experiments described above indicated that csrB negatively regulates UTI89 
fimbriation by influencing fimS phase variation. To verify these results, we analysed the 
potential of the triple recombinase mutants (∆fimX∆fimBE pfimA-H 
Locked) to aggregate GPE. 
Bacteria were statically grown overnight to maximise type I fimbrial expression (78) and 
adapted to an OD600 of 4 while GPE were set to an OD600 of 8. As shown in Figure 4C, 
aggregation was absent in the strain that lacks type I fimbriae (∆fimA-H) as well as strains 
with fimS in the OFF phase (∆fimX∆fimBE pfimA-H
OFF (1.0% of wild type) and ∆fimX∆fimBE 
pfimA-H
OFF* (1.3%)). In contrast, the strain with locked ON fimS (∆fimX∆fimBE pfimA-H
ON 
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(148.3%)) caused an increased aggregation compared to wild type. Importantly, 
overexpression of csrB decreased the ability of UTI89 wild type to aggregate GPE by 95% as 
compared to the vector control (Figure 4C), supporting the hypothesis that elevated levels of 
csrB negatively affect fimbriation. In mutants lacking fimbriae or mutants carrying fimS in the 
OFF state overexpression of csrB showed no effect. This is hardly surprising, as the 
aggregation of these strains is already at the detection limit and cannot be further decreased. 
Importantly, aggregation of a strain with fimS locked in the ON phase resulted in a minor and 
statistically non-significant decreased upon overexpression of csrB (Figure 4C), indicating 
that csrB impacts on fimbriation through its effects on the inversion of fimS.  
The switch state of fimS is heritable over multiple generations allowing a given 
population to grow while stably maintaining fimbriated (fim+) or non-fimbriated (fim-) sub-
populations (94). However, synthesised type I fimbriae may remain intact on the surface of 
bacteria even when fimS is switched OFF and thus fimbriae might not represent the phase of 
fimS. Therefore, a method, which directly reports the orientation of fimS might be more direct 
than the above assays. For this purpose two types of reporter strains were designed, which 
both express GFP as a function of the fimbrial promoter located on fimS (Figure 5A). One 
reporter had GFP inserted into the ORF of fimA, the first gene of fimA-H operon (fimA::gfp), 
and hence this reporter had a disrupted polycistronic fimAICDFGH operon. The other 
reporter had GFP inserted downstream of fimH (fimH-gfp), leaving fimAICDFGH operon 
intact. These two reporter strains were used to directly analyse the effects of csrB on the 
fimbrial switch. Figure 5B illustrates how individual fimA::gfp and fimH-gfp populations 
recorded by flow cytometry were gated in order to obtain the fraction of a bacterial 
population, which represents fimbriated bacteria (for details see Materials and Methods). In 
both reporter strains expression of GFP was observed. However, despite the same growth 
conditions, the fraction of the fim+ population in fimA::gfp and fimH-gfp was significantly 
different (Figure 5B). 
GPE aggregation assays indicated that the UTI89 strain containing the fimH-gfp 
reporter behaved like wild type (Figure 6A). In agreement with this, biofilm formation of the 
fimH-gfp strain was not increased as compared to wild type (Figure 6B). Likewise, fimbriation 
of the fimH-gfp reporter strain was similar to UTI89 wild type, as reported by flow cytometry 
upon staining cells with an anti-FimH primary and a fluorescently labelled secondary 
antibody (Alexa 647) (Figure 6C). The fluorescence distribution within the histogram was 
subdivided into a fimbriated and a non-fimbriated population using the APC signal derived 
from Alexa 647 of the ΔfimA-H mutant (data not shown), which defined the non-pilated 
baseline. As seen in Figure 6C, the results obtained were in agreement with previous our 
results. Although the signal was slightly more scattered in the GFP reporter strain, the 
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majority of cells co-localised to the same area as in wild type (Figure 6C) and the percentage 
of FimH positive cells was similar in the two strains (88.4% for UTI89 wild type and 81.3% for 
the fimH-gfp reporter strain). In summary, it was concluded that this reporter strain behaves 
like wild type and expresses functional type I fimbriae, which phenotypically operate like type 
I fimbriae of the UTI89 wild type. In contrast, the fimA::gfp reporter strain is unable to form 
functional fimbriae due to its disrupted fimAICDFGH mRNA and thus this strain’s phenotypes 
were not included in this study.  
We next used the GFP reporter strains to assay the dynamics of fimbriation during 
growth in LB, both in static, non-shaken (conditions routinely used for biofilm formation and 
fimbrial aggregation) and in aerated, shaken cultures. As indicated already above, the 
fimA::gfp reporter strain showed only a small fraction of GFP positive cells (<5%) and only 
minor differences were observed for this strain when grown either statically or aerated 
(Figure 7A, B). When the same reporter was assayed in a strain background with the fimS 
locus locked in the ON orientation the whole population was reported as fim+ while the whole 
population reported as fim- when fimS was locked in the OFF orientation (Figure 8A). These 
results were as expected, arguing that the fimA::gfp reporter allows to differentiate between 
distinct fimS phases. To assay fimbriation under conditions where the Csr system is 
derepressed the fimA::gfp reporter strain was assayed under csrB overexpressing 
conditions. Under these conditions, a small but significant reduction of GFP expression was 
observed (Figure 8B). Thus, csrB overexpression leads to a slight but significant reduction of 
reported fimbriated fimA::gfp cells, which supports our current hypothesis. 
The most striking difference between the fimA::gfp (fim-) and fimH-gfp (fim+) reporter 
was the maximal level of GFP expression obtained for the two strains (Figures 7, 9). While 
the levels of GFP positive cells did not exceed 5% for the fimA::gfp reporter, the values for 
fimH-gfp were generally much higher (Figure 9 and Supplemental Figure 1 - 3). Importantly, 
the fraction of GFP positive cells from fimH-gfp was higher in static cultures as compared to 
aerated cultures. Noteworthy, the level of fimbriation measured between 18 and 24 hours of 
aerated conditions were very similar to the levels measured for the inoculum of the growth 
curve, which grew overnight under aerated conditions. Intriguingly, the fraction of GFP-
positive fimH-gfp (fim+) cells was relatively low (5-10%) at low cell densities, but increased 
towards the end of the logarithmic growth phase and into the stationary phase. For fimH-gfp 
the increase in fimbriation over time was more pronounced during static growth where the 
fraction of fim+ cells reached maximal levels of up to 50% (Figure 9B). Interestingly, a strain 
overexpressing csrB remained at a relatively low level of GFP positive cells (fim+) compared 
to wild type, even throughout the late stationary phase (Figure 9B). In aerated cultures 
fimbriation stagnated at a level of about 25% of GFP positive cells irrespective of csrB 
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overexpression (Figure 9A). To demonstrate that the observed effects of csrB on fimbriation 
indeed influence the orientation of fimS rather than modulating fimA promoter activity, the 
fimH-gfp reporter was analysed in strains carrying a locked copy of fimS. As shown in Figure 
10 the fraction of GFP positive cells was very high in a strain with fimS locked in the ON 
phase, but at the detection limit in strains with fimS locked in the OFF phase. Likewise, 
strains with fimS locked in ON or OFF phase were unable to respond to increased levels of 
csrB (Figure 11), again arguing that the Csr system negatively influences type I fimbriation in 
UPECs by modulating fimS-mediated phase variation. Altogether, these data suggest that 
the expression of type I fimbriae is favoured under static, non-aerated conditions, especially 
in late stationary phase. This behaviour can be counteracted efficiently by artificially 
increasing csrB levels. 
 
6.5.4 Deletion of FimE and CsrD influences the csrB- effects on the fimS orientation 
To decipher the components involved in csrB dependent phase variation of fimS a 
series of mutant strains containing the fimH-gfp reporter were constructed and analysed by 
flow cytometry. The data obtained for the initial mutant screen is shown in Supplemental 
Experiments, Supplemental Figure 7 and Supplemental Figure 8. The screen included the 
following deletions in UTI89 fimH-gfp: ΔpgaA-D, ΔycdT, ΔydeH, ΔcsrB, ΔcsrC, ΔfimB, ΔfimE, 
ΔfimBE, ΔfimX, ΔycgR, ΔcsgD, ΔyhjH, ΔbcsA, and ΔcsrD. Furthermore, an UPEC specific 
phosphodiesterase (Δc1116) as well as its adjacent gene (Δc1117) reported to influence type 
I fimbriae were also deleted. Both genes are part of the Sfa fimbrial cluster and are located 
on a pathogenicity island (95, 96). From the initial analysis of these mutants in static cultures, 
we found that fimbriation was most altered in the ΔfimB, ΔfimE, and ΔcsrD mutants. 
Importantly, while fimB mutants remained predominantly in the OFF phase, the fimE mutant 
showed constitutively high levels of fimbriation that were insensitive to csrB overexpression 
(Figure 12B, C, D and Supplemental Figures 4 and 5). This strongly suggests that Csr 
mediated control operates through the regulation of fimE expression. 
Finally, CsrD, a factor involved in the degradation of the small RNAs csrB and csrC 
(54) and reported to strongly increase PGA dependent attachment upon deletion (Hosch et 
al., unpublished manuscript) showed a strong influence on fimbriation (Figure 12E and 
Supplemental Figure 6). While the fraction of GFP positive cells in the ΔcsrD mutant 
constantly increased during growth in a similar manner like wild type, overexpression of csrB 
in this mutant background not only caused a strong growth defect (Figure 12A) but also 
changed the dynamics of the fimbrial ON switch. Fractions of fimbriated cells were slightly 
increased and peaked already early during growth, before moderately decreasing thereafter. 
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This argues that CsrD is required for proper fimbriation in the cell and is involved in correctly 
mediating the switch of fimS into the OFF phase once csrB levels are high. Interestingly, the 
reported GFP signal of the CsrD mutant constantly remained below the signal for the wild 
type reporter strain, suggesting that the decreased degradation of csrB (and csrC) in the 
CsrD mutant might already be sufficient to cause a decrease in fimbriation. Whether this 
decrease is significant or not would still need to be investigated. CsrD being a degenerate 
GGDEF/EAL composite protein that might function as a c-di-GMP effector protein allows us 
to further speculate that c-di-GMP levels might also be involved in the inversed regulation of 
the two adhesins. Although this study has identified csrB, FimE and CsrD as components 
involved in type I fimbriae regulation, the mechanism responsible for Csr-mediated down 
regulation of fimbrial expression remains to be uncovered.  
 
6.5.5 PGA and type I fimbriae mediated bacterial self-aggregation can be 
distinguished by flow cytometry 
So far it was concluded that overexpression of csrB negatively interferes with the 
expression of type I fimbriae, while stimulating PGA dependent inter-bacterial and bacterial 
surface interactions. Based on this conclusion we used a flow cytometric assay, which can 
differentiate between type I fimbriae dependent and PGA dependent aggregation of bacteria 
(Figure 13). This differentiation of aggregates is based on the fact that the size of particles or 
aggregates can be monitored by flow cytometry and visualised in a FSC-H vs. SSC-H 
scatter, as seen in rows 1 and 2 of Figure 13. Aggregates which are caused through the 
expression of type I fimbriae but not PGA result in an increased GFP signal derived from the 
fimH-gfp reporter, as seen for the wild type reporter (Figure 13, quadrants 3A) and the strain 
with fimS in a locked ON orientation (Figure 13, quadrants 3B). On the contrary, strains 
whose aggregates are mediated by PGA rather than type I fimbriae, have a reduced or 
absent GFP signal, like the strain with fimS in a locked OFF orientation (Figure 13, quadrants 
3C). Quadrants 1D and 2D of Figure 13 further illustrate that PGA dependent aggregates 
only occur when csrB is overexpressed from plasmid (Figure 13, quadrants 4A). With these 
results in mind we can conclude that the aggregates observed in quadrants 2C of Figure 13 
must be caused by PGA while the aggregates of quadrants 2B of Figure 13 represent a 
combination of type I fimbriae and PGA. Furthermore, columns B and C of Figure 13 once 
more show that csrB can only exert its effects on fimbriation when fimS remains invertible. 
From this assay it can thus again be concluded that csrB overexpression allows pgaA-D 
dependent attachment between bacteria, while reducing type I fimbrial interactions, in a 
mechanism that depends on the invertible element fimS. Furthermore, this assay shows that 
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a ΔpgaA-D population under csrB overexpressed conditions contains very few aggregates 
which are mediated by type I fimbriae. This argues that type I fimbriae are present in biofilms 
that are dominated by the PGA adhesin and that therefore these two structures are not 
mutually exclusive. Thus csrB levels determine the equilibrium between PGA-dependent and 
fim-dependent aggregates in a given population. Alteration of the csrB levels can thus be 
used to push bacteria into fimA-H driven aggregation (low csrB levels) or PGA driven 
aggregation (high csrB levels), which proves that the state of the Csr system (repressed vs. 
derepressed) is crucial to determine which of the two adhesins will be expressed in a given 
situation. 
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6.6 Discussion 
Several studies exist, which report a coordinated expression of adhesins in bacteria 
(16, 95-111): A prominent example is the co-regulatory effect of CsgD on the expression of 
curli and cellulose, which are both adhesive matrix components of E. coli biofilms (97, 111). 
This co-regulatory effect strengthens the matrix of a biofilm and thus enhances the biofilm’s 
survival. Another example is the inverse expression of P fimbriae and type I fimbriae in 
UPECs. This crosstalk is shown to involve the regulator of pyelonephritis-associated pili 
(PapB) and is believed to prevent the expression of multiple types of fimbriae on a single cell 
(16, 98-100). Yet other studies introduce a regulatory link between the expression of type I 
and Sfa fimbriae in pathogenic E. coli (95, 96). In this current study we identified a regulatory 
mechanism which inversely affects the expression of type I fimbriae (which promote bacterial 
adherence to eukaryotic cells and enable UTIs) and the biofilm matrix component PGA 
(which promotes bacterial attachment and stabilises three-dimensional biofilms (15, 40, 42, 
89, 112)). We show that conditions derepressing the Csr system favour PGA expression but 
disfavour the expression of type I fimbriae. On the contrary, a repressed Csr system favours 
the expression of type I fimbriae but disfavours the expression of PGA. While the signalling 
cascade linking the Csr system to PGA expression is known and involves post-transcriptional 
control by CsrA (40, 42, 47, 113), the mechanism responsible for the downregulation of type I 
fimbriae still needs to be unravelled. Our work has identified several components that are 
required for this regulatory mechanism. These include the small RNA csrB, the recombinase 
FimE and the CsrD regulator involved in csrB stability control. Furthermore, we show that the 
Csr system affects type I fimbriae through the switchable element fimS, presumably by post-
transcriptionally affecting the activity of the recombinase FimE via CsrA. This regulatory 
crosstalk between type I fimbriae and PGA expression raises several interesting question 
with respect to its role in vitro or during the progression of urinary tract associated infections: 
Why would the expression of the two surface adhesins need to be spatially and/or temporally 
uncoupled?  
The most important role of type I fimbriae in UPECs is to promote bacterial entry into 
urothelial cells, which ultimately leads to cystitis (10). With respect to our model, this 
suggests that the conditions in urine and/or the epithelial cells of the bladder repress the Csr 
system. Consequently, PGA dependent biofilm formation is disfavoured while the expression 
of type I fimbriae is favoured. Contrary to UPECs, the closely related ABU strains are 
attenuated in their expression of type I fimbriae (114). In the ABU strain 83972, this 
attenuation is due to a large deletion in the fim operon described as fimB’::’DFGH+, which 
results in the loss of fimA, fimI and fimC (115). In order to survive in the bladder 83972 had to 
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adapt and find a way to persist without functional type I fimbriae. This is achieved by either 
fast growth or the formation of biofilms (116, 117). This argues that the nutritional state and 
the environment, which favour type I fimbriae expression in pathogenic UPECs might favour 
PGA expression in ABU strains. Moreover, it suggests that the model established in this work 
could be in place in pathogenic as well as ABU strains but have the opposite effects on 
adhesin expression, despite the same environmental conditions. Interestingly it was shown 
that csrB and csrC levels of 83972 are elevated upon patient colonisation or growth in urine 
(118, 119), which argues for an involvement of the Csr system in the bladder. This finding 
also allows speculating that the Csr system of 83972 is derepressed in ABU strains and 
repressed in cystitis isolates in the absence of physiological BarA/UvrY stimuli. It would be 
interesting to search for SNPs between pathogenic UPECs and ABU strains in the whole Csr 
system and all those components required for the inversed regulation of type I fimbriae and 
PGA. Maybe these SNPs can explain why UPECs express type I fimbriae and ABU strains 
form biofilms in the same host environment. Furthermore, it would be interesting to 
overexpress type I fimbriae from plasmid or delete the pgaA-D genes in ABU strains and see 
if their ability to survive within bladder is affected. This would be expected if our model is 
applicable to ABU strains.  
After successful adherence of pathogenic UPECs (e.g. UTI89) to urothelial cells, they 
are internalised into superficial facet cells where they start to form dense sessile biofilm-like 
structures (IBCs) (1-4). In vitro, type I fimbriae have been implicated in the initial attachment 
of bacteria to abiotic or biotic surfaces (32, 120-122). It is possible that these structures are 
expressed by UPECs in the cytoplasm during the initial phase of intracellular growth and are 
thereafter stably maintained in mature IBCs but without de novo synthesis. It was reported 
that expression of the pgaA-D promoter constantly increases during the 14 hours tested 
(123). So contrary to type I fimbriae, polysaccharide adhesins including PGA are expressed 
in the matrix of mature three-dimensional biofilms and hence appear to be temporally 
separated from the expression of type I fimbriae (28, 34, 122-124). Based on these in vitro 
studies it might be that the expression of type I fimbriae and PGA are temporally separated in 
the development of chronic UTI: type I fimbriae being synthesised in the initial phase of IBC 
development and PGA only being expressed in mature IBCs or long term persisting QIRs. 
Initial data obtained for the UTI89 pgaA-D mutant in a murine cystitis model (Hosch et al., 
unpublished manuscript) does not support this hypothesis and rather suggests that PGA is 
not important during cystitis. However, this study might not be fully conclusive, as the three 
weeks tested might not be sufficient to investigate phenotypical differences between 
persisting UTI89 wild type and UTI89 ΔpgaA-D. Furthermore, a phenotype for the UTI89 
ΔpgaA-D might only manifest itself once mice have suffered from recurring UTIs. This idea is 
supported by another study, which suggested that the pgaA-D genes of UPECs are 
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expressed in vivo and might contribute to virulence, (125). It would be interesting to monitor 
the expression of type I fimbriae and PGA simultaneously in a murine cystitis model using a 
double fimH-gfp pgaD-gfp_uv reporter strain. With this construct, it would be possible to 
differentiate the expression of fimA-H (GFP) from pgaA-D (GFP-UV) during infection without 
disrupting the UTI89 wild type disease progression. The use of such a double reporter strain 
would reveal if the inversed effects imposed by the Csr system occur in vivo and result in 
spatially and/or temporally separated expression of the two adhesins. In the end, the spatial 
and/or temporal separated expression of type I fimbrial and PGA expression has to occur in 
accordance with the environment and thus be regulated somehow. How can the identified 
components impose a signalling cascade, which inversely affects type I fimbriae and PGA? 
Why are type I fimbriae negatively regulated by the Csr system? Is CsrA the central 
component of the inversed regulation of the adhesin? Does CsrA directly regulate the 
expression of fimE, or are other fim components and unidentified factors necessary in the 
signalling cascade? 
 
6.6.1 The inverse effect of the Csr system on type I fimbriae and PGA involves csrB, 
CsrD, FimE and the phase variation of fimS. 
The results presented in this study provide evidence that the interference of type I 
fimbriae and PGA expression is predominantly functional, although an additional structural 
interference might still exist. The identified factors required to inversely regulate the two 
adhesins allow speculating on the hierarchy in the signalling cascade (Figure 14): We 
showed that the centre of the signalling cascade is composed of the Csr system. 
Modifications in the environmental composition require bacteria to quickly adapt, e.g. through 
the formation of PGA dependent biofilms and downregulation of type I fimbriae. The 
involvement of a global regulator, such as CsrA, is a reliable way to this. Upon environmental 
stimuli, it allows a controlled transition from fimbriated to non-fimbriated, PGA expressing 
bacteria. With respect to what is known about the mechanisms implied by the Csr system it 
can be assumed that the effects of csrB overexpression on type I fimbria are mediated 
through the mRNA binding protein CsrA, similar to the mechanism reposted for PGA 
repression (49, 126). As a ΔfimE mutant is irresponsive to alterations of csrB levels, it can be 
concluded that FimE must be downstream of csrB and CsrA in the signalling cascade. 
However, it remains to be elucidated, if CsrA really is involved, and acts on fimE or whether a 
novel role for csrB, which is independent of CsrA, was identified. A suggested interaction of 
CsrA with fimE mRNA could be indirect via inhibition of a positive regulator. Alternatively 
CsrA could exert a direct negative effect on the function of FimE by binding to and 
 Discussion 
- 108 - 
destabilising the fimE mRNA. The construction of a fimE::lacZYA transcriptional reporter with 
β-galactosidase activity could be used under csrB or CsrA overexpressing conditions, to 
elaborate the effect of the Csr system on fimE. Furthermore, direct binding of CsrA to the 
fimE mRNA could be investigated via gel shift assays. The direct interaction of CsrA with 
fimE mRNA would thus put another output system (type I fimbriae) under the direct control of 
CsrA. 
The third factor involved in the Csr mediated inversed effect on type I fimbriae and 
PGA expression was CsrD, a protein reported to ensure homeostatic levels of csrB and csrC. 
CsrD targets csrB and csrC for RNaseE degradation and hence affects their stability and 
cytoplasmic levels. Regarding its function in the Csr system it is expected that the deletion of 
CsrD resulted in a decreased level of fimbriation, even without the overexpression of csrB. 
Fimbriation of a csrD mutant was indeed decreased compared to wild type but only 
marginally. Likely this marginal decrease in fimbriation is due to enhanced stabilisation of 
csrB and csrC and hence a partial derepression of the Csr system. But as the levels of csrB 
and csrC are low under Csr repressed conditions the effects of a csrD mutant must be 
marginal. As for the overexpression of csrB in a csrD mutant, we speculate that the Csr 
system is completely deregulated, which impairs bacteria to express fimbriae in response to 
their environmental and metabolic state. Besides its effects on type I fimbriae, the deletion of 
csrD and simultaneous overexpression of csrB represents a stressful condition that results in 
a growth deficit and a massive increase in PGA dependent biofilm formation (Hosch et al., 
unpublished manuscript). This argues that CsrD ensures a balanced level of type I fimbrial 
expression and PGA production, which is adapted to the environmental conditions 
surrounding the bacteria. Being part of the Csr system, it is likely that the environmental 
cues, which modulate the levels of the two adhesins signal through the BarA/UvrY two 
component system. Unfortunately, the literature on environmental factors influencing the Csr 
system, fimbriation or PGA expression is scarce and based on these studies it is difficult to 
hypothesise, which environmental signals are at the basis of the inversed adhesin regulation. 
However, some of these studies could serve as guidelines in determining which 
environmental cues integrate into this regulatory mechanism. For example, it has previously 
been shown that oxygen limiting conditions, which are found during stationary growth (e.g. 
during static growth) enrich for fimbriated bacteria (127). This is in agreement with our 
findings that fimbriation is highest in a stationary phase culture statically grown and deprived 
of oxygen. Thus the observation that csrB overexpression only downregulates fimbriation 
under static conditions suggests that the described regulatory network is oxygen-sensitive. 
Moreover, an Affymetrix array hybridisation study suggested that the environmental pH might 
influence the translation of type I fimbriae, csrB, many metabolic genes, as well as the 
diguanylate cyclase YdeH (128). And yet another study has reported that the short chain 
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fatty acids acetate and formate, both fermented under carbon limiting conditions, get sensed 
by the BarA/UvrY two-component system and result in a derepressed Csr system (50). 
Moreover, it is known that glycogen synthesis, which is under the control of the Csr system 
as well, starts to increase upon entry into stationary phase (46, 129-133). It is thus plausible 
to speculate that glycogen availability, oxygen, pH and/or short chain fatty acids contribute to 
the Csr-dependent regulation of the two adhesins. Hence, it would be worthwhile to test the 
impact of these stimuli on the dual adhesin system using the fimH-gfp or a fimH-gfp pgaD-
gfp_uv double reporter strain. Of course, this construct could be used in vitro and in vivo to 
identify other metabolic components or other physiological signals that activate the Csr 
cascade and by that adapt the expression pattern of the two adhesins. An in vitro transposon 
screen performed on the double reporter strain should further help to identifying the 
remaining bacterial components that are involved in the regulatory mechanism underlying the 
inversed adhesin regulation that trigger the inversed regulation via the BarA/UvrY TCS.  
 
6.6.2 During biofilm formation type I fimbriae and PGA expression are separated 
The inverse regulation of type I fimbriae and PGA expression indicates that the 
expression of both adhesins must be separated in some way, and that their expression is 
favoured in some but not in other environments. Thus far, it seems that the expression of 
either of the adhesins occurs in response to environmental signals sensed by the Csr 
system. This raises the question whether any signal is strong enough to completely turn off 
the expression of one adhesin and stimulate the expression of the other or whether the 
signal only serves to modulate the abundance of the two structures. Biofilms visualised on 
electron micrographs showed us that the two extracellular adhesin structures do not get co-
expressed on the surface of a single bacterium. Furthermore, the adhesin abundance was 
different over the whole population, arguing for a spatial separation of adhesin-expression 
over the entire population and a clear preference for PGA over the entire population. 
Importantly however, this also suggests that type I fimbriae are not completely absent under 
conditions that favour PGA dependent attachment, as few UTI89 wild type bacteria in a 
biofilm expressed type I fimbriae despite elevated csrB levels. Similarly, overexpression of 
type I fimbriae under conditions which stimulate PGA dependent biofilm formation 
(overexpression of csrB) still allowed the formation of a residual biofilm. Also, we found that 
attachment of UTI89 wild type lays between the attachment of the locked ON and locked 
OFF strains, arguing that bacteria can still form residual PGA dependent biofilms when type I 
fimbriae are highly present. In conclusion it seems that the abundance of both adhesins 
cannot be equal on the surface of a bacterial population but do not necessarily exclude one 
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another. Thus, signals interacting with the BarA/UvrY TCS are not strong enough to 
completely abrogate the expression of the other adhesin. Presumably the different 
environments encountered by UPECs during pathogenesis have exerted a selective 
pressure on bacteria to only expression one of the adhesins. As a result, UPECs, and maybe 
also other bacteria, were able to adapt to several environments by imposing regulatory 
networks which govern over dual adhesin systems.  
Furthermore, we observed that the absence of type I fimbrial expression in a fimS 
locked OFF mutant, does not fully account for the enhanced attachment of a strain, which 
lacks all structural genes (ΔfimA-H). This result was unexpected and will need to be 
elaborated in the future. Possible explanations include the following scenarios: i) maybe the 
deletion of fimA-H results in a polar effect in which the fimbrial promoter is brought into 
proximity of the uxuA gene downstream of fimH. Interestingly, UxuA is involved in the carbon 
metabolism where it interconverts pentose and glucuronate. Thus an uxuA deletion might 
result in a metabolic flux which favours attachment by affecting the Csr signalling. To study 
this “polar effect”, the phenotype of a uxuA deletion mutant in attachment would have to be 
investigated in attachment assays. ii) The increased attachment in a fimA-H mutant 
compared to the locked OFF strains could also be caused by the action of one of the 
recombinases (FimB, FimX or FimE), as their genes are deleted in the locked OFF strains 
but not in UTI89 wt or the fimA-H mutant. To test this hypothesis, the recombinases would 
have to be deleted in the fimA-H mutant and the attachment would have to be compared to 
UTI89 and the recombinase mutants. iii) Alternatively, the difference in attachment might 
result from residual read-through of an upstream promoter into the fim genes. The easiest 
way to test this is by investigating GFP expression of the fimH-gfp reporter strain, which has 
a locked OFF phase of fimS under repressed and derepressed Csr signalling and compare it 
to the results obtained from a fimH-gfp ΔfimA-H. Regardless of the underlying cause the 
difference in attachment between ΔfimA-H and fimS locked OFF mutant remains an 
intriguing result, which suggests that any genetic alteration of the fimBE-fimS-fimAICDFGH 
or fimX locus has an effect in PGA dependent attachment. Furthermore, this result again 
raises the question whether the inversed regulatory effect exerted by the Csr system is 
sufficient for all phenotypes observed, or whether an additional structural interference of the 
two adhesins may further contribute to the observed interference. 
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6.6.3 Disruption of the fimAICDFGH operon reduces the signal reporting fimbrial 
expression  
Besides the novel inversed regulation of type I fimbriae and PGA, this study 
demonstrates that our fimA::gfp reporter strain does not properly represent wild type 
fimbriation. The improperly reported fimbriation must be due to the disruption of the 
fimAICDFGH operon. Similar to other studies (24, 94), fimA::gfp reported very few fim+ 
UTI89 bacteria under the conditions, which usually maximise fimbriation. This result is not in 
agreement with the wild type fimbriation measured by other methods (e.g. aggregometry). A 
possible explanation for the discrepancy in fimbriation levels could be that the expression of 
type I fimbriae underlies a positive feedback mechanism that depends on the correct 
expression of fimA-H. Different studies have reported that the outer membrane composition 
is remodelled once type I fimbriae are inserted into the membrane and interact with abiotic 
surfaces. These remodelling actions affect the protein composition and the physiochemical 
characteristics of the membrane (122, 134, 135). Interestingly, one protein whose abundance 
alters upon insertion of type I fimbriae into the outer membrane was OmpX. Deletion of this 
protein was shown to cause an increase in type I fimbriae mediated interactions with abiotic 
surfaces (136). This suggests that the levels of surface exposed type I fimbria and OmpX 
must be controlled by a feedback mechanisms, which signals into the cell and affects the 
expression of type I fimbriae or ompX, respectively. Regarding our dual adhesin system, a 
similar situation could contribute to the inverse effects of the Csr system. The fimbrial 
proteins are secreted through the SecYEG translocon and only get folded once they reached 
the periplasm. Therefore, it is very unlikely that the structural fim proteins act upon their own 
upregulation. The presence of this hypothesised feedback loop could easily be confirmed by 
overexpressing type I fimbriae from plasmid in the fimA::gfp reporter strain and test if the 
GFP levels reporting fimbriation get complemented to the levels reported for fimH-gfp. An 
interesting candidate involved in the hypothesised feedback loop is FimI, found downstream 
of FimA on the polycistronic fimA-H operon. In E. coli and S. typhimurium, FimI was shown to 
be essential for proper fimbriation. It contains a signal sequence, which directs the protein to 
the outer membrane (77, 137, 138). In S. typhimurium FimI was further suggested to anchor 
type I fimbriae to the cell membrane (138). The precise function of FimI and its location 
outside the cytoplasm could not yet be determined in E. coli. We speculate that FimI might 
be involved in a mechanism, which feeds back from the outer membrane to the regulators 
that affect the expression of type I fimbriae in the periplasm. This function of FimI would be 
novel but it would not contradict previous results. Presumably, a comprehensive search for 
components involved in the overall interference of type I fimbriae and PGA, e.g. via 
transposon screen based on the dual reporter, would identify FimI or the other components 
involved in the mechanism underlying the inversed regulation of type I fimbriae and PGA.  
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In conclusion, this study performed in UPECs has identified a regulatory link between 
the expression of type I fimbriae, which contribute to virulence during UTIs, and the well-
established exopolysaccharide PGA involved in biofilm formation. This regulatory link 
depends on the Csr system which integrates environmental signals to inversely affect the two 
adhesins through post-transcriptional control by CsrA. Repression of the Csr system hinders 
PGA dependent biofilm formation while a derepressed Csr system decreases fimbriation by 
affecting the orientation of fimS, in a process that requires the recombinase FimE. Our model 
further suggests that CsrD is required for the regulatory mechanism leading to a balanced 
dual adhesin expression, which is in accordance with the environmental state. Furthermore 
we hypothesise that the localisation of type I fimbriae to the outer membrane leads to 
membrane modifications, which result in a signalling cascade that further interferes with PGA 
expression and additionally boosts fimbriation. This hypothetical feedback mechanism might 
be integrated into the Csr signalling cascade that affects the expression of type I fimbriae via 
FimE.  
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6.7 Figure Legend 
Figure 1: Phenotypes of type I fimbriae in UTI89. 
The phenotypes of type I fimbriae have been investigated in isogenic ΔfimA-H or ΔfimH 
mutants using UTI89 as parent strain. Complementation of all type I fimbrial phenotypes was 
performed by overexpressing type I fimbriae from plasmid (pPKL4) Error bars of all assays 
are standard errors of the mean A) Deletion of type I fimbriae abolishes GPE 
aggregation: Bacteria were grown for 24 h statically and then adapted to an OD600 of 4, 
GPE were adapted to an OD600 of 4 as well. Aggregation was measured over 10 min and 
was normalised to 0 % aggregation (GPE solution) and 100 % aggregation (PBS). The 
histogram indicates the percentage of aggregated GPE compared to UTI89 wild type (100 
%). Strains without pPKL4 are shown in white; strains carrying pPKL4 are shown in black. In 
some strains, aggregation was not detectable, these strains are indicated as n.d. B) Type I 
fimbriae are detrimental for PGA dependent attachment: Cell density and surface 
attachment was measured as OD600 after static growth for 24 h. Overexpression of csrB was 
performed to derepress the translation of the pgaA-D mRNA required for PGA synthesis. 
Bars represent biofilm formation (surface-attached biomass divided by optical density of total 
cells) compared to UTI89 pcj30 csrB. Data for pcj30 csrB is depicted in black bars; data for 
the control plasmid pcj30 is depicted in white bars. C) Complementation of type I fimbriae 
lowers PGA dependent attachment of UTI89: Cell density and surface attachment was 
determined at 600 nm after statical growth for 24 h. Bars represent biofilm formation 
(surface-attached biomass divided by optical density of total cells) compared to UTI89 pCsrB 
(white bars). Black bars indicate data obtained from strains carrying pCsrB and pPKL4. Data 
is shown with standard errors of the mean. 
 
Figure 2: Scanning electron micrographs of biofilms.  
Electron micrographs of biofilms were taken from strains statically grown on glass 
slides for 24 h in a 24-well plate at 37° C. All strains were grown in the presence of induced 
pcj30 csrB. Scale bars are indicated in each micrograph. Biofilm formation of UTI89 wild type 
is compared to biofilm formation of ΔfimA-H and ΔpgaA-D. A) Images were taken at the 
following magnifications: 2000x for UTI89 and UTI89 ΔpgaA-D and 1700x for UTI89 ΔfimA-
H. B) Images were taken at the following magnifications: 10’000x for UTI89 wt and UTI89 
ΔfimA-H and 6700x for UTI89 ΔpgaA-D. Black arrows points out PGA knobs, the white 
arrows indicate type I fimbriae. The fibrillar structures present in UTI89 ΔfimA-H are thicker 
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than the hair like structures observed in UTI89 and most likely represent flagella. The close 
up images shown in C) are sections of representative images taken from bacteria within 
biofilms that express both type I fimbriae and PGA knobs.  
 
Figure 3: Effects of csrB on the phase of the invertible element fimS.  
The fim OFF to ON ratio was calculated from DNA band intensities of the three primer 
based PCR-products. Determination of this ratio was performed with ImageJ as follows: 
((OFF band intensity – background intensity) / (ON band intensity – background intensity)). 
The data in each box-plot represent the average of at least 8 clones per strain and condition. 
The boxes represent the second and third quartile, the line in the box indicates the mean 
over all clones. The boundaries of the first and fourth quartile are indicated as lines. White 
bars indicate ratios determined from strains carrying noninduced pCsrB [Ratios: UTI89 wild 
type (2.9 ± 0.7), ΔpgaA-D (3.3 ± 1.0), ΔycdT (2.3 ± 1.0) and ΔydeH (2.7 ± 0.9)]. Data shown 
for the induced pCsrB is shown in gray [The calculated ratios were as follows: UTI89 wild 
type (5.1 ± 1.3), ΔpgaA-D (5.9 ± 2.0) ΔycdT (3.8 ± 1.6) and ΔydeH (4.4 ± 0.6)]. The degree of 
significance between noninduced and induced colonies are indicated at the top of the graph 
and were calculated in an unpaired t-test (P>0.05).  
 
Figure 4: Structure and phenotypes of pfimA-H
Locked constructs: 
A: structure of pfimA-H
Locked constructs: The wild type locus of type I fimbriae is 
located at the top. The second line illustrates the UTI89 ΔfimA-H construct. In the lower two 
constructs, the recombinases fimB and fimE are deleted and the orientation of fimS (red) is 
artificially fixed (see Material and Methods). To ensure that fimS remains fixed, fimX was 
additionally deleted in the pre-existing pfimA-H
Locked strains, as illustrated in the fourth construct. 
The red arrow indicates that the invertible element fimS can still be switched and thus the 
promoter of fimbriae can be found in two orientations. In the lower two constructs the arrow 
heads of fimS are missing since the phase of pfimA-H
Locked constructs is fixed in either the ON 
or the OFF configuration. White boxes indicate unmodified areas while grey boxes indicate 
deleted genes. B): Attachment of pfimA-H
Locked strains: Cell density and surface attachment 
was measured and quantified at 600 nm after 24 h static growth. Bars represent biofilm 
formation (surface-attached biomass divided by optical density of total cells) compared to 
UTI89 pcj30 csrB with standard errors of the mean. (Data obtained with the empty vector is 
not shown) C: Aggregation of pfimA-H
Locked strains under csrB overexpressing 
conditions: The capacity of the pfimA-H
Locked mutants to aggregate GPE is quantified as 
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percentage compared to UTI89 wild type mediated aggregation. Data obtained for the empty 
plasmid (pME6032) is shown in white; aggregation of strains with pCsrB is shown in black. 
GPEs were adapted to an OD600 of 8; bacteria to an OD600 of 4. Standard errors of the mean 
are calculated from three measurements of the same culture. The effect of csrB in ΔfimX 
ΔfimBE pfimA-H
Locked ON has been calculated as being non-significant (n.s) in an unpaired t-test 
(P>0.05 ). 
 
Figure 5: Construction of pfimA-H GFP reporter constructs to monitor fimbrial phase 
variation.  
Two distinct fimbrial reporter constructs were made. A): structure of pfimA-H reporter 
constructs: The top line illustrates the wild type locus of type I fimbriae. The green boxes 
indicate the position at which the GFP reporter was inserted. The red arrowheads of fimS 
indicate that phase variation is still possible. White boxes represent genes, which have not 
been modified. Grey boxes indicate that these genes are still present but not expressed due 
to disruption of the polycistronic fimAICDFGH mRNA through GFP insertion into fimA. In 
fimH-gfp the GFP was inserted at the 3’ end of fimH and thus this strain remains fimbriated. 
Expression of GFP is ensured through the insertion of a Shine Dalgarno sequence between 
fimH and gfp. B) Flow cytometric measurement of fimbriation: For each strain we 
captured 50`000 events with a flow cytometer and plotted them according to their size 
(indicated in the left pannel). This plot was subdivided into four quadrants (Q1- Q4), bacteria 
being in the upper right quadrant (Q2). Next, the GFP signal (Alexa-Fluor 488-H) of all events 
in Q2 was plotted against the red channel (PE-H) to exclude a possible increases in 
background fluorescence. Also, the GFP signal of all bacteria in Q2 was plotted in a 
histogram to investigate the distribution of signal intensities. Based on the negative control 
(UTI89 wild type) the intensity plot was subdivided into a GFP minus (fim-) section (left) and 
a GFP positive (fim+) section (right). The percentages of events, which localise in the fim+ 
and fim- section, are indicated in the histogram.  
 
Figure 6: Characterisation of the fimH-gfp reporter strain. 
A) Aggregation of fimH-gfp: Aggregation of fimH-gfp was measured after setting the 
GPE and bacteria to an OD600 of 4. The values in the histogram are shown as the mean of 
three measurements and the standard errors thereof. B) Attachment of fimH-gfp: Cell 
density and surface attachment was measured as OD600 after static growth for 24 h. Bars 
represent biofilm formation (surface-attached biomass divided by optical density of total cells) 
 Figure Legend 
- 116 - 
compared to UTI89 pCsrB. Bars in white indicate attachment measured for strains carrying 
the pME6032 control plasmid. The data of pCsrB is shown in black. The standard error of the 
mean is included for all data sets. C) Fimbriation patterns of fimH-gfp: In the upper panel, 
fimbriation of each strain is shown as pseudocolored, size-dependent distribution in a 
forward-sideward scatter and was measured using a type I fimbriae specific antibody. The 
lower panel depicts histograms showing the Alexa 647 signal distribution measured in the 
APC channel. Histograms have been subdivided into two populations using UTI89 ΔfimA-H 
to determine the non-fimbriated population (Data not shown). The left section of the 
histograms represents non-fimbriated bacteria; the right section represents fimbriated 
bacteria. The percentage of non-fimbriated respectively fimbriated bacteria is indicated in 
each histogram. 
 
Figure 7: Growth dependent analysis of fimbriation in fimA::gfp. 
GFP expression of the fimA::gfp reporter strain was measured over time and under 
aerated (B) as well as static (A) conditions. Samples were taken at the beginning of the 
growth curve as well as after 1, 2, 3, 5, 8 and 24 hours. To measure fimbriation bacteria were 
fixed and processed for flow cytometric analysis. The upper panels in A and B illustrate the 
size distribution of the 10`000 events measured for each sample. The upper right quadrant in 
each SSC-H vs. FCS-H scatter contains bacteria. The GFP signal intensities for all bacteria 
recorded in the upper right quadrant are illustrated in histograms (lower panels). The left 
peak in the histogram corresponds to the signal intensities determined for the negative 
control and thus represents events without GFP signal (fim-). The second peak, at the right 
side of the histograms, corresponds to the fraction of bacteria, which express GFP (fim+). 
The fractions of fim- and fim+ are indicated in each histogram.  
 
Figure 8: Flow cytometric analysis of fimA::gfp pfimA-H
Locked strains. 
The flow cytometric patterns of the pfimA-H
Locked strains are shown in A): The first column 
shows the flow cytometric pattern of the wild type fimA::gfp construct. The second column 
shows flow cytometric patterns of fimA::gfp ∆fimBE pfimA-H
ON, where fimS was locked in the 
ON phase. The last two columns show the data of fimA::gfp ∆fimBE PfimA-H
OFF respectively 
fimA::gfp ∆fimBE PfimA-H
OFF* where fimS is locked in the OFF phase. Subdivision into fim- and 
fim+ bacteria was performed as previously described and the fraction of fim- and fim+ 
bacteria is indicated in each histogram. Figure 8B) shows the effects of csrB overexpression 
on the fim+ fraction in the fimA::gfp reporter stain. As the effect of csrB on fimbriation in 
 Figure Legend 
- 117 - 
fimA::gfp was minor the histograms only considers the fraction of bacteria, which were fim+ 
according to the GFP-signal intensity distribution (histogram of the Alexa-Fluor 488-H signal). 
Per strain, 3 independently grown clones were measured and their mean as well as the 
standard error thereof was calculated. The significance was calculated with an unpaired t-
test (P>0.05).  
 
Figure 9: Growth dependent analysis of fimbriation in fimH-gfp strains. 
The left y-axis indicates the fraction of the bacterial population, which expresses GFP 
(fim+), the right y-axis indicates the optical density of the bacterial culture at the time the 
sample was taken. The data of the growth curve is shown as empty circles, GFP data from 
flow cytometry is indicated as filled squares. Strains without plasmid are shown in a 
continuous line, strains with the pME6032 control plasmid are shown as discontinued line 
and strains with pCsrB are shown as dotted line. The negative control (UTI89 wt) is shown in 
gray. All data points are calculated as the mean ± standard error of the mean of three 
independent samples grown in parallel in 250 ml glass flasks. At each time point, samples 
were collected and processed for flow cytometry. Once all samples were collected, they were 
transferred into a 96 well plate and analysed with a HTS sampler by flow cytometry. A) 
Fimbriation under aerated conditions: Samples were taken at the start of the growth 
culture, after 30 min, 1 h, 2 h, 3 h, 4 h, 5h, 6 h, 7 h, 8 h and 24 h. B) Fimbriation under 
static conditions: Samples were taken at the start of the growth culture and then after 1 h, 2 
h, 3 h, 4 h, 5h, 6 h, 7 h, 8 h, 9 h, 10 h, 12 h, 14 h, 16 h, 18 h, 20 h, 22 h and 24 h. The values 
of three time points (Start, 10 h and 24 h) are calculated from 6 independent samples. 
 
Figure 10: Flow cytometric analysis of fimH-gfp pfimA-H
Locked strains. 
The flow cytometric patterns of the pfimA-H
Locked strains in the fimH-gfp reporter construct. 
Data was obtained from cultures, which grew statically for 24 h. The data for the wild type 
fimH-gfp construct is illustrated in the left column. The fimH-gfp pfimA-H
ON data is shown in the 
second column from the left. The two last columns show the data of fimH-gfp pfimA-H
OFF and 
fimH-gfp pfimA-H
OFF* the ladder of which contains a point mutant in one of the two inverted 
repeats of fimS. Subdivision into fim- and fim+ bacteria was performed as described above 
and the fim+ and fim- fractions are indicated in each graph. 
 
Figure 11: Effects of csrB in fimH-gfp pfimA-H
Locked strains 
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The data obtained in this figure comes from cultures, which grew statically for 18 h in 
50 ml falcon tubes. The data for the fimH-gfp carrying the pME6032 control plasmid is 
illustrated in A). The data for the pCsrB overexpressing plasmid is illustrated in B). The 
gating was performed as described in Materials and Methods or Figure 6B. Subdivision into 
fim- and fim+ bacteria was performed as described above and the fim+ and fim- fractions are 
indicated in each graph. 
 
Figure 12: Growth dependent fimbriation in ΔfimB, ΔfimE and ΔcsrD mutants. 
The mutants fimH-gfp ΔfimB, fimH-gfp ΔfimE and fimH-gfp ΔcsrD were statically 
grown. The first sample was taken after 10 h, thereafter samples were collected every two 
hours up to 24 h. The data illustrated corresponds to the fim+ fraction of the bacterial fimH-
gfp population. Data obtained from strains without plasmid is shown as filled line, data of 
pME6062 is shown as dashed line and the data of pCsrB is shown as dotted line. The growth 
curves of wild type fimH-gfp as well as the three fimH-gfp mutants are shown in A). GFP 
expression profiles of fimH-gfp is shown in B), those of fimH-gfp ΔfimB in C) fimH-gfp ΔfimE 
in D) and fimH-gfp ΔcsrD in E). After sample collection and processing for flow cytometry, the 
samples were stored at 4 °C and all analysed at once in a 96-well plate. Data points are the 
average of three independent clones grown in parallel. Error bars are shown as standard 
errors of the mean. 
 
Figure 13: Flow cytometric differentiation between fimA-H and  pgaA-D mediated 
aggregates. 
GFP expression was determined by flow cytometry from cultures which grew in 50 ml 
falcon tubes for 18 h under static conditions. Row 1 and row 2 represent size dependent 
distributions of bacteria in a forward-sideward-scatter. The GFP signal of all the bacteria in 
the upper right quadrant (Q2) of each FSC-H vs. SSC-H plot are represented as intensity 
distributions in lane 3 and lane 4. Lanes 1 and lane 3 represent strains carrying the 
pME6032 control vector, row 2 and row 4 are data obtained from strains with pCsrB. The 
histograms of row 3 and row 4 are subdivided into a GFP negative (fim-) and a GFP positive 
section (fim+). Column A shows the data obtained for the fimH-gfp wild type, column B and 
column C are data for the pfimA-H
ON and pfimA-H
OFF reporter strains, respectively. The data for 
ΔpgaA-D is shown in column D.  
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Figure 14: Concluding model of inversed adhesin regulation. 
The model illustrates the inversed regulation of PGA and type I fimbrial expression by 
the Csr system (red). Factors affected by CsrA which are not involved in the inversed 
regulation of the two adhesins are not illustrated here. Neither are factors affecting phase 
variation of fimS. Formate, acetate and most certainly other signals derepress the Csr 
cascade through stimulating the BarA/UvrY two component system (TCS). Upon stimulation 
of the TCS, the small RNAs csrB and csrC get synthesised, bind to CsrA and titrate it away 
from its confirmed target mRNAs (nhaR, pgaA-D, ydeH, ycdT) and its postulated target 
mRNAs (fimE or a positive regulator thereof). As a consequence PGA dependent biofilm 
formation occurs and FimE switches fimS into the OFF phase, discontinuing the expression 
of type I fimbriae and counteracting the activity of FimE. CsrD serves as a control, which 
balances the expression of the two adhesins, according to environmental cues. Additional 
known feedback loops of the Csr system are illustrated in the model and also serve to 
stabilise the system.  
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6.9 Tables 
Table 1: Strain used in this study 
Strain 
Ref. 
Strain Name Strain Characterisation Reference 
UTI89 UTI89 wild type Wild type strain and parent of all mutants (7, 77). 
LH022 ∆ycdT clean deletion of ycdT 
Hosch et al., 
unpublished 
LH023 ∆ydeH clean deletion of ydeH 
Hosch et al., 
unpublished 
LH024 ∆pgaA-D clean deletion of pgaA-D 
Hosch et al., 
unpublished 
LH026 ∆fimA-H clean deletion of fimAICDFGH 
(78), this 
study 
LH055 ∆fimA::gfp fimbrial reporter strain where gfp replaces the ORF of fimA this study 
LH064 ∆fimBE pfimA-H 
OFF
 clean deletion of fimBE and a fixed orientation of fimS in the OFF orientation this study 
LH065 ∆fimBE pfimA-H 
ON
 clean deletion of fimBE and a fixed orientation of fimS in the ON orientation this study 
LH066 ∆fimBE pfimA-H 
OFF*
 
clean deletion of fimBE and a fixed orientation of fimS in the OFF orientation with 
an additional point mutation (TTGGGGCCAA in wild type vs. TTAGGGCCAA in 
∆fimBE pfimA-H 
OFF*
) in one of the two inverted repeats of fimS 
this study 
LH109 ∆fimBEX clean deletion of fimBE and fimX this study 
LH116 
∆fimBE ∆fimA::gfp pfimA-
H 
OFF
 
Insertion of the fimA::gfp reporter construct into the clean deletion of fimBE and a 
fixed orientation of fimS in the OFF orientation 
this study 
LH117 
∆fimBE ∆fimA::gfp pfimA-
H 
ON
 
Insertion of the fimA::gfp reporter construct into the  clean deletion of fimBE and a 
fixed orientation of fimS in the ON orientation 
this study 
LH118 
∆fimBE ∆fimA::gfp pfimA-
H 
OFF*
 
Insertion of the fimA::gfp reporter construct into the clean deletion of fimBE and a 
fixed orientation of fimS in the OFF orientation with an additional point mutation 
(TTGGGGCCAA in wild type vs. TTAGGGCCAA in ∆fimBE pfimA-H 
OFF*
) in one of 
the two inverted repeats of fimS 
this study 
LH149 
∆fimX∆fimBE 
∆fimA::gfp pfimA-H 
OFF
 
Insertion of the fimA::gfp reporter construct into the clean deletion of fimBE and 
fimX and a fixed orientation of fimS in the OFF orientation 
this study 
LH150 
∆fimX∆fimBE 
∆fimA::gfp pfimA-H 
ON
  
Insertion of the fimA::gfp reporter construct into the  clean deletion of fimBE and 
fimX and a fixed orientation of fimS in the ON orientation 
this study 
LH151 
∆fimX∆fimBE 
∆fimA::gfp pfimA-H 
OFF*
 
Insertion of the fimA::gfp reporter construct into the clean deletion of fimBE and 
fimX and a fixed orientation of fimS in the OFF orientation with an additional point 
mutation (TTGGGGCCAA in wild type vs. TTAGGGCCAA in ∆fimBE pfimA-H 
OFF*
) in 
one of the two inverted repeats of fimS 
this study 
LH155 ∆fimX∆fimBE pfimA-H 
OFF
 
clean deletion of fimBE and fimX and a fixed orientation of fimS in the OFF 
orientation 
this study 
LH156 ∆fimX∆fimBE pfimA-H 
ON
  
clean deletion of fimBE and fimX and a fixed orientation of fimS in the ON 
orientation 
this study 
LH157 ∆fimX∆fimBE pfimA-H 
OFF*
 
clean deletion of fimBE and fimX and a fixed orientation of fimS in the OFF 
orientation with an additional point mutation in one of the two inverted repeats of 
fimS 
this study 
LH196 fimH-gfp fimbrial reporter strain where GFP is inserted downstream of fimH this study 
LH218 fimH-gfp ΔrelAΔspoT  Insertion of fimH-gfp into ΔrelAΔspoT (Strain still is kan
R
) this study 
LH227 fimH-gfp ΔcsrB  Insertion of ΔcsrB into fimH-gfp   this study 
LH228 fimH-gfp ΔcsrC Insertion of ΔcsrC into fimH-gfp   this study 
LH229 fimH-gfp ΔcsrD Insertion of ΔcsrD into fimH-gfp   this study 
LH230 fimH-gfp ΔycdT  Insertion of ΔycdT into fimH-gfp   this study 
LH231 fimH-gfp Δc1116 Insertion of Δc1116 into fimH-gfp   this study 
LH232 fimH-gfp Δc1117 Insertion of Δc1117 into fimH-gfp   this study 
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LH233 fimH-gfp ΔfimB Insertion of ΔfimB into fimH-gfp   this study 
LH234_2 fimH-gfp ΔfimE Insertion of ΔfimE into fimH-gfp   this study 
LH235 fimH-gfp ΔfimBE Insertion of ΔfimBE into fimH-gfp   this study 
LH236 fimH-gfp ΔfimX Insertion of ΔfimX into fimH-gfp   this study 
LH237 fimH-gfp ΔycgR Insertion of ΔycgR into fimH-gfp   this study 
LH238 fimH-gfp ΔcsgD Insertion of ΔcsgD into fimH-gfp   this study 
LH239 fimH-gfp ΔyhjH Insertion of ΔyhjH into fimH-gfp   this study 
LH240 fimH-gfp ΔbcsA Insertion of ΔbcsA into fimH-gfp   this study 
LH242 fimH-gfp ΔydeH Insertion of ΔydeH into fimH-gfp   this study 
LH243 fimH-gfp ΔpgaA-D Insertion of ΔpgaA-D into fimH-gfp   this study 
LH244 
∆fimX∆fimBE pfimA-H 
OFF 
fimH-gfp  
Insertion of the fimH-gfp reporter construct into the clean deletion of fimBE and 
fimX and a fixed orientation of fimS in the OFF orientation 
this study 
LH245 
∆fimX∆fimBE pfimA-H 
ON 
fimH-gfp  
Insertion of the fimH-gfp reporter construct into the clean deletion of fimBE and 
fimX and a fixed orientation of fimS in the ON orientation 
this study 
LH246 
∆fimX∆fimBE pfimA-H 
OFF* 
fimH-gfp  
Insertion of the fimH-gfp reporter construct into the clean deletion of fimBE and 
fimX and a fixed orientation of fimS in the OFF orientation with an additional point 
mutation (TTGGGGCCAA in wild type vs. TTAGGGCCAA in ∆fimBE pfimA-H 
OFF*
) in 
one of the two inverted repeats of fimS 
this study 
 Tables 
- 136 - 
Table 2: Plasmids used in this study 
Plasmid 
name 
Relevant genotype Comments Reference 
pcj30 lacI
P 
bla
+ 
(amp
R
) IPTG inducible expression vector Bibikov et al., 1997; (139) 
pcj30 csrB  pcj30::csrB (amp
R
) IPTG inducible expression vector 
this study; Hosch et al., 
unpublished manuscript 
pME6032 
pVS1 derived shuttle vector 
(tet
R
) 
IPTG inducible expression vector Heeb et al., 2000; (140) 
pCsrB pME6032::csrB (tet
R
) IPTG inducible expression vector 
this study; Hosch et al., 
unpublished manuscript 
pKM208 lacI
P 
(amp
R
) 
Temperature sensitive replication; λRED-mediated 
recombinogenic plasmid; IPTG inducible 
Murphy et al., 2003; (79)  
pCP20  flp
+ 
(amp
R
) (CM
R
) 
temperature-sensitive replication and induction of 
FLP (recombinase) 
Cherepanov et al., 1995; 
(141) 
pPKL4 pBR322 derivate (amp
R
)  contains the entire fim gene cluster from E. coli K-12  Krogfelt et al., 1988; (92) 
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Table 3: Primers used in this study 
Primer name Primer Sequene 
1545-ycdP_KO_P2 
GTGCAGAGCCCGGGCGAACCGGGCTTTGTTTTGGGTGTTTATGCCCGTCACATATGAATATCCTC
CTTAG 
1546-ycdS-KO-P1 
TAATTAGATACAGAGAGAGATTTTGGCAATACATGGAGTAATACAGGTGTGTAGGCTGGAGCTGC
TTC 
2145-fimA_KO_P1 
GCCCATGTCGATTTAGAAATAGTTTTTTGAAAGGAAAGCAGCATGAAAATTGTAGGCTGGAGCTGC
TTCG 
2146-fimH_KO_P2 
GTAATATTGCGTACCAGCATTAGCAATGTCCTGTGATTTCTTTATTGATACATATGAATATCCTCCT
TAG 
2295_fimE  GCAGGCGGTTTGTTACGGGG 
2296_fimA GATGCGGTACGAACCTGTCC 
2297_inv GAGGTGATGTGAAATTAATTTAC 
2400-ydeH_KO_P1 
TAGAATAGCGCGCACAAGGAACTGTGAAAAAGGAGTGGCAATGATCAAGTGTAGGCTGGAGCTG
CTTCG 
2401-ydeH_KO_P2 
CACAGTAGCATCAGTTTTCTCAATGAATGTTAAACGGAGCTTAAACTCGCATATGAATATCCTCCTT
AG 
2402_ycdT_seq_fwd1 TCATCATCGGTATTGTTTGTGGGCGG 
2762_ycdT_KO_P2 
CCGGGGGGATGAGAAGCCCCAGGCGGAGGTCGACAACTAGCGACAGACTGCCGCTTTATGGTG
ACTCAC 
3156_fimH_KO_P1 
CACCTATACCTACAGCTGAACCCAAAGAGATGATTGTAATGAAACGAGTTTGTAGGCTGGAGCTG
CTTCG 
3182_FimB_KO_P1 
GCACAGCTAGTGCGCGTCTGTAATTATAAGGGAAAACGATGAAGAATAAGTGTGTAGGCTGGAGC
TGCTTCG 
3183_FimB_KO_P2 
GTAGTTTTTAACACCATCCCTGGTATCTCAACTATCTCTATAAAACAGCCATATGAATATCCTCCTT
AG 
3184_FimE_KO_P1 
GTATTCATTCAAATATATCTCAGTCAGGAGTACTACTATTGTGAGTAAACGTTGTGTAGGCTGGAG
CTGCTTCG 
3185_FimE_KO_P2 
GTATTTATTTGTTTTTTAACTTTATTATCAATTAGTTAAATCAAGCTTCTTCCATATGAATATCCTCCT
TAG 
3187_FimA_GFP_repl_P1  
CGACTGCCCATGTCGATTTAGAAATAGTTTTTTTAAAGGAAAGCAGCATGAGTAAAGGAGAAGAAC
TTTTCA 
3188_FimA_GFP_repl_P2 
CGCACAAGGGTGGGCATCCCTGCCCGTAATGACGTCCCTGAACCTGGGTAGGGTGTAGGCTGGA
GCTGCTTC 
3509_fimS_ON_fwd GTTAAAAAACAAATAAATACAAGACAATTGGGGCCAAACTGTCTATATC 
3510_fimS_ON_rev 
CAACACTGCACAGTTTTCCCCCAAAAGATGAAACATTTGGGGCCATTTTGACTCATAGAGGAAAGC
ATCGC 
3511_fimS_OFF_fwd GTTAAAAAACAAATAAATACAAGACAATTGGGGCCATTTTGACTCATAG 
3512_fimS_OFF_rev 
CCAACACTGCACAGTTTTCCCCCAAAAGATGAAACATTTGGGGCCAAACTGTCTATATCATAAATA
AGTTACG 
3513_FimBE_KO_P1 
CCAGCACAGCTAGTGCGCGTCTGTAATTATAAGGGAAAACGATGAAGTGTGTAGGCTGGAGCTGC
TTCG 
3514_FimBE_KO_P2 
CTTGTATTTATTTGTTTTTTAACTTTATTATCAATTAGTTAAATCAAGCTTCATATGAATATCCTCCTT
AG 
3541_fimX_KO_P1 
GATTACATCGATAACGTTCTGATTGCAGGCATACTTATCTGGGTGTGCTGTGTAGGCTGGAGCTG
CTTCG 
3542_fimX_KO_P2 
GGAAAACGTAGGAATCTGACATTTTGAATCAGAAGGTACTGTTTTAACGAGGCATATGAATATCCT
CCTTAG 
3880_CsrD_KO_P1 
GCTAGTATGCCCGCTTCCTCACTATCGGAGTTAACACAAGGATGAGATGTGTAGGCTGGAGCTGC
TTCG 
3881_CsrD_KO_P2 
GCAGCGCGCGTTATTCTACGTGAAAACGGATTAAACGGCAGGTTAAACCGACATATGAATATCCT
CCTTAG 
3916_3’fimH-reporter_rev 
GCTTCAGGTAATATTGCGTACCTGCATTAGCAATGCCCTGTGATTTCTGTGTAGGCTGGAGCTGCT
TCG 
3917_3’fimH-GFP_fwd 
GACTGCAGGGAATGTGCAATCGATTATTGGCGTGACTTTTGTTTATCAATAAAAGGAGATATACAT
ATGAGTAAAGGAGAAGAAC 
3927_relA_test_rev CAATAATTAATTTGCCATCC 
3928_relA_test_fwd ATAAAACTGGAACCTATTCG 
1143_csrB_KO_P1 
CTTGTAAGACTTCGCGAAAAAGACGATTCTATCTTCGTCGACAGGTGTGTAGGCTGGAGCTGCTT
CG 
1144_csrB_KO_P2 CATAAAGCAACCTCAATAAGAAAAACTGCCGCGAAGGATAGCAGGCATATGAATATCCTCCTTAG 
1145_csrC_KO_P1 
TGGCGGTTGATTGTTTGTTTAAAGCAAAGGCGTAAAGTAGCACCCTGTGTAGGCTGGAGCTGCTT
CG 
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1146_csrC_KO_P2 GCCGTTTTATTCAGTATAGATTTGCGGCGGAATCTAACAGAAAGCCATATGAATATCCTCCTTAG 
2878_c1116_KO_P1 
CTTCTGGTCGGGAGGGGCTCATATTTCCGGAGGAGTAATGTCAGGGGCATGTGTAGGCTGGAGC
TGCTTCG 
2879_c1116_KO_P2 
GAACATAAATGCTGGCTGCTGACAAGTCTGTGAAAAAGGATTATCCATGCAGCATATGAATATCCT
CCTTAG 
3547_c1117_KO_P1 
GGAATAAATTGTAGTGGAAAGTCGAAGTTTACCGGATGACTGATGCGCTGTGTAGGCTGGAGCTG
CTTCG 
3548_c1117_KO_P2 
GTCTTTCTGCAACACTACTGCTTTCAACAAGTCAGGCATTTCACACTTTATGACATATGAATATCCT
CCTTAG 
3541_fimX_KO_P1 
GATTACATCGATAACGTTCTGATTGCAGGCATACTTATCTGGGTGTGCTGTGTAGGCTGGAGCTG
CTTCG 
3542_fimX_KO_P2 
GGAAAACGTAGGAATCTGACATTTTGAATCAGAAGGTACTGTTTTAACGAGGCATATGAATATCCT
CCTTAG 
1456-ycgR_KO_P1 AGACAGTTTGTCAGTCAGGAGTTTTTCCGCGTGAGTCATTGTGTAGGCTGGAGCTGCTTC 
1457-ycgR_KO_P2 AAACTTGAGCAGGCACTGGACGCGATGTAAATCAGTCGCGTCACATATGAATATCCTCCTTAG 
1680-csgD_KO_P1 GCGATCAATAAAAAAAGCGGGGTTTCATCATGTTTAATTGTGTAGGCTGGAGCTGCTTCG 
1681-csgD_KO_P2 CACAATCCAGCGTAAATAACGTTTCATGGCTTTATCGCCTCATATGAATATCCTCCTTAG 
1658_yhjH_test_fwd_new TCATGCATTCGCCAATCACGGC 
1659_yhjH_test_rev_new CGCGTGGCAAATGCACCATCG 
3560_BcsA_KO_P1 
GTGCCTGTTAAACTATTCCGGGCTGAAAATGCCAGTCGGGAGTGCATCATGAGTATCTGTGTAGG
CTGGAGCTGCTTCG 
3561_BcsA_KO_P2 
CCAGAGCCACTGCACAAATCCAGAATATTTTTCTTTTCATCGCGTTATCATCATTGTTGCATATGAA
TATCCTCCTTAG 
3927_relA_test_rev CAATAATTAATTTGCCATCC 
3928_relA_test_fwd ATAAAACTGGAACCTATTCG 
2125-spoT_KO_P1 
TGCTGAAGGTCGTCGTTAATCACAAAGCGGGTCGCCCTTGTATCTGTTTTGTAGGCTGGAGCTGC
TTCG 
2126-spoT_KO_P2 GTTGGGTTCATAAAACATTAATTTCGGTTTCGGGTGACTTTAATCACATATGAATATCCTCCTTAG 
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7 Development of an aggregation assay to screen FimH 
antagonists 
 
 
 
 
 
 
 
 
 
 
 
 
 
7.1 Statement of work 
This work was mainly performed by the groups of Beat Ernst from the Institute of 
Molecular Pharmacy from the University of Basel, Switzerland and Andrey Trampuz from the 
Infectious Diseases Service of the University Hospital Basel and later the University of 
Lausanne, Switzerland. My contribution was the construction of UTI89 ΔfimA-H, which was 
used throughout this publication as negative control for the mannose-specific binding of E. 
coli to yeast cells and erythrocytes.  
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Urinary tract infection (UTI)α-D-Mannopyranosides are potent FimH antagonists, which inhibit the adhesion of Escherichia coli to highly
mannosylated uroplakin Ia on the urothelium and therefore offer an efficient therapeutic opportunity for the
treatment and prevention of urinary tract infection. For the evaluation of the therapeutic potential of FimH
antagonists, their effect on the disaggregation of E. coli from Candida albicans and guinea pig erythrocytes
(GPE) was studied.
The mannose-specific binding of E. coli to yeast cells and erythrocytes is mediated by type 1 pili and can be
monitored by aggregometry. Maximal aggregation of C. albicans or GPE to E. coli is reached after 600 s. Then the
FimHantagonistwas addedanddisaggregationdeterminedby light transmissionover a period of 1400 s. A FimH-
deletedmutant of E. coli, which does not induce any aggregation, was used in a control experiment. The activities
of FimH antagonists are expressed as IC50s, the half maximal inhibitory concentration of the disaggregation
potential. n-Heptyl α-D-mannopyranoside (1) was used as a reference compound and exhibits an IC50 of
77.14 μM,whereasmethylα-D-mannopyranoside (2) doesnot lead to anydisaggregationat concentrationsup to
800 μM. o-Chloro-p-[N-(2-ethoxy-3,4-dioxocyclobut-1-enyl)amino]phenyl α-D-mannopyranoside (3) shows a
90-fold and 2-chloro-4-nitrophenylα-D-mannopyranoside (4) a 6-fold increased affinity compared to 1. Finally,
4-nitrophenylα-D-mannopyranoside (5) exhibits an activity similar to1. As negative control, D-galactose (6)was
used.
The standardized aggregation assay generates concentration-dependent, reproducible data allowing the
evaluation of FimH antagonists according to their potency to inhibit E. coli adherence and can therefore be
employed to select candidates for experimental and clinical studies for treatment and prevention of urinary tract
infections.ted at Institute of Molecular
ergstrasse 50, CH-4056 Basel,
67 1552. Trampuz, Infectious
ersity Hospital and University
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Urinary tract infection (UTI) is one of themost common infections,
affecting millions of people each year. Particularly affected are
women, who have a 40–50% risk to experience at least one
symptomatic UTI episode at some time during their life. Furthermore,
more than half of them experience a relapse of the infection within
6 months (Fihn, 2003; Hooton, 2001).
Although UTI rarely cause severe disease such as pyelonephritis or
urosepsis, it is associated with high morbidity and consumesconsiderable healthcare resources (Wiles et al., 2008). Uropathogenic
Escherichia coli (UPEC) is the primary cause of UTIs accounting for 70–
95% of the reported cases. Symptomatic UTIs require antimicrobial
treatment, often resulting in the emergence of resistant microbial
flora. As a consequence, treatment of consecutive infections becomes
increasingly difficult, since the number of antibiotics is limited and the
resistance in E. coli is increasing, especially in patients with diabetes,
urinary tract anomaly, paraplegy and those with permanent urinary
catheter. Therefore, a new approach for the prevention and treatment
of UTI with inexpensive, orally applicable therapeutics with a low
potential for resistance would have a great impact on patient care,
public healthcare and medical expenses.
UPEC strains express a number of well-studied virulence factors
used for a successful colonization of their host (Gouin et al., 2009;
Rosen et al., 2008; Wiles et al., 2008). One important virulence factor
is located on type 1 pili, allowing UPEC to adhere and invade host cells
within the urinary tract. It enables UPEC to attach to oligomannosides,
which are part of the glycoprotein uroplakin Ia on the urinary bladder
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the urinary tract by the bulk flow of urine and at the same time,
enables the invasion of the host cells (Mulvey, 2002; Wiles et al.,
2008).
Type 1 pili are the most prevalent fimbriae encoded by UPEC,
consisting of the four subunits FimA, FimC, FimG and FimH, the latter
located at the tip of the pili (Capitani et al., 2006). As a part of the FimH
subunit, a carbohydrate-recognizing domain (CRD) is responsible for
bacterial interactions with the host cells within the urinary tract
(Mulvey, 2002). The crystal structure of the FimH-CRD was solved
(Choudhury et al., 1999) and its complex with n-butyl α-D-mannopyr-
anoside (Bouckaert et al., 2005) and Manα(1-3)[Manα(1-6)]Man
(Wellens et al., 2008) recently became available.
Previous studies showed that vaccination with FimH adhesin
inhibits colonization and subsequent E. coli infection of the urothe-
lium in humans (Langermann et al., 1997; Langermann et al., 2000). In
addition, adherence and invasion of host cells by E. coli can also be
prevented by α-D-mannopyranosides, which are potent antagonists
of type 1 pili interactions (Bouckaert et al., 2006). Whereas α-D-
mannopyranosides efficiently prevent adhesion of E. coli to human
urothelium, they are not exhibiting a selection pressure to provoke
antimicrobial resistance. Furthermore, environmental contamination
is less problematic compared to antibiotics (Sharon, 2006).
For the evaluation of the inhibitory potential of FimH antagonists
various target-based (Bouckaert et al., 2005; Sperling et al., 2006) and
function-based assays (Ofek and Beachey, 1978; Firon et al., 1987)
were previously described. In this contribution, we present an
advanced and validated approach to evaluate the antagonistic
potential of α-mannopyranosides by a function-based aggregation
assay. The FimH-dependent adhesion of E. coli to the urothelium can
be mimicked by the interaction with mannan-presenting yeast cells
(e.g. Candida albicans) or with the glycocalyx of guinea pig
erythrocytes (GPE), respectively. Both interactions can be specifically
inhibited with α-mannopyranosides (e.g. Giampapa et al., 1988;
Gouin et al., 2009).
Originally, Ofek and Beachey, 1978 and Firon et al., 1982,
monitored the aggregation of mannan-containing yeast cells and
various strains of E. coli by aggregometry, i.e. as a function of the
reduced turbidity caused by the aggregation event. They quantified
the rate of aggregation by the steepest slope in the curve produced by
increasing light transmission (Baumgartner and Born, 1968). In this
communication, various parameters of the aggregometry assay were
optimized and the potential of FimH antagonists quantified by the
AUC (area under the curve) of the disaggregation curves. As a result,
the hitherto predominantly visual examination of the aggregation
event can now be quantitatively detected and reported by IC50-values.
The assay is standardized and allows the accurate, rapid and
reproducible high-throughput screening of compound libraries toFig. 1. Structures of the tested FimH antagonists 1–5 and the negative control D-galactose (6)
(2-ethoxy-3,4-dioxocyclobut-1-enyl)amino]phenyl α-D-mannopyranoside (3), 2-chloro-4-n
14identify FimH antagonists qualified for an evaluation in a disease
model (Hvidberg et al., 2000).
2. Materials and methods
2.1. Test and control microorganisms
The clinicalE. coli isolateUTI89 (Mulvey et al., 2001) and theC. albicans
strainATCC60193wereused.Microorganismswere stored at−70 °C and
before experiment incubated at 37 °C in 10 mlmediumusing 50 ml tubes.
Prior to each experiment, themicroorganismswerewashed twice and re-
suspended in phosphate buffered saline (PBS) at pH 7.4 to reach the
desired concentration. Bacterial and yeast concentrations were deter-
mined by plating serial 1:10 dilutions on blood agar, followed by colony
counting on plates with 20–200 colonies after overnight incubation at
37 °C.
As control, a E. coli UTI89 fimA-H:kan mutant strain, lacking FimH-
specific aggregation, was constructed. For this purpose, the parent E.
coli UTI89 strain was transformed with the temperature sensitive
plasmid pKM208 (Addgene plasmid 13077) containing the red
recombination genes (Murphy and Campellone, 2003). Transformants
carrying pKM208 were grown in LB medium without NaCl, supple-
mentedwith ampicillin (100 μg/ml) at 30 °C to late logarithmic phase.
The red gene expression was induced for 30 min with 1 mM IPTG at
37 °C. Bacteria were subjected to a 15 min heat shock at 42 °C and
rapidly cooled in an ice slurry before washing twice with PBS and
concentrating 100-fold in 10 % glycerol. A kanamycin resistance
cassette was PCR amplified from pKD3 (Datsenko and Wanner, 2000)
with primer 2145-fimA_KO_P1 (gcc cat gtc gat tta gaa ata gtt ttt tga
aag gaa agc agc ATG AAA ATt gta ggc tgg agc tgc ttc g) and primer
2146-fimH_KO_P2 (gta ata ttg cgt acc agc att agc aat gtc ctg tga ttt ctT
TAT TGA TAc ata tga ata tcc tcc tta g). PCR fragments were gel purified
(MN Nucleospin Extract II, Machery Nagel, Oensingen, Switzerland)
and 10–100 ng purified DNA was mixed with 65 μl recombination
competent UTI89 cells followed by electroporation in 1 mm Gene
Pulser Cuvettes using a Gene Pulser (BioRad, Reinach, Switzerland) set
to 1.75 V, 25 μF and 400 Ω. Shocked cells were mixed with cold (4 °C)
salt optimized broth (2 % (w/v) bacto trypton; 0.5 % (w/v) yeast
extract; 10 mMNaCl and 2.5 mMKCl), incubated for 1.5 h at 37 °C and
plated out on LB agar plates containing 20 μg/ml kanamycin. Resistant
clones were colony purified on LB medium containing kanamycin,
tested by PCR and sequenced for correct insertion of the resistance
cassette into the fimA-H locus.
2.2. Nutrients and solutions
The following media were used to investigate the optimal growth
conditions for the microorganisms: Luria-Bertani broth (LB),. n-Heptylα-D-mannopyranoside (1), methylα-D-mannopyranoside (2), o-chloro-p-[N-
itrophenyl α-D-mannopyranoside (4) and 4-nitrophenyl α-D-mannopyranoside (5).
8
Fig. 2. Schematic overview of the evaluation process of the aggregometer data. (A) During measurements, the aggregometer software is plotting the aggregation curve as % of
aggregation over time. For establishment of themethod, the aggregation slope and themaximal aggregation were optimized. (B) The data exported from the aggregometer is plotted
as absorbance (OD740) over time. The aggregation phase is identical for all measurements whereas the disaggregation phase depends on the potency of FimH antagonists. For further
evaluation only the disaggregation curves were taken into consideration. (C) Disaggregation curves of a serial dilution of a FimH antagonist after subtraction of the baseline. (D) For
visualization purposes the disaggregation curves were inverted and normalized. At 100% of aggregation cells were maximally aggregated and disaggregation was monitored over
1400 s. (E) The AUC of the disaggregation curves are plotted against the concentration to determine the IC50.
Fig. 3. Aggregation of E. coliwith C. albicans, previously incubated in different cultivation
media. Bars in black are representing the maximal aggregation (in %) and the white bars
are showing the aggregation slope (in %/min). The bars represent means±SD. MHB,
Mueller-Hinton broth; TSB, trypticase soy broth; LB, Luria-Bertani broth; NB, nutrient
broth. The highest values for the aggregation phase were obtain with C. albicans grown in
NB and E. coli in LB, resulting in amaximal aggregation slope of 64.15 %/min (±6.0 %/min)
and a maximal aggregation of 54.65 % (±4.6 %).
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broth (NB). Media were dissolved in deionized water, autoclaved at
121 °C for 15 min and the pH was adjusted to 7.3. All media were
purchased from Becton, Dickinson and Company (Le Pont de Claix,
France). Autoclaved, endotoxin-free phosphate buffered saline (PBS),
pH 7.4 was purchased from the Hospital Pharmacy at the University
Hospital Basel, Switzerland.
2.3. Guinea pig erythrocytes (GPE)
Guinea pig blood was purchased from Charles River Laboratories,
Sulzfeld, Germany. To separate GPE from other blood components,
1 ml of guinea pig blood was carefully added to 1 ml of Histopaque
(density of 1.077 g/ml at 24 °C, Sigma-Aldrich, Buchs, Switzerland)
and centrifuged at 24 °C for 30 min at 400 g. GPE were diluted in PBS
to an OD600 of 4 and their number was determined using an
automated cell counter (Invitrogen AG, Basel, Switzerland) resulting
in 2.2×106 cells/ml.
2.4. Synthesis of the FimH antagonists
The FimH antagonists tested are listed in Fig. 1. The synthesis of n-
heptyl α-D-mannopyranoside (1) is described in the supplementary
content. Methylα-D-mannopyranoside (2) was purchased from Fluka
Chemie GmbH (Buchs, Switzerland). o-Chloro-p-[N-(2-ethoxy-3,4-
dioxocyclobut-1-enyl)amino]phenyl α-D-mannopyranoside (3) and
2-chloro-4-nitrophenyl α-D-mannopyranoside (4) were synthesized
as previously described (Sperling et al., 2006). 4-Nitrophenyl α-D-149mannopyranoside (5) and D-galactose (6) were purchased from
Sigma (Buchs, Switzerland).
Table 1
Influence of E. coli and C. albicans concentrations on aggregation measurements. The
values represent means±SD of the maximal aggregation and the aggregation slope.
C. albicans
OD600 of 2a OD600 of 3b
E. coli Maximal
aggregation (%)
Aggregation
slope (%/min)
Maximal
aggregation (%)
Aggregation
slope (%/min)
OD600 2c 50.68±4.61 64.15±6.02 – –
OD600 3d 40.99±5.11 53.34±22.19 41.77 ±2.41 65.95±6.53
a OD600 of 2 for C. albicans corresponds to 2×108 CFU/ml.
b OD600 of 3 for C. albicans corresponds to 3×108 CFU/ml.
c OD600 of 2 for E. coli corresponds to 9.6×107 CFU/ml.
d OD600 of 3 for E. coli corresponds to 1.4×108 CFU/ml.
Fig. 4. Evaluation of the best aggregation conditions using E. coli and GPE at different
concentrations, measured as OD600. Bars in black are representing the maximal
aggregation (in %) and the white bars are showing the aggregation slope (in %/min).
The bars represent means±SD. For E. coli, OD600 of 1 corresponds to 4.7×107 CFU/ml,
OD600 of 3 to 1.4×108 CFU/ml and OD600 of 4 to 1.9×108 CFU/ml. For GPE, OD600 of 1
corresponds to 5.5×105 cells/ml, OD600 of 2 to 1.1×106 cells/ml, OD600 of 3 to 1.7×106
cells/ml and OD600 of 4 to 2.2×106 cells/ml.
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The percentage of aggregation of E. coliwith C. albicans or GPE was
quantitatively determined by measuring the optical density at
740 nm, 37 °C under stirring at 1000 rpm using an APACT 4004
aggregometer (Endotell AG, Allschwil, Switzerland). Bacteria and
yeast were statically incubated overnight (12 h) in TSB at 37 °C. Prior
to the measurements, the cell densities were adjusted to OD600 of 2,
corresponding to 9.6×107 CFU E. coli/ml and 2×108 CFU C. albicans/ml,
respectively. For the calibration of the instrument, the aggregation of
protein poor plasma (PPP) using PBS alone was set as 100% and the
aggregation of protein rich plasma (PRP) as 0%. After calibration,
measurements were performed with 250 μl C. albicans or GPE and
50 μl bacterial suspension and the aggregationmonitored over 600 s.
To optimize the assay, different bacterial and yeast growth condi-
tions and measurement conditions were evaluated for the aggrega-
tion phase.
With the optimized assay parameters, the disaggregation potential
of FimH antagonists was evaluated. After an aggregation phase of
600 s, 25 μl of antagonist was added to each cuvette and disaggrega-
tion was monitored for 1400 s. A two-fold serial dilution of a stock
solution of the FimH antagonists 1 to 5 and the negative control D-
galactose (6), starting at 769 μM, was tested in triplicates.2.6. Data analysis
The data for the aggregation and the disaggregation phase were
plotted using the APACT 4 LPC software version 1.21c from Labor
BioMedical Technologies (LABiTec GmbH, Ahrensburg, Germany). For
the aggregation phase, the initial slope (in %/min) and the maximal
aggregation (in %) were determined (Fig. 2A). Values for the
absorption at 740 nm were measured with the aggregometer every
0.2 s. For the disaggregation phase, the baseline was determined by
calculating the average value between 530 and 590 s and subtracted
from the disaggregation curves (Fig. 2B and C). The curves were then
inverted and the baseline before addition of the antagonist was set as
100% aggregation (Fig. 2D). For calculating the potency of FimH
antagonists, the area under each disaggregation curve from 600 s until
2000 s (AUC600–2000 s) was determined and plotted against the
concentration of the antagonist to obtain the half maximal inhibitory
concentration (IC50) (Fig. 2E). Mean values, standard deviation (SD),
AUC and the plots were calculated and plotted using GraphPad Prism
5.0a (GraphPad Software, La Jolla, CA).Fig. 5. Disaggregation curves and corresponding IC50 values, calculated using the AUC6
measurements. (A) 1 shows an IC50 of 77.14 μM and represents the reference antagonist. (B)
(C) 3 exhibits the best inhibitory potential of all measured FimH antagonists with an IC50 of 0.
2, resulting in an IC50 62.96 μM.
153. Results
3.1. Optimization of the aggregation assay
3.1.1. Initial growth and measurement conditions
Bacteria and yeast were incubated overnight (12 h) in TSB at 37 °C
without shaking, leading to a maximal aggregation slope for E. coli
with C. albicans of 23.78 %/min (±4.09 %/min) and a maximal
aggregation of 36.89 % (±1.63 %). With the E. coli ΔfimA-H mutant,
virtually no aggregation was observed with C. albicans, resulting in a
maximal aggregation slope of 0.25 %/min (±0.29 %/min) and a
maximal aggregation of 0.02 % (±0.1 %) (Fig. 2A). After 600 s of
measurement, a stable baseline was achieved, a prerequisite for a
reliable determination of the disaggregation potency of FimH
antagonists (Fig. 2B).
3.1.2. Shaking versus static incubation
Compared to static incubation (see above), E. coli and C. albicans
incubated overnight under shaking conditions (250 rpm) exhibited a
13-fold lower aggregation slope of 1.82 %/min (±0.61 %/min) and a 5-
fold lower aggregation maximum of 8.38 % (±0.69 %). In the
optimized assay format, E. coli was therefore incubated overnight
under static conditions whereas C. albicans was agitated at 250 rpm.
3.1.3. Bacterial and yeast growth media
In Fig. 3, the maximal aggregation (%) and the aggregation slope
(%/min) of E. coli and C. albicans incubated in different growth media
are presented. The best values were obtained when E. coli was
cultivated in LB broth and C. albicans in NB medium, resulting in an
aggregation slope of 64.15 %/min (±6.0 %/min) and a maximal
aggregation of 54.65 % (±4.6 %). These conditions were therefore
applied for all further measurements.00–2000s of the disaggregation curves. Values represent the mean±SD of triplicate
2 does not exhibit a measurable disaggregation potency at concentrations up to 769 μM,
87 μM, (D) 4 has an IC50 of 13.92 μM, (E) 5 shows almost the same inhibitory potential as
0
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For both E. coli and C. albicans, the highest maximal aggregation of
50.68 % (±4.61 %) was obtained at an OD600 of 2 (Table 1). This
concentration represents a bacteria to yeast ratio of 10:1
(4.8×106 CFU/50 μl: 5×107 CFU/250 μl). When the concentration of
E. coli exceeds this ratio, a reduction of the maximal aggregation was
observed.
3.1.5. Incubation time
For the optimization of the incubation time, cultures of E. coli and C.
albicans incubated overnight, for 24 h and 48 h were compared. For C.
albicans, the incubation time did not influence the aggregation behavior
(data not shown). However, for E. coli the aggregation slope was
increased by approx. 10 % and the maximal aggregation by approxi-
mately 5 % after incubation for 24 h compared to those incubated
overnight. Incubation for 48 h resulted in a 16.1 % increase of the
aggregation slope, but a 6.3 % reduction of the maximal aggregation.
Since a 24 h incubationperiod resulted in thebestmaximal aggregation,
it was applied for all further measurements.
3.1.6. Ratio of GPE and E. coli
To obtain an optimal aggregation phase, different ratios of E. coli and
GPE were tested (Fig. 4). For both, an OD600 of 4 showed the best
aggregation potential [aggregation slope of 62.2 %/min (±2.4 %/min) and
amaximal aggregation of 65.1 % (±5.6 %)]. This concentration represents
a bacteria to GPE ratio of 17:1 (9.6×106 CFU/50 μl: 5.8×105 cells/250 μl).
Since the aggregation of E. coli with GPE showed less variability
and a higher reproducibility than those of E. coliwith C. albicans (data
not shown), they were exclusively employed for evaluation of the
disaggregation potential of FimH antagonists.
3.2. Disaggregation potential of FimH antagonists
The disaggregation potential of five α-D-mannopyranosides and D-
galactose was determined with the optimized conditions (see sec-
tion 3.1). Fig. 5 shows the disaggregation curves for two-fold serial
dilutions of the antagonists and the corresponding IC50 curves,
calculated using theAUC600–2000 s. The AUC of each curvewas calculated
and plotted against the concentration. The reference compound 1
exhibits an IC50 of 77.14±8.7 μM. For compound 2 no disaggregation
could be observed up to 769 μM. Compounds 4 and 5 showed IC50s of
13.92±1.23 μM and 62.96±9.78 μM, respectively. The best disaggre-
gation potential was achieved with compound 3, resulting in an IC50 of
0.87±0.13 μM. Compound 6was used as negative control and showed
no disaggregation up to 769 μM.
In order to optimize the measurement time, the effect of a shorter
disaggregation period was evaluated. When the AUC for a disaggre-
gation phase of 700 s (AUC600–1300 s) and 1400 s (AUC600–2000 s) were
compared, no significant difference of the IC50s (± SD) for the
antagonists 1, 3 and 4 was observed. However, for compound 5
(Fig. 5E), an approx. 50 % higher IC50-value was obtained with a 700 s
disaggregation phase, because the baseline is not reached at that time
point (IC50 of 92.86 μM vs. 62.96±9.78 μM). Therefore, a standard
disaggregation phase of 1400 s (AUC600–2000 s) was applied.
4. Discussion
In the initially reported aggregometry assay by Ofek and Beachey
in 1978, E. coli and yeast cells were used and the potential of FimH
antagonists was evaluated and quantified based on the slope of the E.
coli-yeast disaggregation curve. Since for our investigation a different
assay set-up, other E. coli strains, and different aggregation cells were
applied, the measurement settings had to be re-evaluated and
validated.
Due to the suppression of type 1 pili expression under shaking
incubation (Hultgren, 1986), a significant decrease in aggregationwas15observed using E. coli cultures agitated overnight. C. albicans showed
no reduction of aggregation after shaking incubation, indicating that
the mannan-structures on the cell wall are constantly expressed. Due
to a higher yield of microorganisms grown under shaking conditions,
C. albicanswas incubated at 250 rpm for all further experiments. With
the ΔfimA-H deletion mutant of E. coli, we could demonstrate that the
aggregation depends exclusively on type 1 pili mediated adherence to
C. albicans and GPE, respectively.
Todetermine theoptimalnutrient conditions for type1pili expression,
variousgrowthmediawere investigated.WithE. coli incubated in LBbroth
and C. albicans grown inNBmedium, the highest aggregation valueswere
achieved (Hultgren, 1986; Ofek and Beachey, 1978). In addition, optimal
aggregation conditionswere obtainedwhen E. coli andC. albicans samples
with an OD600 of 2 were used. As recommended (Blood and Curtis, 1995;
Firon et al., 1983; Giampapa et al., 1988) the best results were obtained
when the cultures were incubated for at least 24 h. Whereas overnight
incubation led to less aggregation, similar values were obtained with
cultures incubated for 48 h.
Themajority of the disaggregation data reported in literature were
obtained by a visual and therefore only semiquantitative interpreta-
tion of the disaggregation potential of the investigated FimH
antagonists (e.g. Nagahori et al., 2002; Gouin et al., 2009). In addition,
quantitative disaggregation data were also determined with an
aggregometry assay reported by Ofek and Beachey, 1978 and Firon
et al., 1983. In contrast, in this communication IC50 values were
determined from the AUCs of the disaggregation curves obtained of
serially diluted antagonists. In addition, the various assay parameters
as growth and measurement conditions, cell types were thoroughly
optimized.
Optimization experiments clearly showed the advantages of blood
cells (GPE, Fig. 4) over yeast (C. albicans, Fig. 3).With GPE themaximal
aggregation is independent on the OD600s within 60–66 %, whereas
the aggregation slope is heavily depending on the OD600 of both GPE
and E. coli. The present format leads to a substantial improvement of
the maximal aggregation (from 36.9 % to 65.1 %) and the ascending
slope (from 23.8 %/min to 62.2 %/min).
The aggregometry assay was validated with five FimH antagonists
(1–5) and a negative control (6) measured in serial dilutions starting
with a concentration of 769 μM (Table 2). The determination of the
dependence of the AUCs from the antagonist concentration (Fig. 5)
leads to the IC50-values. n-Heptyl α-D-mannopyranoside (1) was
employed as reference compound. Methyl α-D-mannopyranoside (2)
exhibited no disaggregation at a concentration up to 769 μM.
Furthermore, 3 showed the lowest IC50 of all tested antagonists. 4
exhibited a slight improvement of activity compared to reference
compound 1, whereas 5 was equally active as 1. With D-galactose (6)
disaggregation could not be enforced and was therefore used as
negative control (e.g. Clegg et al., 1984; Nagahori et al., 2002).
In Table 2 the IC50-values are summarized and compared to those
reported in literature. A direct comparison, however, is not possible,
since the antagonistic potencies were measured in different assay
formats and are reported relative to methyl α-D-mannopyranoside
(2), which does not contribute to disaggregation up to a concentration
of 769 μM in our aggregometry assay. Since the literature values for
the disaggregation potencies are expressed as relative inhibitory
potentials (rIPs) compared to 2, the IC50s were transformed into rIPs
(Table 2). Except for 5, our rIPs correlate well with values found in
literature. Whereas 5 showed equal activity than the reference
compound 1 in the aggregometry assay, a 6-fold lower activity is
reported in literature.
Compared to previously described aggregation- and hemaggluti-
nation assays (Firon et al., 1983; Nagahori et al., 2002; Gouin et al.,
2009) the presented aggregometry assay was optimized and
standardized allowing the accurate and reproducible high-through-
put screening of FimH antagonists. Instead of a visual and therefore
only semi-quantitative analysis of the disaggregation event, a2
Table 2
IC50 values determined with the aggregometry assay using E. coliwith GPE. The relative
IC50 (rIC50) of the reference compound 1was defined as 1. The rIP of each substance was
calculated by dividing the IC50 of the reference compound 1 by the IC50 of the compound
of interest. This results in rIPs above 1.00 for derivatives binding better than 1 and rIPs
below 1.00 for compounds with a lower affinity than 1. (n.d.: not determinable).
FimH antagonist Aggregometry assay Literature
IC50 [μM] rIC50 rIP rIP
n-Heptyl α-D-mannopyranoside (1) 77.14±8.7 1 1 440a
Methyl α-D-mannopyranoside (2) n.d. n.d. n.d. 1a,b,c
o-Chloro-p-[N-(2-ethoxy-3,
4-dioxocyclobut-1-enyl)amino]phenyl
α-D-mannopyranoside (3)
0.87±0.13 0.011 90 6900b
2-Chloro-4-nitrophenyl
α-D-mannopyranoside (4)
13.92±1.23 0.18 6 717c
4-Nitrophenyl α-D-mannopyranoside (5) 62.96±9.8 0.82 1 70c
a RIP determinedby surface plasmon resonancemeasurements (Bouckaert et al., 2005).
b RIP determined by ELISA measurements (Sperling et al., 2006).
c RIP determined by aggregometer measurements (Firon et al., 1987).
255D. Abgottspon et al. / Journal of Microbiological Methods 82 (2010) 249–255quantitative method to determine the inhibitory potential of FimH
antagonists was developed. The results (IC50) of this function-based
assay can be applied to determine the therapeutic dosage for in vivo
studies.
The potential of anti-virulence therapies for UTI is investigated for
a long period of time (Collier and De Miranda, 1955; Old, 1972; Ofek
and Beachey, 1978; Firon et al., 1983; Bouckaert et al., 2005; Ernst and
Magnani, 2009) and is still actively pursued (Cegelski et al., 2008). The
reported new assay format will hopefully contribute to this endeavor
by supporting the identification of carbohydrate-derived FimH
antagonists with a therapeutic potential.
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8 Appendix 
8.1 Supplemental Results and Discussion 
8.1.1 Raw data for flow cytometric analysis of fimH-gfp construct 
It was previously established that flow cytometry can be used to visualise the degree of 
bacterial aggregate formation. Repression of the Csr system was shown to produce type I 
fimbriae mediated aggregates while derepression of the Csr system primarily promotes PGA 
mediated aggregates. Supplemental Figures 1-6 contain the raw data acquired by flow 
cytometry during growth curves of fimH-gfp, fimH-gfp ΔfimB, fimH-gfp ΔfimE, and fimH-gfp 
ΔcsrD. The results of these figures are discussed in detail in chapter 6.5.4, they are 
averaged over three independent clones per strain and condition. The flow cytometric 
analysis of these supplemental figures is restricted to one out of three clones per fimH-gfp 
reporter strain and condition and are meant to illustrate the formation of type I fimbrial vs. 
PGA aggregates over time.  
 
8.1.2 C-di-GMP and ppGpp affect the phase variation in fimH-gfp  
The involvement of selected genes in the phase variable regulation of type I fimbriae 
was screened in the fimH-gfp reporter construct and analysed after 18 h of static growth. The 
aim was to identify components that are required for the dual adhesin regulation by the Csr 
system. All tested genes have previously been reported to i) affect the regulation of type I 
fimbriae, ii) belong to the Csr system, iii) contribute to c-di-GMP signalling or iv) be required 
for the synthesis of EPS matrix components. The results for this initial screen are subdivided 
into two Figures where Supplemental Figure 7 illustrates the difference in GFP expression 
between the wild type reporter strain and the mutant reporter strains. Supplemental Figure 8 
illustrates the effect of csrB overexpression in the wild type reporter vs. the mutant reporter 
strains. All tested strains except the deletions of the small RNAs csrB and csrC affected GFP 
expression in the fimH-gfp reporter (Supplemental Figure 7). This result for csrB and csrC 
was not surprising, since both small RNAs are published to result in a modest compensatory 
increase in the levels of the other small RNA upon deletion, complementing any phenotype 
(139, 144). Most likely, an effect of the two small RNAs would require the construction of a 
fimH-gfp ΔcsrB ΔcsrC double reporter mutant. According to the established model, such a 
double mutant should have an increased fraction of GFP expressing bacteria compared to 
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wild type. Importantly, the results obtained for the fimB and fimE recombinases were as 
expected and confirmed their effect on fimbriation. Both recombinases have been 
investigated in detail in chapter 6. Interestingly, the construction of the fimBE mutant resulted 
in a strain, which expressed very low amounts of GFP, indicative of a very low level of 
fimbriation. In this mutant, fimbriation can only be controlled by the third known recombinase 
(FimX), which was reported to be very slow in vitro and predominantly switch fimS from the 
OFF to the ON phase (264). This could explain the residual fimbriation in the fimBE mutant. 
However, lack of FimB and FimE should result in a mutant strain, which is bi-stable and 
occur in either a predominant OFF or a predominant ON state. Thus, it would be worthwhile 
to simultaneously investigate and compare several clones of the fimH-gfp ΔfimBE mutant 
and see how often the OFF versus the ON versions occur. Such a comparison should give 
insight into the activity and directionality of the remaining recombinase FimX. Deletion of 
fimX resulted in a strain whose fimbriation depends on FimB and FimE. In a fimX mutant, the 
OFF to ON switching predominantly relies on FimB alone while the ON to OFF switching 
depends on the strong FimE. Since FimE was reported to be more active in vitro compared 
to FimB (245, 247, 249-251) the fimX mutant should have reduced ON to OFF switching and 
result in elevated levels of GFP expression, which was indeed the case. Interestingly, 
deletion of the PGA machinery pgaA-D, the curli master regulator csgD as well as the 
cellulose synthase bcsA all resulted in a slight decrease in GFP expression, similar to ydeH, 
csrD from the Csr cascade or the Sfa fimbrial gene c1117. However, to proof whether 
fimbriation is really affected by any of these genes, a more precise investigation over time is 
required. In agreement with a previous publication (285) the screening results obtained for 
the PDEs YhjH and C1116 as well as the DGC YcdT support the notion that fimbriation is 
enhanced under lower levels of c-di-GMP. Moreover, the PilZ containing c-di-GMP effector 
protein YcgR or a downstream component thereof was previously suggested to regulate the 
expression and/or activities of the Fim recombinases (285). This finding is compatible with 
the result obtained in this study. Interestingly, a study performed by Jonas et al., has shown 
that overexpression of the DGC YdeH abolished the presence of fimbrial structures on the 
bacterial surface (213). However, fimH-gfp ΔydeH constructed in this study did not support 
this finding. However, it is necessary to follow up on this discrepancy by a more detailed 
investigation of fimH-gfp ΔydeH over time, as a single time point does not give a decisive 
result. Finally, the construction of a strain, which lacks the alarmone ppGpp (fimH-gfp ΔrelA 
ΔspoT; ppGpp0) resulted in a complete loss of GFP expression. This finding is very 
important, as ppGpp0 strains strongly induce PGA dependent biofilm formation (see chapter 
5). In conclusion, the mutant screen performed in this study (Supplemental Figure 7) 
provides evidence that fimbriation under a repressed Csr system is strongly affected by the 
stress alarmone ppGpp and moderately affected by c-di-GMP, presumably through the 
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activities of YhjH, YcgR and YcdT. To follow up on the effect of c-di-GMP on fimbriation it 
would be interesting to see if overexpression of any strong DGC or PDE might cause an 
effect, or whether the effect observed is specific for the proteins investigated here. 
The second aim of the mutant screen was to identify components, which are required 
to mediate the switching of fimS into the OFF phase upon derepression of the Csr system. 
The difference between the GFP signal derived from reporter mutants containing the empty 
vector or the csrB overexpressing plasmid was compared to the difference in the wild type 
fimH-gfp reporter (Supplemental Figure 8). If the deleted gene is involved in the Csr 
dependent switching of fimS, the effects of csrB overexpression in the wild type would have 
to be different than those observed in the mutant reporter. With this reasoning, we were able 
to show that fimE and csrD were both involved in the csrB-dependent switching of fimS OFF 
(see chapter 6.5.4 for detail). However, our results suggest that these two components are 
not the only ones, which are directly or indirectly involved in the crsB-dependent dual 
adhesin system affecting the phase of fimS. The initial screening results for fimH-gfp ΔycgR 
indicate that overexpression of csrB upon deletion of ycgR is impaired to reduce fimbriation, 
suggesting that this protein might serve as effector in the dual adhesin regulation as well. 
However, similar to CsrD its effect could also affect the correct timing of fimbriation during 
growth. It would thus be necessary to investigate fimbriation of fimH-gfp ΔycgR over time 
with and without csrB overexpression. For many mutants tested (ΔydeH, ΔycdT, ΔyjhH, 
ΔpgaA-D, ΔbcsA and ΔcsgD) the results obtained at the one time point were inconclusive. In 
order to properly investigate their involvement in the signalling cascade affecting phase 
variation of fimS these mutant strains would have to be investigated individually in more 
detail as well. Finally, the results obtained for fimH-gfp Δc1116 and fimH-gfp Δc1117 show 
that these two Sfa fimbrial proteins are not involved in the Csr mediated switching of fimS. In 
principle, this result would support the hypothesis that the effects of the Csr system on the 
phase of fimS is conserved among all E. coli strains and thus only involves factors, which are 
present in all strains of E. coli and does not involve factors encoded on genomic regions that 
are only found on pathogenic E. coli.  
In the end, the obtained screening data can be integrated into the regulatory signalling 
mechanism, which gets triggered once uropathogenic UTI89 change from a planktonic 
lifestyle, capable of causing acute urinary tract infections, to a sessile lifestyle, during which 
bacteria persist as biofilms (Supplemental Figure 9). Under laboratory conditions, this 
lifestyle switch can occurs when bacteria change from logarithmic to stationary growth. At 
this transition, nutrients and oxygen become limiting and bacteria initiate metabolic fluxes 
toward glycogen biosynthesis (130, 296). This is often associated with the derepression of 
the Csr system. Maybe a similar metabolic adaptation occurs upon entry of bacteria into the 
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bladder lumen or upon internalisation into urothelial cells. At this time, bacteria start to 
increase fimbriation if the Csr system is repressed, or prepare for PGA dependent biofilm 
formation if the Csr system is derepressed. Thus it is likely that environmental cues and 
consequently the state of the Csr system act as checkpoint deciding over the population’s 
fate whether to become virulent (fimbriated) or become sessile (formation of PGA dependent 
biofilms). Most likely the checkpoint’s decision between an acute and persistent lifestyle 
depends on the directionality of metabolic carbon fluxes (129, 132, 143, 297), similar to the in 
vitro situation. Furthermore, if external and internal signals favour a sessile lifestyle, c-di-
GMP will accumulate and enhance biofilm formation within the host. On the other hand, 
elevated ribosomal stress, which results in ppGpp accumulation, should retain bacterial 
motility, which permits them to seek a more favourable environment (e.g. cytoplasm of 
urothelial cells). Thus the feedback loops between the dominant Csr system, the levels of c-
di-GMP and ppGpp, continuously stabilize the population’s lifestyle unless environmental 
signals reprogram the lifestyle of the bacterial cells. 
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8.2 Supplemental Figure Legends  
Supplemental Figure 1: Aerated growth and fimbriation of UTI89 fimH-gfp (0h-8h & 
24h) 
GFP expression of the fimH-gfp reporter strain was measured over time under aerated 
conditions and analysed by flow cytometry. The data is shown for one out of three wild type 
fimH-gfp reporter clones tested in parallel (A) fimH-gfp without plasmid, (B) fimH-gfp with the 
empty vector (pME6032), (C) fimH-gfp overexpressing csrB (pME6032 csrB). The top row for 
each strain depicts the population’s size distribution in a forward-sideward scatter. The 
forward scatter is shown on the x-axis and the sideward scatter on the y-axis. Both scales 
range from 0 to 104. All events are gated into four quadrants, bacteria being in the upper right 
quadrant (Q2). The lower row for each strain depicts the GFP signal distribution. The 
intensity of the recorded GFP signal is shown on the x-axis (from 0 to 104), cell counts on the 
y-axis. In the histogram, only events in Q2 were considered. The left peak in each histogram 
corresponds to the fraction of events without GFP signal and the right peak to the fraction of 
events with GFP signal. For each sample 50’000 events were analysed. Time points during 
growth at which samples were analysed are indicated at the bottom of (C). 
 
Supplemental Figure 2: Static growth and fimbriation of UTI89 fimH-gfp (0h-8h & 24h) 
GFP expression of the fimH-gfp reporter strain was measured over time under static 
conditions and analysed by flow cytometry. The data is shown for one out of three wild type 
fimH-gfp reporter clones tested in parallel (A) fimH-gfp without plasmid, (B) fimH-gfp with the 
empty vector (pME6032), (C) fimH-gfp overexpressing csrB (pME6032 csrB). The top row for 
each strain depicts the population’s size distribution in a forward-sideward scatter. The 
forward scatter is shown on the x-axis and the sideward scatter on the y-axis. Both scales 
range from 0 to 104. All events are gated into four quadrants, bacteria being in the upper right 
quadrant (Q2). The lower row for each strain depicts the GFP signal distribution. The 
intensity of the recorded GFP signal is shown on the x-axis (from 0 to 104), cell counts on the 
y-axis. In the histogram, only events in Q2 were considered. The left peak in each histogram 
corresponds to the fraction of events without GFP signal and the right peak to the fraction of 
events with GFP signal. For each sample 50’000 events were analysed. Time points during 
growth at which samples were analysed are indicated at the bottom of (C). 
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Supplemental Figure 3: Static growth and fimbriation of UTI89 fimH-gfp (10h - 24h) 
GFP expression of the fimH-gfp reporter strain was measured over time under static 
conditions and analysed by flow cytometry. The data is shown for one out of three wild type 
fimH-gfp reporter clones tested in parallel and compared to UTI89 as GFP negative control: 
(A) UTI89 wt as negative control (B) fimH-gfp without plasmid, (C) fimH-gfp with the empty 
vector (pME6032), (D) fimH-gfp overexpressing csrB (pME6032 csrB). The top row for each 
strain depicts the population’s size distribution in a forward-sideward scatter. The forward 
scatter is shown on the x-axis and the sideward scatter on the y-axis. Both scales range from 
0 to 104. All events are gated into four quadrants, bacteria being in the upper right quadrant 
(Q2). The lower row for each strain depicts the GFP signal distribution. The intensity of the 
recorded GFP signal is shown on the x-axis (from 0 to 104), cell counts on the y-axis. In the 
histogram, only events in Q2 were considered. The left peak in each histogram corresponds 
to the fraction of events without GFP signal and the right peak to the fraction of events with 
GFP signal. For each sample 50’000 events were analysed. Time points during growth at 
which samples were analysed are indicated at the bottom of (D). 
 
Supplemental Figure 4: Static growth and fimbriation of UTI89 ΔfimB fimH-gfp (10h - 
24h) 
GFP expression of the ΔfimB fimH-gfp reporter strain was measured over time under 
static conditions and analysed by flow cytometry. The data is shown for one out of three wild 
type ΔfimB fimH-gfp reporter clones tested in parallel and compared to UTI89 fimH-gfp. (A) 
UTI89 wt as negative control (B) ΔfimB fimH-gfp without plasmid, (C) ΔfimB fimH-gfp with the 
empty vector (pME6032), (D) ΔfimB fimH-gfp overexpressing csrB (pME6032 csrB). The top 
row for each strain depicts the population’s size distribution in a forward-sideward scatter. 
The forward scatter is shown on the x-axis and the sideward scatter on the y-axis. Both 
scales range from 0 to 104. All events are gated into four quadrants, bacteria being in the 
upper right quadrant (Q2). The lower row for each strain depicts the GFP signal distribution. 
The intensity of the recorded GFP signal is shown on the x-axis (from 0 to 104), cell counts 
on the y-axis. In the histogram, only events in Q2 were considered. The left peak in each 
histogram corresponds to the fraction of events without GFP signal and the right peak to the 
fraction of events with GFP signal. For each sample 50’000 events were analysed. Time 
points during growth at which samples were analysed are indicated at the bottom of (D). 
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Supplemental Figure 5: Static growth and fimbriation of UTI89 ΔfimE fimH-gfp (10h - 
24h) 
GFP expression of the ΔfimE fimH-gfp reporter strain was measured over time under 
static conditions and analysed by flow cytometry. The data is shown for one out of three wild 
type ΔfimE fimH-gfp reporter clones tested in parallel and compared to UTI89 fimH-gfp. (A) 
UTI89 wt as negative control (B) ΔfimE fimH-gfp without plasmid, (C) ΔfimE fimH-gfp with the 
empty vector (pME6032), (D) ΔfimE fimH-gfp overexpressing csrB (pME6032 csrB). The top 
row for each strain depicts the population’s size distribution in a forward-sideward scatter. 
The forward scatter is shown on the x-axis and the sideward scatter on the y-axis. Both 
scales range from 0 to 104. All events are gated into four quadrants, bacteria being in the 
upper right quadrant (Q2). The lower row for each strain depicts the GFP signal distribution. 
The intensity of the recorded GFP signal is shown on the x-axis (from 0 to 104), cell counts 
on the y-axis. In the histogram, only events in Q2 were considered. The left peak in each 
histogram corresponds to the fraction of events without GFP signal and the right peak to the 
fraction of events with GFP signal. For each sample 50’000 events were analysed. Time 
points during growth at which samples were analysed are indicated at the bottom of (D). 
 
Supplemental Figure 6: Static growth and fimbriation of UTI89 ΔcsrD fimH-gfp (10h - 
24h) 
GFP expression of the ΔcsrD fimH-gfp reporter strain was measured over time under 
static conditions and analysed by flow cytometry. The data is shown for one out of three wild 
type ΔcsrD fimH-gfp reporter clones tested in parallel and compared to UTI89 fimH-gfp. (A) 
UTI89 wt as negative control (B) ΔcsrD fimH-gfp without plasmid, (C) ΔcsrD fimH-gfp with 
the empty vector (pME6032), (D) ΔcsrD fimH-gfp overexpressing csrB (pME6032 csrB). The 
top row for each strain depicts the population’s size distribution in a forward-sideward scatter. 
The forward scatter is shown on the x-axis and the sideward scatter on the y-axis. Both 
scales range from 0 to 104. All events are gated into four quadrants, bacteria being in the 
upper right quadrant (Q2). The lower row for each strain depicts the GFP signal distribution. 
The intensity of the recorded GFP signal is shown on the x-axis (from 0 to 104), cell counts 
on the y-axis. In the histogram, only events in Q2 were considered. The left peak in each 
histogram corresponds to the fraction of events without GFP signal and the right peak to the 
fraction of events with GFP signal. For each sample 50’000 events were analysed. Time 
points during growth at which samples were analysed are indicated at the bottom of (D). 
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Supplemental Figure 7: Knowledge based screen of fimH-gfp mutants under a 
repressed Csr system 
Each histogram compares the GFP signal intensity distribution of a fimH-gfp mutant 
(blue) to the distribution of the fimH-gfp wild type reporter strain (red). The fraction of GFP 
expressing cells (fim+) for both strains is indicated at the right sight of each graph and 
corresponds to the fraction associated to the right peak of the histogram. The left peak of 
each histogram corresponds to the non-GFP expressing events (fim-). A small vertical black 
line in each histogram indicates the border between fim+ and fim-. In each case, the mutant 
and the wild type samples were prepared simultaneously after 18 h of static growth. Per 
sample 50’000 events were recorded. The GFP signal intensity distribution was only 
calculated after gating each sample and selecting for bacteria. The x-axis of all histograms 
range from 0 to 104 and the y-axis range from 0 % to 100 % as indicated in the graph of the 
ΔydeH mutant. 
 
Supplemental Figure 8: Knowledge based screen of fimH-gfp mutants under a 
derepressed Csr system 
Each histogram compares the GFP signal intensity distribution of a fimH-gfp mutant 
(orange and green) to the distribution of the fimH-gfp wild type reporter strain (blue and red). 
Green and red show data obtained with the pME6032 control vector while orange and blue 
show data obtained from strains overexpressing csrB (pCsrB). The fraction of GFP 
expressing cells (fim+) for all strains is indicated at the right sight of each graph and 
corresponds to the fraction of events associated to the right peak of the histogram. The left 
peak of each histogram corresponds to the non-GFP expressing events (fim-). A small 
vertical black line in each histogram indicates the border between fim+ and fim-. In each 
case, the mutant and the wild type samples were prepared simultaneously after 18 h of static 
growth in LB supplemented with tetracycline and IPTG for plasmid induction. Also, the 
samples were taken together with those illustrated in Supplemental Figure 7. Per sample 
50’000 events were recorded. The GFP signal intensity distribution was only calculated after 
gating each sample and selecting for bacteria. The x-axis of all histograms range from 0 to 
104 and the y-axis range from 0 % to 100 % as indicated in the graph of the ΔydeH mutant. 
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Supplemental Figure 9: Inversed effects of the Csr system, c-di-GMP and ppGpp on 
fimbriation and PGA dependent biofilm 
Fimbriation is favoured when c-di-GMP levels are kept low, when the Csr system is 
repressed and FimE activity is high, and when ppGpp levels are elevated. On the contrary, 
PGA dependent biofilm formation is favoured when the Csr system is derepressed, lowering 
FimE activity, when c-di-GMP levels are high and when ppGpp levels are low. In the end, the 
state of the Csr system is a major factor deciding over fimbriation and PGA dependent 
biofilm formation, respectively. It affects both output systems (Fimbriation vs. PGA) 
depending on the presence or absence of nutrients and environmental signals. C-di-GMP 
and ppGpp levels inversely depend on the Csr system and might be used to boost the effects 
of the Csr system. In this model, CsrD is part of a feedback loop within the Csr system, which 
ensures homeostatic levels of fimbriation versus PGA expression and thus avoids stressful 
conditions. While the DGCs YdeH and YcdT have been shown to boost PGA dependent 
biofilm formation, the precise effect of the PDE YhjH and the c-di-GMP receptor YcgR on 
fimbriation remains to be elucidated. Also, it was not yet determined, whether the effects of 
ppGpp on Fimbriation are direct or indirect (e.g. via FimE) and whether CsrA directly or 
indirectly interferes with FimE activity, as indicated by the question mark. 
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9 Outlook 
In this work, the PGA dependent biofilm formation of uropathogenic E. coli was 
investigated and a novel regulatory link between the expression of type I fimbriae and the 
PGA adhesin was discovered. It shows that the mechanisms leading to PGA dependent 
biofilm formation in UPECs follow the same principles as in non-pathogenic E. coli: This 
biofilm formation requires a derepressed Csr system and gets stimulated by elevated levels 
of c-di-GMP or sub-MICs of translation inhibitors, latter of which is elicited by the ribosome 
via ppGpp signalling upon translational stress. This work shows that type I fimbriae 
negatively interfere with PGA dependent attachment on a regulatory level. Derepression of 
the Csr system enhances PGA dependent biofilm formation and simultaneously hinders type 
I fimbriae expression through the activity of the recombinase FimE. The involvement of the 
Csr system makes this regulatory link susceptible to environmental queues, which signal to 
the Csr system via the BarA/UvrY TCS and thus allow environmental adaptation of adhesin 
expression. Furthermore, this dual adhesin regulation is inversely affected by c-di-GMP and 
ppGpp, which appear to balance or modulated the expression profile of the two adhesins. 
Also, this work hypothesizes a positive feedback loop between the correct surface 
exposure of type I fimbriae and the expression thereof. It is suggested that the correct 
insertion of type I fimbriae into the membrane signals back to the cell and results in 
enhanced fimbriation, which in turn causes decreased PGA expression. It is thus argued that 
this positive feedback integrates into the dual adhesin regulation by the Csr system. Future 
experiments should address the existence of such a feedback loop and investigate the role 
of FimI in it. It should be addressed how such a feedback would affect PGA expression by 
clarifying if it is integrated into the mechanism proposed here and whether FimI, or OmpX, 
are involved. Furthermore, the precise role and function of c-di-GMP and ppGpp in the dual 
adhesin regulation should be addressed in more detail. As previously mentioned, 
growthcurves of fimH-gfp ppGpp0, fimH-gfp ΔyhjH and fimH-gfp ΔycgR, or the expression of 
a strong DGC and PDE in fimH-gfp under Csr repressed and derepressed conditions would 
be a good starting point.  
The discovered link between type I fimbriae and PGA dependent biofilm formation 
raises many questions especially regarding its importance and role in vivo. Most importantly, 
it has to be asked where, when and why the dual adhesin regulation is relevant during UTIs. 
Is the expression of type I fimbriae and PGA spatially and/or temporally separated during 
infections? If spatially separated, does it involve different organs e.g. type I fimbriae 
expression in the bladder and PGA expression in kidneys? Or does it involve different cell 
types within the urothelium, e.g. type I fimbriae for interacting with fully differentiated 
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superficial facet cells and PGA expression for survival in undifferentiated cell layers 
susceptible for reservoir formation? Maybe PGA expression is not required for UTI but 
involved for survival in the gastrointestinal tract, from which UPECs often originate. On the 
other hand temporal separation of the two surface exposed adhesins would support the 
notion that type I fimbriae are required during the acute phase of infection allowing initial 
adherence of cells to the urothelium while PGA expression, usually occurring during 
maturation of biofilms, might only get synthesised intracellularly when UPECs start to form 
IBCs and QIR. Any temporal and/or spatial separated expression of the two adhesions poses 
the question why this is needed? Is wrongful expression of any adhesion during UTIs 
detrimental for the pathogen’s fitness? Or is the dual adhesin regulation in place to safe 
energy?  
Importantly, the established model of inversed adhesin regulation is supported by the 
notion that ABU strains, which do not express type I fimbriae, usually display enhanced 
biofilm formation (16, 298, 299). The lack of expressed type I fimbriae and their excellent 
ability to cause long-term asymptomatic baceriuria raises the question of where ABU strains 
reside within the bladder to persist. With regard to the inversed adhesin expression and the 
observation that ABU strains are strong biofilms formers it could be argued that non-
fimbriated strains (including ABU stains or UTI89 ΔfimA-H) might be able to colonise an 
alternative (intra- or extracellular) niche within the bladder. Likely, this alternative niche would 
get colonised through PGA dependent biofilms and thus harbour non-fimbriated bacteria. 
This hypothesis could also explain our results obtained for UTI89 ΔfimA-H, which lack type I 
fimbriae but were shown to survive in the bladder over a period of 3 weeks at low titres. 
Interestingly, it was also shown that UPECs become non-fimbriated upon arrival into murine 
kidneys (300, 301), whose cells are reported to comprise very few mannose receptors (302). 
This argues that expression of type I fimbriae might not be favourable during pyelonephritis 
and raises the question whether PGA might be expressed in kidneys rather than bladders 
and thus contribute to pyelonephritis.  
The majority of these scenarios with spatially and/or temporally separated expression 
of type I fimbriae and PGA could be investigated through the construction of a fimH-gfp 
pgaD-gfp_uv double reporter strain in the UTI89 background. Importantly the use of this 
double reporter strain would allow the simultaneous investigation of both adhesins without 
biasing the pathogenesis of the wild type strain. After infection of mice and establishment of 
cystitis or pyelonephritis, organs of interest could be prepared for histological analysis by 
fluorescence microscopy. Analysis of the fluorescent GFP and GFP_UV signals would aid in 
localising the bacteria within the organ and directly indicate which of the two adhesins 
dominates in a particular niche or organ. Flow cytometric analysis of organ homogenates 
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could further be used to compare the fraction of a population, which expresses GFP versus 
the fraction that expresses GFP_UV and thus elucidate the abundance of both adhesins per 
organ. Finally, follow-up in-vivo experiments with different UTI89 double reporter mutants 
(e.g. ΔfimE, ΔcsrBC, ΔcsrD, ΔycgR, ΔyhjH, ΔfimA-H and ΔpgaA-D) could be performed to 
investigate and confirm the established model in vivo.  
 
Taken together the follow up experiments suggested here could reveal the importance 
of the dual adhesin regulation in vitro and in vivo. They could give detailed knowledge on the 
interlinked regulatory mechanisms as well as the expression and importance of each adhesin 
in relationship to the other one during UTI. This would take us a step closer in understanding 
how UPECs cause acute or chronic infections and may even reveal alternative targets for 
UTI therapies in the future.  
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